0001634452 abpcic:TermLoanMember abpcic:HealthcareHcitMember abpcic:SymplrSoftwareIncMember abpcic:SecondLienJuniorSecuredDebtAtTwoPointOneSixMember abpcic:UsCorporateDebtMember 2023-06-30 0001634452 abpcic:TheCenterForOrthopedicAndResearchExcellenceIncOneMember abpcic:HealthcareAndHCITMember abpcic:FirstLienSeniorSecuredDebtAt234.31Member abpcic:DelayedDrawTermLoanMember abpcic:UsCorporateDebtMember 2022-12-31 0001634452 abpcic:RepTecIntermediateHoldingsIncMember abpcic:SeniorSecuredDebtFirstLienMember us-gaap:RevolvingCreditFacilityMember 2023-01-01 2023-06-30 0001634452 abpcic:HealthcareHcitMember abpcic:FirstLienSeniorSecuredDebtAt241.16Member abpcic:UsCorporateDebtMember abpcic:TermLoanMember abpcic:AnalogicCorporationTwoMember 2023-01-01 2023-06-30 0001634452 abpcic:FatbeamLlcOneMember abpcic:DigitalInfrastructureAndServicesMember abpcic:FirstLienSeniorSecuredDebtAt234.31Member abpcic:DelayedDrawTermLoanMember abpcic:UsCorporateDebtMember 2022-01-01 2022-12-31
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM
10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBERJUNE 30, 20172023

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER:
814-01196

AB Private Credit Investors Corporation

(Exact name of registrant as specified in its charter)

Maryland
 47-5049745
81-2491356
(State of incorporation)
 

(I.R.S. Employer

Identification No.)

1345 AvenuesAvenue of the Americas

New York, NY 10105

(Address of principal executive offices)

(212)
969-1000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes   ☒    No   ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of
RegulationS-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes       No   ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.

Large accelerated filer   Accelerated filer 
Non-accelerated
filer
   (do not check if a smaller reporting company)  Smaller reporting company 

Emerging Growth Company

    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).     Yes   ☐    No   ☒

The issuer
had 2,50052,814,846.030 shares
of common stock, $0.01 par value per share, outstanding
as of November 13, 2017.August 14, 2023
.


AB PRIVATE CREDIT INVESTORS CORPORATION

FORM10-Q FOR THE QUARTER ENDED SeptemberJUNE 30, 20172023

Table of Contents

 

  

INDEX

  PAGE

NO.
 

PART I.

 FINANCIAL INFORMATION  3

Item 1.

 Consolidated Financial Statements   3
Statement of Assets and Liabilities as of September 30, 2017 (unaudited) and December 31, 20163
Statement of Operations for the three and nine months ended September 30, 2017 (unaudited)4 

Item 2.

 Management’s Discussion and Analysis of Financial Condition and Results of Operations   1159 

Item 3.

 Quantitative and Qualitative Disclosures About Market Risk   2074 

Item 4.

 Controls and Procedures   2075 

PART II.

 OTHER INFORMATION   2175 

Item 1.

 Legal Proceedings   2175 

Item 1A.

 Risk Factors   2175 

Item 2.

 Unregistered Sales of Equity Securities and Use of Proceeds   2176 

Item 3.

 Defaults Upon Senior Securities   2176 

Item 4.

 Mine Safety Disclosures   2176 

Item 5.

 Other Information   2176 

Item 6.

 Exhibits   2177 

SIGNATURES

   78


Item 1.
Financial Statements

AB Private Credit Investors Corporation

Unaudited Statement

Consolidated Statements of Assets and Liabilities

   

September 30,
2017

(unaudited)

   

December 31,

2016

 

ASSETS:

    

Cash

  $25,000   $1,000 

Expense Payment from Adviser

  $565,647   

Deferred Offering Cost

  $235,353   
  

 

 

   

 

 

 

Total Assets

  $826,000   $1,000 
  

 

 

   

 

 

 

LIABILITIES:

    

Organizational and Offering Expenses

  $703,000   

Professional Fees

  $98,000   
  

 

 

   

 

 

 

Total Liabilities

  $801,000   $0 
  

 

 

   

 

 

 

Net Assets

  $25,000   $1,000 

Composition of Net Assets:

    

Common Stock, $0.01 par value

  $25   $1 

Additional paid in capital

   24,975    999 
  

 

 

   

 

 

 
  $25,000   $1,000 
  

 

 

   

 

 

 

Shares

    

Net asset value per share
(2,500 and 100 shares of Common Stock issued and outstanding at September 30, 2017 and December 31, 2016, respectively)

  $10.00   $10.00 

   
As of

June 30, 2023
(Unaudited)
  
As of

December 31,
2022
 
Assets
 
Investments, at fair value 
Non-controlled/non-affiliated
investments (amortized cost of $1,253,961,795 and $1,146,231,264, respectively)
  $1,227,308,366  $1,122,343,258 
Non-controlled
affiliated investments (amortized cost of $10 and $0)
   —     —   
Controlled affiliated investments (amortized cost of $0 and $0)   264,486   173,837 
         
Total investments, at fair value (amortized cost of $1,253,961,805 and $1,146,231,264)   1,227,572,852   1,122,517,095 
Cash and cash equivalents   76,104,236   48,785,985 
Interest receivable   14,067,944   9,795,021 
Deferred financing costs   1,367,187   1,146,619 
Receivable for investments sold   422,829   6,428,709 
Receivable for fund shares   135,376   2,834,026 
Prepaid expenses   —     226,644 
Prepaid directors’ fee   179   —   
         
Total assets  $1,319,670,603  $1,191,734,099 
         
Liabilities
 
Notes payable (net of unamortized discount of $408,664 and $414,624, respectively, and debt issuance costs of $4,400,013 and $1,229,809, respectively)  $541,941,323  $245,105,567 
Credit facility payable   253,400,000   448,000,000 
Payable for investments purchased   11,070,115   1,990,087 
Interest and borrowing expenses payable   10,818,347   8,311,138 
Distribution payable   4,849,521   8,909,055 
Payable for fund shares repurchased   4,225,901   6,304,249 
Management fees payable   4,204,038   3,778,123 
Incentive fee payable   2,600,473   2,534,935 
Payable to Adviser   1,114,370   1,347,210 
Administrator and custodian fees payable   670,668   725,470 
Professional fees payable   358,284   594,355 
Accrued tax liability   320,348   1,303,918 
Accrued expenses and other liabilities   232,846   —   
Directors’ fees payable   45,329   —   
Transfer agent fees payable   36,214   34,224 
Secured borrowings   —     5,917,275 
         
Total liabilities  $835,887,777  $734,855,606 
         
Commitments and Contingencies (Note 6)
 
Net Assets
 
Common stock, par value $0.01 per share (200,000,000 shares authorized, 52,816,794 and 50,228,088 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively)   528,168   502,281 
Paid-in
capital in excess of par value
   509,937,301   485,940,938 
Distributable earnings (accumulated loss)   (26,718,668  (29,599,112
         
Total net assets of AB Private Credit Investors Corporation  $483,746,801  $456,844,107 
         
Non-Controlling
Interest in ABPCIC Equity Holdings, LLC
  $36,025  $34,386 
         
Total net assets  $483,782,826  $456,878,493 
         
Total liabilities and net assets  $1,319,670,603  $1,191,734,099 
         
Net asset value per share of AB Private Credit Investors Corporation  $9.16  $9.10 
         
See accompanying notesNotes to financial statements.

Unaudited Consolidated Financial Statements

3

AB Private Credit Investors Corporation

Unaudited StatementConsolidated Statements of Operations

   Three Months
Ended
September 30, 2017
  Nine Months
Ended
September 30, 2017
 

Investment income

   

Total Investment Income

  $0  $0 

Operating expenses

   

Organizational and Offering Expenses

   467,647   467,647 

Directors’ Fees

   149,000   149,000 

Professional Fees

   385,500   385,500 

Total Operating Expenses

   1,002,147   1,002,147 
  

 

 

  

 

 

 

Expense Payment

   (1,002,147  (1,002,147
  

 

 

  

 

 

 

Net Income

  $0  $0 
  

 

 

  

 

 

 

   
For the three months ended

June 30,
  
For the six months ended

June 30,
 
   
2023
  
2022
  
2023
  
2022
 
Investment Income:
 
From
non-controlled/non-affiliated
investments:
 
Interest income, net of amortization/accretion  $35,269,067  $19,249,271  $67,028,005  $38,268,334 
Payment-in-kind
interest
   662,830   605,426   1,696,231   1,199,825 
Dividend income   355,306   17,027   407,758   25,614 
From controlled affiliated investments:
 
Interest income, net of amortization/accretion   —     64,846   —     130,234 
                 
Total investment income   36,287,203   19,936,570   69,131,994   39,624,007 
                 
Expenses:
 
Interest and borrowing expenses   17,260,122   7,046,218   31,041,782   12,187,003 
Management fees   4,204,038   3,391,227   8,142,942   6,794,019 
Income-based incentive fee   2,600,473   951,206   5,355,077   2,883,145 
Professional fees   681,896   339,678   1,197,209   816,658 
Administration and custodian fees   294,109   245,103   558,564   468,340 
Insurance expenses   135,986   155,509   271,972   308,748 
Directors’ fees   69,875   50,000   139,750   100,000 
Transfer agent fees   36,215   29,841   71,487   55,517 
Collateral management fees   —     131,978   —     588,476 
Capital gains incentive fee   —        (237,304  —     (784,037
Other expenses   368,384   331,513   677,959   631,138 
                 
Total expenses   25,651,098   12,434,969   47,456,742   24,049,007 
Reimbursement payments to Adviser (See Note 3: Expense Support and Conditional Reimbursement Agreement)   —     —     —     259,263 
Waived collateral management fees   —     (131,978  —     (588,476
Waived management fees   —     —     —     (283,566
                 
Net expenses   25,651,098   12,302,991   47,456,742   23,436,228 
                 
Net investment income before taxes   10,636,105   7,633,579   21,675,252   16,187,779 
                 
Income tax expense, including excise tax   260,725   258,256   278,026   567,083 
                 
Net investment income after tax   10,375,380   7,375,323   21,397,226   15,620,696 
                 
Net realized and change in unrealized gains (losses) on investment transactions:
 
Net realized gain (loss) from: 
Non-controlled/non-affiliated
investments
   (303,851  644,621   (298,398  816,953 
Net change in unrealized appreciation (depreciation) from: 
Non-controlled/non-affiliated
investments
   (7,287,835  (2,462,862  (2,765,423  (6,589,612
Non-controlled
affiliated investments
   (10  —     (10  —   
Controlled affiliated investments   90,649   631,721   90,649   1,852,476 
                 
Net realized and change in unrealized gains (losses) on investment transactions   (7,501,047  (1,186,520  (2,973,182  (3,920,183
                 
Net increase in net assets resulting from operations  $2,874,333  $6,188,803  $18,424,044  $11,700,513 
                 
Less: Net increase (decrease) in net assets resulting from operations related to
Non-Controlling
Interest in ABPCIC Equity Holdings, LLC
  $516  $4,545  $1,639  $4,555 
                 
Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation  $2,873,817  $6,184,258  $18,422,405  $11,695,958 
                 
Net investment income per share (basic and diluted):
 
Net investment income per share (basic and diluted):  $0.20  $0.18  $0.42  $0.40 
Earnings per share (basic and diluted):  $0.06  $0.15  $0.36  $0.30 
Weighted average shares outstanding:   51,975,095   41,885,326   51,104,578   39,180,515 
See Notes to Unaudited Consolidated Financial Statements

4
AB Private Credit Investors Corporation
Unaudited Consolidated Statements of Changes in Net Assets
   
Common Stock
             
   
Shares
  
Par Amount
  
Paid in Capital
in

Excess of Par
  
Distributable

Earnings
  
Non-Controlling

Interest -

ABPCIC

Equity

Holdings, LLC
  
Total

Net Assets
 
Net assets at March 31, 2023
   49,895,174  $498,952  $482,847,144  $(19,190,141 $35,509  $464,191,464 
Increase (decrease) in net assets resulting from operations:
 
Net investment income   —     —     —     10,375,562   (182  10,375,380 
Net realized gain (loss) on investments   —     —     —     (303,851  —     (303,851
Net change in unrealized appreciation (depreciation) on investments   —     —     —     (7,197,894  698   (7,197,196
Capital transactions:
 
Issuance of common stock   2,776,754   27,768   25,764,683   —     —     25,792,451 
Issuance of common shares pursuant to distribution reinvestment plan   606,230   6,062   5,546,761   —     —     5,552,823 
Repurchase of common stock   (461,364  (4,614  (4,221,287  —     —     (4,225,901
Distributions to stockholders   —     —     —     (10,402,344  —     (10,402,344
                         
Total increase (decrease) for the three months ended June 30, 2023   2,921,620   29,216   27,090,157   (7,528,527  516   19,591,362 
                         
Net assets at June 30, 2023
   52,816,794  $528,168  $509,937,301  $(26,718,668 $36,025  $483,782,826 
                         
Distributions declared per share
   —    $—    $—    $0.20  $—    $0.20 
                         
Net assets at December 31, 2022
   50,228,088  $502,281  $485,940,938  $(29,599,112 $34,386  $456,878,493 
Increase (decrease) in net assets resulting from operations:
 
Net investment income   —     —     —     21,398,031   (805  21,397,226 
Net realized gain (loss) on investments   —     —     —     (298,398  —     (298,398
Net change in unrealized appreciation (depreciation) on investments   —     —     —     (2,677,228  2,444   (2,674,784
Capital transactions:
 
Issuance of common stock   2,776,754   27,768   25,764,683   —     —     25,792,451 
Issuance of common shares pursuant to distribution reinvestment plan   900,834   9,008   8,284,685   —     —     8,293,693 
Repurchase of common stock   (1,088,882  (10,889  (10,053,005  —     —     (10,063,894
Distributions to stockholders   —     —     —     (15,541,961  —     (15,541,961
                         
Total increase (decrease) for the six months ended June 30, 2023   2,588,706   25,887   23,996,363   2,880,444   1,639   26,904,333 
                         
Net assets at June 30, 2023
   52,816,794  $528,168  $509,937,301  $(26,718,668 $36,025  $483,782,826 
                         
Distributions declared per share
   —    $—    $—    $0.30  $—    $0.30 
                         
See Notes to Unaudited Consolidated Financial Statements
5

AB Private Credit Investors Corporation
Unaudited Consolidated Statements of Changes in Net Assets
   
Common Stock
             
   
Shares
  
Par Amount
  
Paid in Capital
in

Excess of Par
  
Distributable

Earnings
  
Non-Controlling

Interest -

ABPCIC

Equity

Holdings, LLC
  
Total

Net Assets
 
Net assets at March 31, 2022
   38,544,494  $385,445  $370,964,346  $2,416,317  $24,762  $373,790,870 
Increase (decrease) in net assets resulting from operations:
 
Net investment income   —     —     —     7,375,517   (194  7,375,323 
Net realized gain (loss) on investments   —     —     —     644,621   —     644,621 
Net change in unrealized appreciation (depreciation) on investments   —     —     —     (1,835,880  4,739   (1,831,141
Capital transactions:
 
Issuance of common stock   5,759,395   57,594   56,205,634   —     —     56,263,228 
Contribution of
non-controlling
interest into ABPCIC Equity Holdings, LLC
   —     —     —     —     1,345   1,345 
Issuance of common shares pursuant to distribution reinvestment plan   360,978   3,609   3,497,119   —     —     3,500,728 
Repurchase of common stock   (617,738  (6,177  (5,984,588  —     —     (5,990,765
Distributions to stockholders   —     —     —     (6,590,492  —     (6,590,492
                         
Total increase (decrease) for the three months ended June 30, 2022   5,502,635   55,026   53,718,165   (406,234  5,890   53,372,847 
                         
Net assets at June 30, 2022
   44,047,129  $440,471  $424,682,511  $2,010,083  $30,652  $427,163,717 
                         
Distributions declared per share
   —    $—    $—    $0.15  $—    $0.15 
                         
Net assets at December 31, 2021
   35,343,949  $353,440  $339,292,017  $6,614,462  $16,761  $346,276,680 
Increase (decrease) in net assets resulting from operations:
 
Net investment income   —     —     —     15,621,084   (388  15,620,696 
Net realized gain (loss) on investments   —     —     —     816,953   —     816,953 
Net change in unrealized appreciation (depreciation) on investments   —     —     —     (4,742,079  4,943   (4,737,136
Capital transactions:
 
Issuance of common stock   8,854,641   88,546   86,858,682   —     —     86,947,228 
Contribution of
non-controlling
interest into ABPCIC Equity Holdings, LLC
   —     —     —     —     9,336   9,336 
Issuance of common shares pursuant to distribution reinvestment plan   887,141   8,871   8,593,561   —     —     8,602,432 
Repurchase of common stock   (1,038,602  (10,386  (10,061,749  —     —     (10,072,135
Distributions to stockholders   —     —     —     (16,300,337  —     (16,300,337
                         
Total increase (decrease) for the six months ended June 30, 2022   8,703,180   87,031   85,390,494   (4,604,379  13,891   80,887,037 
                         
Net assets at June 30, 2022
   44,047,129  $440,471  $424,682,511  $2,010,083  $30,652  $427,163,717 
                         
Distributions declared per share
   —    $—    $—    $0.40  $—    $0.40 
                         
See Notes to Unaudited Consolidated Financial Statements
6
AB Private Credit Investors Corporation
Unaudited Consolidated Statements of Cash Flows
   
Six Months Ended

June 30, 2023
  
Six Months Ended

June 30, 2022
 
Cash flows from operating activities
 
Net increase (decrease) in net assets resulting from operations  $18,424,044  $11,700,513 
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash
provided by (used for) operating activities:
 
Purchases of investments   (151,475,757  (235,107,930
Payment-in-kind
investments
   (1,696,231  (1,199,825
Proceeds from sales of investments and principal repayments   48,240,929   98,587,876 
Net realized (gain) loss on investments   298,398   (816,953
Net change in unrealized (appreciation) depreciation on investments   2,674,784   4,737,136 
Amortization of premium and accretion of discount, net   (3,097,880  (3,309,963
Amortization of discount, debt issuance and deferred financing costs   2,135,003   2,706,070 
Increase (decrease) in operating assets and liabilities:
 
(Increase) decrease in receivable for investments sold   6,005,880   508,158 
(Increase) decrease in interest receivable   (4,272,923  (4,475,685
(Increase) decrease in prepaid directors’ fee   (179  25,869 
(Increase) decrease in prepaid expenses   226,644   256,534 
Increase (decrease) in payable for investments purchased   9,080,028   (9,637,245
Increase (decrease) in management fees payable   425,915   738,175 
Increase (decrease) in payable to Adviser   (232,840  (1,018,719
Increase (decrease) in administrator and custodian fees payable   (54,802  308,177 
Increase (decrease) in professional fees payable   (236,071  9,391 
Increase (decrease) in accrued tax liability   (983,570  494,625 
Increase (decrease) in incentive fee payable   65,538   721,820 
Increase (decrease) in directors’ fees payable   45,329   —   
Increase (decrease) in transfer agent fees payable   1,990   6,822 
Increase (decrease) in interest and borrowing expenses payable   2,507,209   1,354,170 
Increase (decrease) in accrued expenses and other liabilities   232,846   105,169 
         
Net cash provided by (used for) operating activities   (71,685,716  (133,305,815
         
Cash flows from financing activities
 
Issuance of common stock   28,491,101   106,736,240 
Contribution of
Non-Controlling
Interest into ABPCIC Equity Holdings, LLC
   —     9,336 
Repurchase of common stock   (12,142,242  (8,817,509
Distributions paid   (11,307,802  (6,949,041
Financing costs paid   (5,519,815  (2,041,238
Borrowings on notes   300,000,000   246,321,363 
Repayments of notes   —     (213,150,000
Borrowings on credit facility   214,400,000   121,500,000 
Repayments of credit facility   (409,000,000  (100,000,000
Proceeds on secured borrowings   8,889,878   6,092,153 
Repayments on secured borrowings   (14,807,153  (10,228,115
         
Net cash provided by (used for) financing activities   99,003,967   139,473,189 
         
Net increase (decrease) in cash   27,318,251   6,167,374 
Cash and cash equivalents, beginning of period   48,785,985   54,489,043 
         
Cash and cash equivalents, end of period
  $76,104,236  $60,656,417 
         
Supplemental and
non-cash
financing activities
 
Cash paid during the period for interest  $25,856,860  $7,866,430 
Issuance of common shares pursuant to distribution reinvestment plan  $8,293,693  $8,602,432 
State taxes paid  $1,261,596  $72,459 
See Notes to Unaudited Consolidated Financial Statements
7

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Investments at Fair Value (++) + * # ^ - 253.74%
 
U.S. Corporate Debt
- 243.32%
 
1st Lien/Senior Secured Debt
- 241.16%
 
AmerCareRoyal, LLC
(1)
 Business Services Delayed Draw Term Loan 11.73% (S + 6.50%; 0.50% PIK; 1.00% Floor) 11/25/2025 $495,514  $488,405  $491,797 
AmerCareRoyal, LLC
(1) (2)
 Business Services Term Loan 11.73% (S + 6.50%; 0.50% PIK; 1.00% Floor) 11/25/2025  4,106,194   4,007,147   4,075,398 
AmerCareRoyal, LLC
(2) (3)
 Business Services Term Loan 11.73% (S + 6.50%; 0.50% PIK; 1.00% Floor) 11/25/2025  509,992   498,542   506,167 
AmerCareRoyal, LLC
(1) (4)
 Business Services Term Loan 11.79% (S + 6.50%; 0.50% PIK; 1.00% Floor) 11/25/2025  1,995,122   1,973,605   1,980,159 
Cerifi, LLC
(5)
 Business Services Revolver 10.96% (S + 5.75%; 1.00% Floor) 04/01/2027  369,264   351,908   349,877 
Cerifi, LLC
(2) (3) (4)
 Business Services Term Loan 11.00% (S + 5.75%; 1.00% Floor) 03/31/2028  15,985,824   15,721,199   15,706,072 
Engage2Excel, Inc. Business Services Revolver 12.69% (S + 7.25%; 1.00% Floor) 02/15/2024  379,732   375,634   374,036 
Engage2Excel, Inc.
(1)
 Business Services Term Loan 12.21% (S + 7.25%; 1.00% Floor) 12/31/2023  1,029,478   1,021,776   1,014,036 
Engage2Excel, Inc.
(1)
 Business Services Term Loan 12.21% (S + 7.25%; 1.00% Floor) 02/15/2024  2,966,257   2,944,303   2,921,763 
Metametrics, Inc.
(5) (6)
 Business Services Revolver 10.32% (S + 5.00%; 1.00% Floor) 09/10/2025  —     (4,835  —   
Metametrics, Inc.
(1) (2)
 Business Services Term Loan 10.34% (S + 5.00%; 1.00% Floor) 09/10/2025  4,470,586   4,433,537   4,470,586 
Mr. Greens Intermediate, LLC
(5) (6)
 Business Services Delayed Draw Term Loan 11.51% (S + 6.25%; 1.00% Floor) 05/01/2029  —     (78,905  (78,905
Mr. Greens Intermediate, LLC
(5) (6)
 Business Services Revolver 11.51% (S + 6.25%; 1.00% Floor) 05/01/2029  —     (30,726  (31,562
Mr. Greens Intermediate, LLC
(2) (3)
 Business Services Term Loan 11.51% (S + 6.25%; 1.00% Floor) 05/01/2029  6,312,406   6,124,885   6,123,034 
MSM Acquisitions, Inc. Business Services Delayed Draw Term Loan 11.26% (S + 6.00%; 1.00% Floor) 12/09/2026  366,391   365,065   349,903 
MSM Acquisitions, Inc.
(2)
 Business Services Delayed Draw Term Loan 11.26% (S + 6.00%; 1.00% Floor) 12/09/2026  2,989,830   2,951,116   2,855,288 
MSM Acquisitions, Inc.
(5)
 Business Services Revolver 11.26% (S + 6.00%; 1.00% Floor) 12/09/2026  998,412   984,125   943,285 
MSM Acquisitions, Inc.
(1) (2) (4)
 Business Services Term Loan 11.26% (S + 6.00%; 1.00% Floor) 12/09/2026  8,170,552   8,080,085   7,802,877 
Rep Tec Intermediate Holdings, Inc.
(5)
 Business Services Revolver 11.74% (S + 6.50%; 1.00% Floor) 12/01/2027  381,472   374,023   361,741 
Rep Tec Intermediate Holdings, Inc.
(1) (2) (4)
 Business Services Term Loan 11.89% (S + 6.50%; 1.00% Floor) 12/01/2027  14,495,043   14,350,879   14,132,667 
Sako and Partners Lower Holdings
LLC
(2) (5)
 Business Services Delayed Draw Term Loan 11.39% (S + 6.00%; 1.00% Floor) 09/15/2028  1,908,086   1,850,458   1,863,815 
Sako and Partners Lower Holdings
LLC
(5) (6)
 Business Services Revolver 11.39% (S + 6.00%; 1.00% Floor) 09/15/2028  —     (32,547  (24,859
Sako and Partners Lower Holdings
LLC
(1) (2) (3) (4)
 Business Services Term Loan 11.39% (S + 6.00%; 1.00% Floor) 09/15/2028  14,840,671   14,451,512   14,543,857 
Valcourt Holdings II, LLC
(1) (3)
 Business Services Delayed Draw Term Loan 10.64% (S + 5.25%; 1.00% Floor) 01/07/2027  1,704,190   1,685,774   1,704,190 
Valcourt Holdings II, LLC
(2)
 Business Services Term Loan 10.64% (S + 5.25%; 1.00% Floor) 01/07/2027  2,627,722   2,594,707   2,627,722 
Valcourt Holdings II, LLC
(1) (2)
 Business Services Term Loan 10.64% (S + 5.25%; 1.00% Floor) 01/07/2027  6,247,059   6,170,351   6,247,059 
Valcourt Holdings II, LLC
(2)
 Business Services Term Loan 10.64% (S + 5.25%; 1.00% Floor) 01/07/2027  1,149,408   1,132,314   1,149,408 
AEG Holding Company, Inc.
(1)
 Consumer
Non-Cyclical
 Delayed Draw Term Loan 10.98% (S + 5.50%; 1.00% Floor) 07/01/2024  1,040,284   1,038,730   1,037,683 
AEG Holding Company, Inc. Consumer
Non-Cyclical
 Revolver 10.98% (S + 5.50%; 1.00% Floor) 07/01/2024  1,116,864   1,115,080   1,114,072 
AEG Holding Company, Inc.
(4)
 Consumer
Non-Cyclical
 Term Loan 10.98% (S + 5.50%; 1.00% Floor) 07/01/2024  1,810,256   1,806,885   1,805,731 
AEG Holding Company, Inc.
(1)
 Consumer
Non-Cyclical
 Term Loan 10.98% (S + 5.50%; 1.00% Floor) 07/01/2024  5,481,809   5,473,317   5,468,105 
Ampler QSR Holdings, LLC
(2) (3) (4)
 Consumer
Non-Cyclical
 Term Loan 11.41% (L + 5.875%; 1.00% Floor) 07/21/2027  12,284,286   12,126,286   11,854,336 
Blink Holdings, Inc. Consumer
Non-Cyclical
 Delayed Draw Term Loan 13.89% (L + 5.50%; 3.00% PIK; 1.00% Floor) 11/08/2024  898,933   895,774   786,566 
Blink Holdings, Inc.
(1)
 Consumer
Non-Cyclical
 Delayed Draw Term Loan 13.89% (L + 5.50%; 3.00% PIK; 1.00% Floor) 11/08/2024  1,121,039   1,117,716   980,909 
Blink Holdings, Inc.
(1)
 Consumer
Non-Cyclical
 Term Loan 13.89% (L + 5.50%; 3.00% PIK; 1.00% Floor) 11/08/2024  1,566,998   1,562,325   1,371,123 
Krispy Krunchy Foods, L.L.C
(2)
 Consumer
Non-Cyclical
 Term Loan 9.70% (S + 4.50%; 1.00% Floor) 11/17/2027  8,365,062   8,241,281   8,239,586 
Mathnasium LLC
(5)
 Consumer
Non-Cyclical
 Revolver 10.24% (S + 5.00%; 0.75% Floor) 11/15/2027  87,043   77,426   75,619 
Mathnasium LLC
(1) (2)
 Consumer
Non-Cyclical
 Term Loan 10.24% (S + 5.00%; 0.75% Floor) 11/15/2027  5,372,200   5,293,404   5,278,186 
MMP Intermediate, LLC
(5) (6)
 Consumer
Non-Cyclical
 Revolver 10.97% (S + 5.75%; 1.00% Floor) 02/15/2027  —     (8,101  (15,204
MMP Intermediate, LLC
(1) (2)
 Consumer
Non-Cyclical
 Term Loan 10.97% (S + 5.75%; 1.00% Floor) 02/15/2027  7,986,902   7,865,304   7,767,262 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 10.08% (S + 5.00%; 1.00% Floor) 07/11/2025  116,539   114,227   113,625 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 10.10% (S + 5.00%; 1.00% Floor) 07/11/2025  235,479   230,809   229,592 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 10.23% (S + 5.00%; 1.00% Floor) 07/11/2025  1,960,726   1,953,162   1,911,708 
TBG Food Acquisition Corp
(5) (6)
 Consumer
Non-Cyclical
 Delayed Draw Term Loan 10.72% (S + 5.50%; 0.75% Floor) 12/25/2027  —     (7,961  (60,726
TBG Food Acquisition Corp
(5) (6)
 Consumer
Non-Cyclical
 Revolver 10.72% (S + 6.00%; 0.75% Floor) 12/25/2027  —     (1,990  (15,182
TBG Food Acquisition Corp
(1) (3)
 Consumer
Non-Cyclical
 Term Loan 10.72% (S + 5.50%; 0.75% Floor) 12/25/2027  6,501,641   6,463,852   6,127,797 
Airwavz Solutions, Inc.
(5) (6)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.89% (S + 5.50%; 1.00% Floor) 03/31/2027  —     (51,257  (52,061
See Notes to Unaudited Consolidated Financial Statements
8
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Airwavz Solutions, Inc.
(4) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.89% (S + 5.50%; 1.00% Floor) 03/31/2027 $2,610,959  $2,570,183  $2,553,845 
Airwavz Solutions, Inc.
(5) (6)
 Digital Infrastructure & Services Revolver 10.89% (S + 5.50%; 1.00% Floor) 03/31/2027  —     (8,636  (13,055
Airwavz Solutions, Inc.
(4)
 Digital Infrastructure & Services Term Loan 10.89% (S + 5.50%; 1.00% Floor) 03/31/2027  5,221,919   5,152,835   5,117,480 
Avant Communications, LLC
(5) (6)
 Digital Infrastructure & Services Revolver 11.14% (S + 5.75%; 1.00% Floor) 11/30/2026  —     (7,830  (9,921
Avant Communications, LLC
(1) (2) (3)
 Digital Infrastructure & Services Term Loan 11.14% (S + 5.75%; 1.00% Floor) 11/30/2026  15,040,002   14,801,432   14,776,802 
Bridgepointe Technologies, LLC
(4)
 Digital Infrastructure & Services Delayed Draw Term Loan 11.89% (S + 6.50%; 1.00% Floor) 12/31/2027  2,751,747   2,731,851   2,689,833 
Bridgepointe Technologies, LLC
(1) (2)
 Digital Infrastructure & Services Delayed Draw Term Loan 11.89% (S + 6.50%; 1.00% Floor) 12/31/2027  3,868,035   3,824,399   3,781,004 
Bridgepointe Technologies, LLC
(1) (2) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 11.74% (S + 6.50%; 1.00% Floor) 12/31/2027  3,544,961   3,439,229   3,445,446 
Bridgepointe Technologies, LLC
(5)
 Digital Infrastructure & Services Revolver 11.89% (S + 6.50%; 1.00% Floor) 12/31/2027  116,624   104,895   99,131 
Bridgepointe Technologies, LLC
(1) (2)
 Digital Infrastructure & Services Term Loan 11.89% (S + 6.50%; 1.00% Floor) 12/31/2027  4,729,498   4,654,991   4,623,085 
Bridgepointe Technologies, LLC
(1) (2)
 Digital Infrastructure & Services Term Loan 11.89% (S + 6.50%; 1.00% Floor) 12/31/2027  2,282,779   2,203,011   2,231,416 
Coretelligent Intermediate LLC
(2) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.84% (L + 5.50%; 1.00% Floor) 10/21/2027  1,909,275   1,887,267   1,824,225 
Coretelligent Intermediate LLC
(5)
 Digital Infrastructure & Services Revolver 12.75% (P + 4.50%; 1.00% Floor) 10/21/2027  63,321   49,545   31,661 
Coretelligent Intermediate LLC
(1) (2) (4)
 Digital Infrastructure & Services Term Loan 10.84% (L + 5.50%; 1.00% Floor) 10/21/2027  7,908,673   7,822,643   7,710,956 
EvolveIP, LLC
(2)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.70% (S + 5.50%; 1.00% Floor) 06/07/2025  110,539   110,912   105,841 
EvolveIP, LLC
(5) (7)
 Digital Infrastructure & Services Revolver 10.72% (S + 5.50%; 1.00% Floor) 06/07/2025  472,390   469,348   448,298 
EvolveIP, LLC
(1)
 Digital Infrastructure & Services Term Loan 10.70% (S + 5.50%; 1.00% Floor) 06/07/2025  6,401,056   6,366,683   6,129,011 
Firstdigital Communications LLC
(5)
 Digital Infrastructure & Services Revolver 9.50% (L + 4.25%; 0.75% Floor) 12/17/2026  412,549   390,341   349,080 
Firstdigital Communications LLC
(2) (4)
 Digital Infrastructure & Services Term Loan 9.50% (L + 4.25%; 0.75% Floor) 12/17/2026  13,645,840   13,454,853   13,100,007 
FirstLight Holdco, Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 9.50% (S + 4.00%; 1.00% Floor) 07/23/2025  6,133,231   6,014,894   5,918,568 
Greenlight Intermediate II, Inc.
(2) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.74% (S + 5.50%; 0.75% Floor) 06/01/2028  2,365,441   2,284,697   2,365,441 
Greenlight Intermediate II, Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 10.91% (S + 5.50%; 0.75% Floor) 06/01/2028  5,331,605   5,239,242   5,291,618 
MBS Holdings, Inc.
(5)
 Digital Infrastructure & Services Revolver 10.93% (S + 5.75%; 1.00% Floor) 04/16/2027  155,867   143,372   121,771 
MBS Holdings, Inc.
(1) (2) (3) (4)
 Digital Infrastructure & Services Term Loan 10.95% (S + 5.75%; 1.00% Floor) 04/16/2027  10,310,607   10,185,083   9,949,736 
MSP Global Holdings, Inc.
(4) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027  611,697   592,719   584,611 
MSP Global Holdings, Inc.
(5) (6)
 Digital Infrastructure & Services Revolver 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027  —     (10,653  (19,033
MSP Global Holdings, Inc.
(2) (4)
 Digital Infrastructure & Services Term Loan 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027  7,831,454   7,729,314   7,655,246 
NI Topco, Inc
(2) (4)
 Digital Infrastructure & Services Term Loan 11.09% (S + 5.75%; 0.75% Floor) 12/28/2028  6,605,918   6,483,624   6,539,859 
NI Topco, Inc
(1)
 Digital Infrastructure & Services Term Loan 11.09% (S + 5.75%; 0.75% Floor) 12/28/2028  1,224,370   1,200,843   1,212,126 
Race Finco LLC
(5) (6)
 Digital Infrastructure & Services Delayed Draw Term Loan 12.07% (S + 7.00%; 1.00% Floor) 01/10/2028  —     (49,789  (45,735
Race Finco LLC
(5) (6)
 Digital Infrastructure & Services Revolver 12.07% (S + 7.00%; 1.00% Floor) 01/10/2028  —     (16,609  (16,769
Race Finco LLC
(2) (4)
 Digital Infrastructure & Services Term Loan 12.07% (S + 7.00%; 1.00% Floor) 01/10/2028  4,878,384   4,745,517   4,744,229 
Single Digits, Inc.
(3)
 Digital Infrastructure & Services Delayed Draw Term Loan 9.75% (S + 4.25%; 3.25% PIK; 1.00% Floor) 06/19/2026  606,963   608,532   531,093 
Single Digits, Inc.
(5) (6)
 Digital Infrastructure & Services Revolver 9.75% (S + 4.25%; 3.25% PIK; 1.00% Floor) 06/19/2026  —     (400  (52,019
Single Digits, Inc.
(1)
 Digital Infrastructure & Services Term Loan 9.75% (S + 4.25%; 3.25% PIK; 1.00% Floor) 06/19/2026  2,841,114   2,833,741   2,485,975 
Stratus Networks, Inc.
(2) (4) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.45% (S + 5.25%; 1.00% Floor) 12/15/2027  1,518,150   1,477,033   1,488,447 
Stratus Networks, Inc.
(5)
 Digital Infrastructure & Services Revolver 10.45% (S + 5.25%; 1.00% Floor) 12/15/2027  792,078   777,220   774,751 
See Notes to Unaudited Consolidated Financial Statements
9

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Stratus Networks, Inc.
(2)
    
 Digital Infrastructure & Services Term Loan 10.45% (S + 5.25%; 1.00% Floor) 12/15/2027 $7,920,781  $7,797,393  $7,782,168 
Thrive Buyer, Inc.
(1) (2)
 Digital Infrastructure & Services Delayed Draw Term Loan 11.39% (S + 6.00%; 1.00% Floor) 01/22/2027  8,215,882   8,106,444   8,154,263 
Thrive Buyer, Inc.
(5)
 Digital Infrastructure & Services Revolver 13.25% (P + 5.00%; 2.00% Floor) 01/22/2027  369,907   355,819   361,585 
Thrive Buyer, Inc.
(3)
 Digital Infrastructure & Services Term Loan 11.89% (S + 6.50%; 1.00% Floor) 01/22/2027  1,204,373   1,168,242   1,204,373 
Thrive Buyer, Inc.
(1) (2) (4)
 Digital Infrastructure & Services Term Loan 11.39% (S + 6.00%; 1.00% Floor) 01/22/2027  11,705,630   11,560,629   11,617,837 
Towerco IV Holdings, LLC
(1) (2) (3) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 9.22% (S + 4.00%; 1.00% Floor) 04/23/2026  19,360,162   19,190,410   19,042,538 
Transtelco Holding, Inc
(1) (4)
 Digital Infrastructure & Services Term Loan 10.74% (S + 5.50%; 1.00% Floor) 03/26/2026  8,503,727   8,308,868   8,312,393 
Transtelco Holding, Inc.
(1) (2) (4)
 Digital Infrastructure & Services Term Loan 10.99% (S + 5.75%; 0.50% Floor) 03/26/2026  4,661,043   4,640,088   4,626,085 
Transtelco Holding, Inc.
(2)
 Digital Infrastructure & Services Term Loan 10.49% (S + 5.25%; 0.50% Floor) 03/26/2026  4,661,043   4,639,354   4,579,475 
Accelerate Resources Operating, LLC
(5) (6)
 Energy Revolver 10.70% (S + 5.50%; 1.00% Floor) 02/24/2027  —     (3,745  —   
Accelerate Resources Operating, LLC
(1)
 Energy Term Loan 10.70% (S + 5.50%; 1.00% Floor) 02/24/2027  3,505,062   3,473,500   3,505,062 
Foundation Risk Partners, Corp.
(4)
 Financials Delayed Draw Term Loan 11.59% (S + 6.25%; 0.75% Floor) 10/29/2028  2,111,433   2,098,755   2,042,811 
Foundation Risk Partners, Corp.
(4) (5)
 Financials Delayed Draw Term Loan 11.59% (S + 6.25%; 0.75% Floor) 10/30/2028  1,879,978   1,846,889   1,785,218 
Foundation Risk Partners, Corp.
(5) (6)
 Financials Revolver 11.59% (S + 6.25%; 0.75% Floor) 10/29/2027  —     (9,320  (33,737
Foundation Risk Partners, Corp.
(1) (2) (4)
 Financials Term Loan 11.59% (S + 6.25%; 0.75% Floor) 10/29/2028  9,708,172   9,616,226   9,392,657 
Foundation Risk Partners, Corp.
(2)
 Financials Term Loan 11.59% (S + 6.25%; 0.75% Floor) 10/30/2028  783,324   773,684   757,866 
Galway Borrower, LLC
(5) (6)
 Financials Delayed Draw Term Loan 10.59% (S + 5.25%; 0.75% Floor) 09/29/2028  —     (297  (980
Galway Borrower, LLC
(5) (6)
 Financials Revolver 10.59% (S + 5.25%; 0.75% Floor) 09/30/2027  —     (3,874  (9,464
Galway Borrower, LLC
(1) (2)
 Financials Term Loan 10.59% (S + 5.25%; 0.75% Floor) 09/29/2028  4,229,498   4,179,246   4,081,465 
Higginbotham Insurance Agency, Inc.
(1) (2)
 Financials Delayed Draw Term Loan 10.45% (S + 5.25%; 1.00% Floor) 11/25/2026  3,323,432   3,302,907   3,290,197 
Higginbotham Insurance Agency,
Inc.
(1) (2) (4)
 Financials Term Loan 10.45% (S + 5.25%; 1.00% Floor) 11/25/2026  8,002,652   7,932,186   7,922,625 
Peter C. Foy & Associates Insurance Services, LLC
(1) (4)
 Financials Delayed Draw Term Loan 11.22% (S + 6.00%; 0.75% Floor) 11/01/2028  5,899,654   5,853,508   5,693,166 
Peter C. Foy & Associates Insurance Services, LLC
(4)
 Financials Delayed Draw Term Loan 11.22% (S + 6.00%; 0.75% Floor) 11/01/2028  1,250,536   1,234,225   1,206,768 
Peter C. Foy & Associates Insurance Services, LLC
(1)
 Financials Term Loan 11.22% (S + 6.00%; 0.75% Floor) 11/01/2028  499,743   493,434   482,252 
RSC Acquisition, Inc.
(5)
 Financials Delayed Draw Term Loan 10.89% (S + 5.50%; 0.75% Floor) 10/30/2026  983,811   971,131   942,059 
RSC Acquisition, Inc.
(2)
 Financials Delayed Draw Term Loan 10.91% (S + 5.50%; 0.75% Floor) 10/30/2026  5,370,453   5,360,438   5,236,191 
Wealth Enhancement Group, LLC
(1) (2) (3)
 Financials Delayed Draw Term Loan 11.28% (S + 6.25%; 1.00% Floor) 10/04/2027  6,262,979   6,252,854   6,169,035 
Wealth Enhancement Group, LLC
(5)
 Financials Delayed Draw Term Loan 10.56% (S + 6.25%; 1.00% Floor) 10/04/2027  962,300   958,806   945,287 
Wealth Enhancement Group, LLC
(5) (6)
 Financials Revolver 11.28% (S + 6.25%; 1.00% Floor) 10/04/2027  —     (1,303  (6,861
AAH Topco, LLC
(1) (2) (3) (4) (5)
 Healthcare & HCIT Delayed Draw Term Loan 10.69% (S + 5.50%; 0.75% Floor) 12/22/2027  5,912,559   5,771,403   5,572,308 
AAH Topco, LLC
(5) (6)
 Healthcare & HCIT Revolver 10.70% (S + 5.50%; 0.75% Floor) 12/22/2027  —     (11,864  (39,364
AAH Topco, LLC
(1) (2) (4)
 Healthcare & HCIT Term Loan 10.70% (S + 5.50%; 0.75% Floor) 12/22/2027  6,452,627   6,348,285   6,129,995 
American Physician Partners, LLC
(1) (2) (8)
 Healthcare & HCIT Delayed Draw Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  1,126,889   1,084,517   3,279 
American Physician Partners, LLC
(8)
 Healthcare & HCIT Delayed Draw Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  848,566   820,005   225,820 
American Physician Partners, LLC
(8)
 Healthcare & HCIT Revolver — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  346,322   345,024   1,008 
American Physician Partners, LLC
(8)
 Healthcare & HCIT Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 06/30/2023  87,247   86,687   43,687 
American Physician Partners, LLC
(8)
 Healthcare & HCIT Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  1,291,983   1,250,593   —   
American Physician Partners, LLC
(1) (8)
 Healthcare & HCIT Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  2,398,163   2,245,758   —   
American Physician Partners, LLC
(8)
 Healthcare & HCIT Term Loan — (S + 6.75%; 3.50% PIK; 1.00% Floor) 09/30/2023  6,035,900   5,733,816   —   
Analogic Corporation
(5) (7)
 Healthcare & HCIT Revolver 10.45% (S + 5.25%; 1.00% Floor) 06/24/2024  158,428   158,428   157,359 
See Notes to Unaudited Consolidated Financial Statements
10
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Analogic Corporation
(1) (4)
    
 Healthcare & HCIT Term Loan 10.45% (S + 5.25%; 1.00% Floor) 06/22/2024 $2,064,028  $2,056,456  $2,053,708 
AOM Acquisition, LLC.
(5) (6)
 Healthcare & HCIT Revolver 10.14% (S + 4.75%; 1.00% Floor) 02/18/2027  —     (17,875  (3,047
AOM Acquisition, LLC.
(1) (2)
 Healthcare & HCIT Term Loan 10.14% (S + 4.75%; 1.00% Floor) 02/18/2027  6,158,526   6,065,137   6,143,130 
BAART Programs, Inc.
(1)
 Healthcare & HCIT Delayed Draw Term Loan 10.50% (L + 5.00%; 1.00% Floor) 06/11/2027  3,895,596   3,867,800   3,720,294 
BAART Programs, Inc.
(1) (2)
 Healthcare & HCIT Term Loan 10.50% (S + 5.00%; 1.00% Floor) 06/11/2027  4,697,916   4,668,662   4,486,509 
BV EMS Buyer, Inc.
(2) (5)
 Healthcare & HCIT Delayed Draw Term Loan 10.94% (S + 5.75%; 1.00% Floor) 11/23/2027  1,817,264   1,764,360   1,729,181 
BV EMS Buyer, Inc.
(2) (3)
 Healthcare & HCIT Term Loan 10.95% (S + 5.75%; 1.00% Floor) 11/23/2027  3,503,238   3,413,224   3,415,657 
Caregiver 2, Inc.
(2)
 Healthcare & HCIT Delayed Draw Term Loan 10.68% (S + 5.25%; 2.25% PIK; 1.00% Floor) 07/24/2025  1,541,496   1,518,428   1,452,860 
Caregiver 2, Inc.
(4)
 Healthcare & HCIT Term Loan 10.68% (S + 5.25%; 2.25% PIK; 1.00% Floor) 07/24/2025  4,617,464   4,577,572   4,351,960 
Caregiver 2, Inc.
(4)
 Healthcare & HCIT Term Loan 10.68% (S + 5.25%; 2.25% PIK; 1.00% Floor) 07/24/2025  662,755   654,242   624,647 
Caregiver 2, Inc.
(2)
 Healthcare & HCIT Term Loan 10.68% (S + 5.25%; 2.25% PIK; 1.00% Floor) 07/24/2025  632,817   621,650   596,430 
Choice Health At Home, LLC,
(1) (5) (7)
 Healthcare & HCIT Delayed Draw Term Loan 13.02% (L + 6.75%; 1.00% PIK; 1.00% Floor) 12/29/2026  949,361   932,235   835,871 
Choice Health At Home, LLC,
(1) (2)
 Healthcare & HCIT Term Loan 12.02% (L + 6.75%; 1.00% PIK; 1.00% Floor) 12/29/2026  2,568,097   2,539,792   2,426,852 
Coding Solutions Acquisition, Inc
(5)
 Healthcare & HCIT Delayed Draw Term Loan 10.58% (S + 5.50%; 0.75% Floor) 05/11/2028  173,516   158,144   123,827 
Coding Solutions Acquisition, Inc
(5)
 Healthcare & HCIT Revolver 10.60% (S + 5.50%; 0.75% Floor) 05/11/2028  159,072   146,775   127,258 
Coding Solutions Acquisition, Inc
(2) (4)
 Healthcare & HCIT Term Loan 10.60% (S + 5.50%; 0.75% Floor) 05/11/2028  5,488,984   5,399,368   5,269,424 
Community Based Care Acquisition,
Inc.
(2) (5)
 Healthcare & HCIT Delayed Draw Term Loan 10.59% (S + 5.25%; 1.00% Floor) 09/16/2027  2,023,869   1,997,496   1,981,206 
Community Based Care Acquisition,
Inc.
(5) (6)
 Healthcare & HCIT Delayed Draw Term Loan 10.59% (S + 5.75%; 1.00% Floor) 09/16/2027  —     (49,667  (36,401
Community Based Care Acquisition,
Inc.
(5) (6)
 Healthcare & HCIT Revolver 10.59% (S + 5.25%; 1.00% Floor) 09/16/2027  —     (12,264  (17,276
Community Based Care Acquisition,
Inc.
(1) (2)
 Healthcare & HCIT Term Loan 10.59% (S + 5.25%; 1.00% Floor) 09/16/2027  5,261,917   5,185,052   5,156,679 
Delaware Valley Management Holdings, Inc.
(8)
 Healthcare & HCIT Delayed Draw Term Loan — (11.50% PIK; 1.00% Floor) 03/21/2024  392,298   348,770   247,540 
Delaware Valley Management Holdings, Inc.
(5) (8)
 Healthcare & HCIT Delayed Draw Term Loan — (11.50% PIK; 1.00% Floor) 03/21/2024  558,273   535,558   352,261 
Delaware Valley Management Holdings, Inc.
(8)
 Healthcare & HCIT Revolver — (11.50% PIK; 1.00% Floor) 03/21/2024  579,494   541,505   365,661 
Delaware Valley Management Holdings, Inc.
(8)
 Healthcare & HCIT Term Loan — (11.50% PIK; 1.00% Floor) 03/21/2024  3,726,832   3,446,462   2,351,631 
FH MD Buyer, Inc.
(1) (2)
 Healthcare & HCIT Term Loan 10.22% (S + 5.11%; 0.75% Floor) 07/22/2028  5,437,735   5,396,567   4,893,962 
GHA Buyer, Inc.
(3)
 Healthcare & HCIT Delayed Draw Term Loan 9.89% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  821,636   814,165   790,825 
GHA Buyer, Inc.
(5) (6)
 Healthcare & HCIT Revolver 9.89% (S + 4.50%; 3.25% PIK; 1.00% Floor) 06/24/2026     (1,847  (35,665
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 13.64% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  566,612   561,084   545,364 
GHA Buyer, Inc.
(1) (4)
 Healthcare & HCIT Term Loan 9.89% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  5,422,293   5,375,632   5,218,957 
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 13.64% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  1,982,100   1,979,311   1,907,772 
GHA Buyer, Inc.
(4)
 Healthcare & HCIT Term Loan 9.89% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  4,695,064   4,650,852   4,518,999 
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 9.89% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  735,523   726,731   707,940 
Honor HN Buyer, Inc
(2) (3) (7)
 Healthcare & HCIT Delayed Draw Term Loan 10.95% (S + 5.75%; 1.00% Floor) 10/15/2027  1,648,563   1,624,391   1,648,563 
Honor HN Buyer, Inc
(3) (5)
 Healthcare & HCIT Delayed Draw Term Loan 11.20% (S + 6.00%; 1.00% Floor) 10/15/2027  1,013,178   984,055   1,013,178 
Honor HN Buyer, Inc
(5)
 Healthcare & HCIT Revolver 13.00% (P + 4.75%; 1.00% Floor) 10/15/2027  38,012   33,633   38,012 
Honor HN Buyer, Inc
(1) (2)
 Healthcare & HCIT Term Loan 11.14% (S + 5.75%; 1.00% Floor) 10/15/2027  2,603,645   2,565,994   2,603,645 
Medbridge Holdings, LLC
(5) (6)
 Healthcare & HCIT Revolver 11.39% (S + 6.00%; 1.00% Floor) 12/23/2026  —     (16,124  (20,643
Medbridge Holdings, LLC
(1) (2) (4)
 Healthcare & HCIT Term Loan 11.39% (S + 6.00%; 1.00% Floor) 12/23/2026  15,367,872   15,180,955   15,137,353 
Medbridge Holdings, LLC
(1)
 Healthcare & HCIT Term Loan 11.39% (S + 6.00%; 1.00% Floor) 12/23/2026  974,356   959,422   959,741 
Medical Management Resource Group, LLC
(1) (7)
 Healthcare & HCIT Delayed Draw Term Loan 10.89% (S + 5.75%; 0.75% Floor) 09/30/2027  1,566,254   1,527,103   1,495,773 
Medical Management Resource Group, LLC
(5)
 Healthcare & HCIT Revolver 10.95% (S + 5.75%; 0.75% Floor) 09/30/2026  126,566   122,404   112,327 
Medical Management Resource Group, LLC
(2)
 Healthcare & HCIT Term Loan 10.95% (S + 5.75%; 0.75% Floor) 09/30/2027  3,792,709   3,738,373   3,622,037 
Medsuite Purchaser, LLC
(5) (6)
 Healthcare & HCIT Delayed Draw Term Loan 9.95% (S + 4.75%; 1.00% Floor) 10/22/2026  —     (35,798  —   
Medsuite Purchaser, LLC
(5) (6)
    
 Healthcare & HCIT Revolver 9.95% (S + 4.75%; 1.00% Floor) 10/22/2026  —     (6,827  (1,701
See Notes to Unaudited Consolidated Financial Statements
11

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Medsuite Purchaser, LLC
(1) (2)
 Healthcare & HCIT Term Loan 9.95% (S + 4.75%; 1.00% Floor) 10/22/2026 $4,758,379  $4,710,632  $4,746,483 
OMH-HealthEdge
Holdings, LLC
(5) (6)
 Healthcare & HCIT Revolver 10.03% (L + 5.25%; 1.00% Floor) 10/24/2024  —     (2,760  —   
OMH-HealthEdge
Holdings, LLC
(1)
 Healthcare & HCIT Term Loan 10.03% (L + 5.25%; 1.00% Floor) 10/24/2025  3,642,529   3,606,515   3,642,529 
OMH-HealthEdge
Holdings, LLC
(2)
 Healthcare & HCIT Term Loan 10.03% (S + 5.25%; 1.00% Floor) 10/24/2025  2,111,027   2,086,734   2,111,027 
OMH-HealthEdge
Holdings, LLC
(2)
 Healthcare & HCIT Term Loan 10.03% (S + 5.25%; 1.00% Floor) 10/24/2025  958,783   944,884   958,783 
Pace Health Companies,
LLC
(5) (6)
 Healthcare & HCIT Revolver 6.75% (S + 4.50%; 1.00% Floor) 08/02/2024  —     (1,411  —   
Pace Health Companies, LLC
(1)
 Healthcare & HCIT Term Loan 9.89% (S + 4.50%; 1.00% Floor) 08/02/2024  5,114,338   5,101,539   5,114,338 
Pinnacle Dermatology Management, LLC
(5)
 Healthcare & HCIT Delayed Draw Term Loan 11.19% (S + 5.75%; 0.75% Floor) 12/08/2028  651,549   639,219   591,776 
Pinnacle Dermatology Management, LLC
(5)
 Healthcare & HCIT Revolver 9.49% (P + 3.00%) 12/08/2026  322,617   313,268   315,896 
Pinnacle Dermatology Management,
LLC
(1) (2) (4)
 Healthcare & HCIT Term Loan 11.05% (S + 5.75%; 0.75% Floor) 12/08/2028  5,580,466   5,475,966   5,287,491 
Pinnacle Treatment Centers, Inc.
(2)
 Healthcare & HCIT Delayed Draw Term Loan 12.16% (S + 6.75%; 1.00% Floor) 01/02/2026  341,878   340,651   335,040 
Pinnacle Treatment Centers, Inc.
(5)
 Healthcare & HCIT Revolver 12.16% (S + 6.75%; 1.00% Floor) 01/02/2026  146,477   145,220   140,618 
Pinnacle Treatment Centers, Inc.
(2) (4)
 Healthcare & HCIT Term Loan 12.16% (S + 6.75%; 1.00% Floor) 01/02/2026  4,065,068   4,050,206   3,983,767 
Pinnacle Treatment Centers, Inc.
(4)
 Healthcare & HCIT Term Loan 12.16% (S + 6.75%; 1.00% Floor) 01/02/2026  147,176   146,280   144,233 
Pinnacle Treatment Centers, Inc.
(4)
 Healthcare & HCIT Term Loan 12.16% (S + 6.75%; 1.00% Floor) 01/02/2026  285,347   280,015   279,640 
Priority Ondemand Midco 2,L.P
(5)
 Healthcare & HCIT Delayed Draw Term Loan 10.59% (S + 5.25%; 1.00% Floor) 07/17/2028  119,410   98,427   105,808 
Priority Ondemand Midco 2,L.P
(1) (2)
 Healthcare & HCIT Term Loan 10.69% (S + 5.25%; 1.00% Floor) 07/17/2028  7,579,793   7,466,892   7,485,046 
RCP Encore Acquisition, Inc.
(8)
 Healthcare & HCIT Term Loan — (L + 5.00%; 1.00% Floor) 06/07/2025  3,328,678   3,248,433   33,287 
Redwood Family Care Network,
Inc.
(2) (5)
 Healthcare & HCIT Delayed Draw Term Loan 10.61% (S + 5.50%; 1.00% Floor) 06/18/2026  963,354   881,540   919,923 
Redwood Family Care Network,
Inc.
(1) (2)
 Healthcare & HCIT Delayed Draw Term Loan 10.61% (S + 5.50%; 1.00% Floor) 06/18/2026  5,800,363   5,732,804   5,698,856 
Redwood Family Care Network,
Inc.
(5) (6)
 Healthcare & HCIT Revolver 10.61% (S + 5.50%; 1.00% Floor) 06/18/2026  —     (7,081  (10,302
Redwood Family Care Network,
Inc.
(2) (3) (4)
 Healthcare & HCIT Term Loan 10.61% (S + 5.50%; 1.00% Floor) 06/18/2026  6,634,705   6,554,111   6,518,597 
Salisbury House, LLC
(5) (6)
 Healthcare & HCIT Revolver 10.78% (S + 5.00%; 1.00% Floor) 08/30/2025  —     (5,002  (11,209
Salisbury House, LLC
(1) (2)
 Healthcare & HCIT Term Loan 10.78% (S + 5.50%; 1.00% Floor) 08/30/2025  3,934,410   3,885,484   3,836,049 
Salisbury House, LLC
(1)
 Healthcare & HCIT Term Loan 10.78% (S + 5.50%; 1.00% Floor) 08/30/2025  1,131,385   1,121,807   1,103,100 
Salisbury House, LLC
(1)
 Healthcare & HCIT Term Loan 10.78% (S + 5.50%; 1.00% Floor) 08/30/2025  1,231,322   1,213,721   1,200,539 
Sandstone Care Holdings, LLC
(2) (5)
 Healthcare & HCIT Delayed Draw Term Loan 10.30% (S + 5.50%; 1.00% Floor) 06/28/2028  99,867   89,216   99,867 
Sandstone Care Holdings, LLC
(5)
 Healthcare & HCIT Revolver 10.65% (S + 5.50%; 1.00% Floor) 06/28/2028  194,344   180,533   190,222 
Sandstone Care Holdings, LLC
(1) (4)
 Healthcare & HCIT Term Loan 10.65% (S + 5.50%; 1.00% Floor) 06/28/2028  4,664,266   4,576,406   4,640,945 
SCA Buyer, LLC
(5)
 Healthcare & HCIT Revolver 11.96% (S + 6.50%; 1.00% Floor) 01/20/2026  515,079   510,065   487,716 
SCA Buyer, LLC
(2)
 Healthcare & HCIT Term Loan 11.96% (S + 6.50%; 1.00% Floor) 01/20/2026  3,776,175   3,745,772   3,615,687 
SIS Purchaser, Inc.
(5) (6)
 Healthcare & HCIT Revolver 11.20% (S + 6.00%; 1.00% Floor) 10/15/2026  —     (11,307  (20,404
SIS Purchaser, Inc.
(1) (2) (4)
 Healthcare & HCIT Term Loan 11.20% (S + 6.00%; 1.00% Floor) 10/15/2026  12,073,170   11,950,300   11,861,889 
SIS Purchaser, Inc.
(2)
 Healthcare & HCIT Term Loan 11.20% (S + 6.00%; 1.00% Floor) 10/15/2026  2,311,084   2,285,173   2,270,640 
Smile Brands, Inc.
(4)
 Healthcare & HCIT Delayed Draw Term Loan 9.65% (S + 4.50%; 0.75% Floor) 10/12/2025  480,501   479,436   439,659 
Smile Brands, Inc.
(5)
 Healthcare & HCIT Revolver 9.82% (P + 3.50%; 1.00% Floor) 10/12/2025  237,820   237,671   216,162 
Smile Brands, Inc.
(1)
 Healthcare & HCIT Term Loan 9.65% (S + 4.50%; 0.75% Floor) 10/12/2025  1,582,547   1,578,701   1,448,030 
Spark DSO LLC
(5)
 Healthcare & HCIT Revolver 12.29% (S + 7.25%; 1.00% Floor) 04/20/2026  248,796   237,644   185,215 
Spark DSO LLC
(1) (3) (4)
 Healthcare & HCIT Term Loan 12.29% (S + 6.65%; 1.00% Floor) 04/19/2026  7,233,791   7,163,041   6,817,848 
Telcor Buyer, Inc.
(5) (6)
 Healthcare & HCIT Revolver 9.69% (L + 4.50%; 1.00% Floor) 08/20/2027     (3,043  (5,815
Telcor Buyer, Inc.
(1) (2)
 Healthcare & HCIT Term Loan 9.69% (L + 4.50%; 1.00% Floor) 08/20/2027  7,921,215   7,838,320   7,762,790 
The Center for Orthopedic and Research Excellence, Inc.
(2) (3)
 Healthcare & HCIT Delayed Draw Term Loan 10.90% (S + 5.50%; 1.00% Floor) 08/15/2025  1,726,397   1,711,625   1,696,185 
The Center for Orthopedic and Research Excellence, Inc.
(5)
 Healthcare & HCIT Delayed Draw Term Loan 10.90% (S + 5.50%; 1.00% Floor) 08/15/2025  531,168   518,741   514,093 
The Center for Orthopedic and Research Excellence, Inc.
(1) (2)
 Healthcare & HCIT Delayed Draw Term Loan 10.70% (S + 5.50%; 1.00% Floor) 08/15/2025  1,135,774   1,132,247   1,115,898 
The Center for Orthopedic and Research Excellence, Inc.
(5)
 Healthcare & HCIT Revolver 10.70% (S + 5.50%; 1.00% Floor) 08/15/2025  552,426   547,973   540,341 
The Center for Orthopedic and Research Excellence, Inc.
(2)
 Healthcare & HCIT Term Loan 10.74% (S + 5.50%; 1.00% Floor) 08/15/2025  3,216,089   3,179,195   3,159,807 
The Center for Orthopedic and Research Excellence, Inc.
(1) (4)
 Healthcare & HCIT Term Loan 10.70% (S + 5.50%; 1.00% Floor) 08/15/2025  4,818,619   4,784,912   4,734,293 
See Notes to Unaudited Consolidated Financial Statements
12
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
West Dermatology
(5) (6)
    
 Healthcare & HCIT Delayed Draw Term Loan 12.90% (S + 7.25%; 1.00% Floor) 03/17/2028 $—    $(30,762 $(279,883
West Dermatology
(5) (6)
 Healthcare & HCIT Revolver 12.90% (S + 7.25%; 1.00% Floor) 03/17/2028  —     (20,526  (105,733
West Dermatology
(1) (2) (3) (4)
 Healthcare & HCIT Term Loan 12.90% (S + 7.25%; 1.00% Floor) 03/17/2028  11,305,471   11,180,596   10,344,506 
Activ Software Holdings, LLC Software & Tech Services Delayed Draw Term Loan 11.32% (S + 6.25%; 1.00% Floor) 05/04/2027  630,802   613,949   611,878 
Activ Software Holdings, LLC
(5) (6)
 Software & Tech Services Revolver 11.79% (L + 6.25%; 1.00% Floor) 05/04/2027  —     (8,435  (19,465
Activ Software Holdings, LLC
(1)
 Software & Tech Services Term Loan 11.28% (S + 6.25%; 1.00% Floor) 05/04/2027  2,523,209   2,455,796   2,447,512 
Activ Software Holdings, LLC
(1) (2) (3) (4)
 Software & Tech Services Term Loan 11.79% (L + 6.25%; 1.00% Floor) 05/04/2027  7,948,255   7,847,571   7,709,807 
Admiral Buyer, Inc
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.74% (S + 5.50%; 0.75% Floor) 05/08/2028  —     (12,828  —   
Admiral Buyer, Inc
(5) (6)
 Software & Tech Services Revolver 10.74% (S + 5.50%; 0.75% Floor) 05/08/2028  —     (9,172  —   
Admiral Buyer, Inc
(1) (2) (3)
 Software & Tech Services Term Loan 10.74% (S + 5.50%; 0.75% Floor) 05/08/2028  5,813,353   5,718,319   5,813,353 
AMI US Holdings, Inc.
(5)
 Software & Tech Services Revolver 10.45% (S + 5.25%) 04/01/2024  131,353   127,779   131,353 
AMI US Holdings, Inc.
(1) (3)
 Software & Tech Services Term Loan 10.45% (S + 5.25%; 1.00% Floor) 04/01/2025  7,965,440   7,908,426   7,965,440 
Avalara, Inc.
(5) (6)
 Software & Tech Services Revolver 12.49% (S + 7.25%; 0.75% Floor) 10/19/2028  —     (23,644  (21,308
Avalara, Inc.
(1) (4)
 Software & Tech Services Term Loan 12.49% (S + 7.25%; 0.75% Floor) 10/19/2028  10,653,748   10,417,287   10,440,673 
Avetta, LLC
(5) (6)
 Software & Tech Services Revolver 11.02% (L + 5.75%; 1.00% Floor) 04/10/2024  —     (1,306  (4,944
Avetta, LLC
(1)
 Software & Tech Services Term Loan 11.02% (L + 5.75%; 1.00% Floor) 04/10/2024  4,174,231   4,158,825   4,132,489 
Avetta, LLC
(1) (4)
 Software & Tech Services Term Loan 11.02% (L + 5.75%; 1.00% Floor) 04/10/2024  3,170,317   3,154,328   3,138,613 
Avetta, LLC
(2)
 Software & Tech Services Term Loan 11.02% (L + 5.75%; 1.00% Floor) 04/10/2024  6,734,288   6,695,455   6,666,945 
Bonterra, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 11.79% (L + 6.25%; 0.75% Floor) 09/08/2027  —     (13,522  (42,354
Bonterra, LLC
(5)
 Software & Tech Services Revolver 11.79% (L + 6.25%; 0.75% Floor) 09/08/2027  1,133,230   1,121,037   1,104,436 
Bonterra, LLC
(1) (2) (3) (4)
 Software & Tech Services Term Loan 11.79% (L + 6.25%; 0.75% Floor) 09/08/2027  15,921,710   15,761,898   15,523,667 
Brightspot Buyer, Inc
(5) (6)
 Software & Tech Services Revolver 11.84% (S + 6.50%; 0.75% Floor) 11/16/2027  —     (10,028  (17,007
Brightspot Buyer, Inc
(1) (4)
 Software & Tech Services Term Loan 11.84% (S + 6.50%; 0.75% Floor) 11/16/2027  5,215,571   5,140,116   5,085,182 
Brightspot Buyer, Inc
(4)
 Software & Tech Services Term Loan 11.84% (S + 6.75%; 0.75% Floor) 11/16/2027  1,448,598   1,414,570   1,412,383 
BSI2 Hold Nettle, LLC
(5)
 Software & Tech Services Revolver 9.84% (S + 4.75%; 0.75% Floor) 06/30/2028  294,461   287,058   284,155 
BSI2 Hold Nettle, LLC
(2) (4)
 Software & Tech Services Term Loan 10.09% (S + 4.75%; 0.75% Floor) 06/30/2028  4,676,045   4,617,261   4,594,214 
BusinesSolver.com, Inc.
(5)
 Software & Tech Services Delayed Draw Term Loan 10.84% (S + 5.50%; 0.75% Floor) 12/01/2027  169,030   161,003   134,281 
BusinesSolver.com, Inc.
(2) (4)
 Software & Tech Services Term Loan 10.84% (S + 5.50%; 0.75% Floor) 12/01/2027  7,287,713   7,233,416   7,123,740 
Certify, Inc
(4)
 Software & Tech Services Delayed Draw Term Loan 10.70% (S + 5.50%; 1.00% Floor) 02/28/2024  479,627   478,462   479,627 
Certify, Inc Software & Tech Services Delayed Draw Term Loan 10.70% (S + 5.50%; 1.00% Floor) 02/28/2024  399,689   398,567   399,689 
Certify, Inc
(5)
 Software & Tech Services Revolver 10.70% (S + 5.50%; 1.00% Floor) 02/28/2024  39,969   39,895   39,969 
Certify, Inc
(1) (4)
 Software & Tech Services Term Loan 10.70% (S + 5.50%; 1.00% Floor) 02/28/2024  3,916,954   3,906,265   3,916,954 
Community Brands Parentco, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.70% (S + 5.50%; 0.75% Floor) 02/24/2028  —     (6,516  (20,860
Community Brands Parentco, LLC
(5) (6)
 Software & Tech Services Revolver 10.70% (S + 5.50%; 0.75% Floor) 02/24/2028  —     (6,523  (14,602
Community Brands Parentco, LLC
(1) (2)
 Software & Tech Services Term Loan 10.70% (S + 5.50%; 0.75% Floor) 02/24/2028  7,003,872   6,890,583   6,758,737 
Coupa Holdings, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 12.60% (S + 7.50%; 0.75% Floor) 02/27/2030  —     (11,850  (11,850
Coupa Holdings, LLC
(5) (6)
 Software & Tech Services Revolver 12.60% (S + 7.50%; 0.75% Floor) 02/27/2029  —     (18,147  (18,147
Coupa Holdings, LLC
(1) (2) (3)
 Software & Tech Services Term Loan 12.60% (S + 7.50%; 0.75% Floor) 02/27/2030  10,617,824   10,355,560   10,352,378 
Datacor, Inc.
(2) (5)
 Software & Tech Services Delayed Draw Term Loan 10.85% (S + 5.75%; 1.00% Floor) 12/29/2025  1,113,561   1,089,441   1,081,745 
Datacor, Inc.
(5) (6)
 Software & Tech Services Revolver 10.85% (S + 5.75%; 1.00% Floor) 12/29/2025  —     (6,393  (14,487
Datacor, Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 10.85% (S + 5.75%; 1.00% Floor) 12/29/2025  13,841,011   13,645,023   13,529,588 
Degreed, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 12.20% (S + 5.50%; 1.50% PIK; 1.00% Floor) 05/29/2026  —     (3,222  (31,306
Degreed, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 12.20% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  —     (10,230  (23,129
Degreed, Inc.
(5) (6)
 Software & Tech Services Revolver 12.20% (S + 5.50%; 1.50% PIK; 1.00% Floor) 05/29/2026  —     (1,228  (11,490
Degreed, Inc.
(4)
 Software & Tech Services Term Loan 12.20% (S + 5.50%; 1.50% PIK; 1.00% Floor) 05/29/2026  2,808,520   2,798,438   2,731,286 
Degreed, Inc.
(4)
 Software & Tech Services Term Loan 12.20% (S + 5.50%; 1.50% PIK; 1.00% Floor) 05/29/2026  5,200,673   5,179,473   5,057,654 
Dispatch Track, LLC
(5) (6)
 Software & Tech Services Revolver 9.69% (S + 4.50%; 1.00% Floor) 12/17/2026  —     (1,355  (3,019
Dispatch Track, LLC
(1) (2)
 Software & Tech Services Term Loan 9.69% (S + 4.50%; 1.00% Floor) 12/17/2026  9,849,936   9,795,851   9,751,437 
Drilling Info Holdings, Inc.
(1)
 Software & Tech Services Term Loan 9.45% (S + 4.25%) 07/30/2025  3,274,994   3,269,890   3,234,057 
EET Buyer, Inc.
(5) (6)
 Software & Tech Services Revolver 11.67% (S + 6.50%; 0.75% Floor) 11/08/2027  —     (18,471  (28,507
EET Buyer, Inc.
(3)
 Software & Tech Services Term Loan 11.67% (S + 6.50%; 0.75% Floor) 11/08/2027  4,150,025   4,049,237   4,035,899 
EET Buyer, Inc.
(2) (3) (4)
 Software & Tech Services Term Loan 11.67% (S + 6.50%; 0.75% Floor) 11/08/2027  6,821,588   6,721,882   6,633,994 
Exterro, Inc.
(5)
 Software & Tech Services Revolver 12.75% (P + 4.50%; 1.00% Floor) 05/31/2024  369,281   351,114   369,281 
Exterro, Inc.
(1)
 Software & Tech Services Term Loan 10.93% (S + 5.50%; 1.00% Floor) 05/31/2024  2,793,450   2,783,968   2,793,450 
Exterro, Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 10.93% (S + 5.50%; 1.00% Floor) 05/31/2024  6,237,900   6,200,464   6,237,900 
Exterro, Inc.
(1) (2)
 Software & Tech Services Term Loan 10.93% (S + 5.50%; 1.00% Floor) 05/31/2024  5,809,123   5,763,168   5,809,123 
See Notes to Unaudited Consolidated Financial Statements
13

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Faithlife, LLC
(1) (2)
    
 Software & Tech Services Delayed Draw Term Loan 10.84% (S + 5.50%; 1.00% Floor) 09/18/2025 $708,304  $702,061  $708,304 
Faithlife, LLC
(5) (6)
 Software & Tech Services Revolver 10.84% (S + 5.50%; 1.00% Floor) 09/18/2025  —     (2,503  —   
Faithlife, LLC
(1) (2)
 Software & Tech Services Term Loan 10.84% (S + 5.50%; 1.00% Floor) 09/18/2025  304,180   301,433   304,180 
Fusion Holding Corp
(5) (6)
 Software & Tech Services Revolver 11.59% (S + 6.25%; 0.75% Floor) 09/15/2027  —     (26,255  (20,688
Fusion Holding Corp
(1) (2) (3) (4)
 Software & Tech Services Term Loan 11.59% (S + 6.25%; 0.75% Floor) 09/15/2029  16,810,586   16,460,552   16,558,427 
Fusion Risk Management, Inc.
(5) (6)
 Software & Tech Services Revolver 12.13% (S + 7.00%; 1.00% Floor) 05/22/2029  —     (16,508  (16,801
Fusion Risk Management, Inc.
(4)
 Software & Tech Services Term Loan 12.13% (S + 7.00%; 1.00% Floor) 05/22/2029  7,000,419   6,862,854   6,860,410 
G Treasury SS, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 11.23% (S + 6.00%; 1.00% Floor) 06/29/2029  —     (18,286  (18,294
G Treasury SS, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 11.23% (S + 6.00%; 1.00% Floor) 06/29/2029  —     (11,429  (11,434
G Treasury SS, LLC
(5) (6)
 Software & Tech Services Revolver 11.23% (S + 6.00%; 1.00% Floor) 06/29/2029  —     (18,286  (18,294
G Treasury SS, LLC
(1) (4)
 Software & Tech Services Term Loan 11.23% (S + 6.00%; 1.00% Floor) 06/29/2029  3,658,885   3,604,020   3,619,002 
Genesis Acquisition Co.
(4)
 Software & Tech Services Revolver 10.24% (S + 5.00%; 1.00% Floor) 07/31/2025  202,400   201,640   200,376 
Genesis Acquisition Co. Software & Tech Services Term Loan 10.24% (S + 5.00%; 1.00% Floor) 07/31/2025  343,487   340,052   340,052 
Genesis Acquisition Co.
(1) (2)
 Software & Tech Services Term Loan 10.24% (S + 5.00%; 1.00% Floor) 07/31/2025  3,651,039   3,622,528   3,614,528 
Greenhouse Software, Inc.
(5) (6)
 Software & Tech Services Revolver 12.24% (S + 7.00%; 1.00% Floor) 09/01/2028  —     (17,223  (21,564
Greenhouse Software, Inc.
(5) (6)
 Software & Tech Services Revolver 12.24% (S + 7.00%; 1.00% Floor) 09/01/2028  —     (13,094  (10,579
Greenhouse Software, Inc.
(4)
 Software & Tech Services Term Loan 12.24% (S + 7.00%; 1.00% Floor) 09/01/2028  12,376,845   12,202,693   12,160,250 
Greenhouse Software, Inc.
(1) (4)
 Software & Tech Services Term Loan 12.24% (S + 7.00%; 1.00% Floor) 09/01/2028  14,507,975   14,192,551   14,254,085 
Gryphon-Redwood Acquisition LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 9.24% (S + 4.00%; 6.00% PIK; 1.00% Floor) 09/16/2028  —     (24,218  (11,895
Gryphon-Redwood Acquisition LLC
(1)
 Software & Tech Services Term Loan 9.24% (S + 4.00%; 6.00% PIK; 1.00% Floor) 09/16/2028  3,611,583   3,559,003   3,584,496 
GS AcquisitionCo, Inc.
(5)
 Software & Tech Services Revolver 11.14% (S + 5.75%; 1.00% Floor) 05/22/2026  152,233   150,987   137,390 
GS AcquisitionCo, Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 11.14% (S + 5.75%; 1.00% Floor) 05/22/2026  9,430,337   9,409,133   9,123,851 
Hirevue, Inc.
(5) (6)
 Software & Tech Services Revolver 12.34% (S + 7.25%; 1.00% Floor) 05/03/2029  —     (40,097  (41,154
Hirevue, Inc.
(2) (3)
 Software & Tech Services Term Loan 12.34% (S + 7.25%; 1.00% Floor) 05/03/2029  12,934,244   12,613,861   12,610,888 
Iodine Software, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 11.20% (S + 7.00%; 1.00% Floor) 05/19/2027  —     (36,520  —   
Iodine Software, LLC
(2) (4)
 Software & Tech Services Delayed Draw Term Loan 11.20% (S + 6.00%; 1.00% Floor) 05/19/2027  7,915,927   7,811,704   7,816,978 
Iodine Software, LLC
(5) (6)
 Software & Tech Services Revolver 11.20% (S + 6.00%; 1.00% Floor) 05/19/2027  —     (14,295  (13,613
Iodine Software, LLC
(1) (2)
 Software & Tech Services Term Loan 11.20% (S + 6.00%; 1.00% Floor) 05/19/2027  5,254,876   5,185,900   5,189,190 
Kaseya Inc.
(5)
 Software & Tech Services Delayed Draw Term Loan 8.86% (S + 3.75%; 2.50% PIK; 0.75% Floor) 06/25/2029  38,843   30,415   22,924 
Kaseya Inc.
(5)
 Software & Tech Services Revolver 8.86% (S + 3.75%; 2.50% PIK; 0.75% Floor) 06/25/2029  159,194   155,107   138,499 
Kaseya Inc.
(1) (2) (3)
 Software & Tech Services Term Loan 8.85% (S + 5.75%; 0.75% Floor) 06/25/2029  10,506,804   10,375,930   10,165,333 
Mavenlink, Inc.
(5)
 Software & Tech Services Revolver 10.80% (S + 5.50%; 0.75% Floor) 06/03/2027  715,926   690,080   680,130 
Mavenlink, Inc.
(1) (4)
 Software & Tech Services Term Loan 10.82% (L + 5.50%; 0.75% Floor) 06/03/2027  15,034,451   14,812,119   14,733,762 
Moon Buyer, Inc.
(2)
 Software & Tech Services Delayed Draw Term Loan 10.34% (S + 5.00%; 1.00% Floor) 04/21/2027  578,987   575,820   551,485 
Moon Buyer, Inc.
(5)
 Software & Tech Services Revolver 10.39% (S + 5.00%; 1.00% Floor) 04/21/2027  465,517   454,293   410,237 
Moon Buyer, Inc.
(1) (2) (3) (4)
 Software & Tech Services Term Loan 10.34% (S + 5.00%; 1.00% Floor) 04/21/2027  6,272,844   6,211,550   5,974,884 
Mykaarma Acquisition LLC
(5) (6)
 Software & Tech Services Revolver 8.00% (S + 3.00%; 3.75% PIK; 1.00% Floor) 03/21/2028  —     (9,388  (8,898
Mykaarma Acquisition LLC
(2) (4)
 Software & Tech Services Term Loan 8.00% (S + 3.00%; 3.75% PIK; 1.00% Floor) 03/21/2028  6,219,971   6,122,277   6,126,672 
Navigate360, LLC
(2)
 Software & Tech Services Delayed Draw Term Loan 11.25% (S + 6.00%; 1.00% Floor) 03/17/2027  1,799,110   1,779,872   1,776,621 
Navigate360, LLC Software & Tech Services Revolver 11.19% (S + 6.00%; 1.00% Floor) 03/17/2027  604,235   595,212   596,682 
Navigate360, LLC
(4)
 Software & Tech Services Term Loan 11.25% (S + 6.00%; 1.00% Floor) 03/17/2027  4,176,775   4,112,314   4,124,566 
Navigate360, LLC
(2) (3)
 Software & Tech Services Term Loan 11.25% (S + 6.00%; 1.00% Floor) 03/17/2027  2,254,438   2,215,221   2,226,258 
Netwrix Corporation And Concept Searching Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.20% (S + 5.00%; 0.75% Floor) 06/11/2029  —     (3,201  (21,340
Netwrix Corporation And Concept Searching Inc.
(5)
 Software & Tech Services Revolver 10.24% (S + 5.00%; 0.75% Floor) 06/11/2029  193,689   191,517   185,941 
Netwrix Corporation And Concept Searching Inc.
(1) (2) (3)
 Software & Tech Services Term Loan 10.30% (S + 5.00%; 0.75% Floor) 06/11/2029  9,834,984   9,814,576   9,736,634 
Ping Identity Corporation
(5) (6)
 Software & Tech Services Revolver 12.08% (S + 7.00%; 0.75% Floor) 10/17/2028  —     (26,691  (24,067
Ping Identity Corporation
(1) (2) (3) (4)
 Software & Tech Services Term Loan 12.08% (S + 7.00%; 0.75% Floor) 10/17/2029  12,033,445   11,760,941   11,792,776 
Ranger Buyer, Inc.
(5) (6)
 Software & Tech Services Revolver 10.45% (S + 5.50%; 0.75% Floor) 11/18/2027  —     (17,810  (26,983
Ranger Buyer, Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 10.45% (S + 5.25%; 0.75% Floor) 11/17/2028  14,210,905   13,980,325   13,891,160 
Sauce Labs, Inc.
(4)
 Software & Tech Services Delayed Draw Term Loan 11.15% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  1,929,737   1,902,975   1,886,318 
Sauce Labs, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.65% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  —     (19,579  (29,594
Sauce Labs, Inc.
(5) (6)
 Software & Tech Services Revolver 10.65% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  —     (17,853  (28,841
Sauce Labs, Inc.
(4)
 Software & Tech Services     Term Loan 10.65% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  7,522,091   7,403,841   7,352,844 
See Notes to Unaudited Consolidated Financial Statements
14
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Saviynt, Inc.
(5)
 Software & Tech Services Delayed Draw Term Loan 12.70% (S + 4.00%; 3.50% PIK; 1.00% Floor) 12/22/2027 $1,836,331  $1,699,341  $1,698,970 
Saviynt, Inc.
(5) (6)
 Software & Tech Services Revolver 12.70% (S + 4.00%; 3.50% PIK; 1.00% Floor) 12/22/2027  —     (13,699  (13,720
Saviynt, Inc.
(1) (4)
 Software & Tech Services Term Loan 9.20% (S + 4.00%; 3.50% PIK; 1.00% Floor) 12/22/2027  18,634,474   18,208,685   18,215,199 
ScyllaDB, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 11.59% (S + 6.50%; 1.00% Floor) 09/08/2027  —     (2,779  (4,956
ScyllaDB, Inc.
(5) (6)
 Software & Tech Services Revolver 11.59% (S + 6.50%; 1.00% Floor) 09/08/2027  —     (2,224  (3,304
ScyllaDB, Inc.
(4)
 Software & Tech Services Term Loan 11.59% (S + 6.50%; 1.00% Floor) 09/08/2027  2,643,348   2,584,099   2,610,306 
Securonix, Inc.
(5) (6)
 Software & Tech Services Revolver 11.42% (S + 6.50%; 0.75% Floor) 04/05/2028  —     (21,536  (84,609
Securonix, Inc.
(1) (4)
 Software & Tech Services Term Loan 11.42% (S + 6.50%; 0.75% Floor) 04/05/2028  8,546,314   8,427,943   8,076,267 
Serrano Parent, LLC
(5) (6)
 Software & Tech Services Revolver 11.59% (S + 6.50%; 1.00% Floor) 05/13/2030  —     (51,182  (52,150
Serrano Parent, LLC
(1) (2) (3) (4)
 Software & Tech Services Term Loan 11.59% (S + 6.50%; 1.00% Floor) 05/13/2030  21,207,477   20,685,707   20,677,290 
Sirsi Corporation
(5) (6)
 Software & Tech Services Revolver 9.70% (S + 4.50%; 1.00% Floor) 03/15/2024  —     (1,269  (1,384
Sirsi Corporation
(1) (2)
 Software & Tech Services Term Loan 9.70% (S + 4.50%; 1.00% Floor) 03/15/2024 ��6,449,050   6,433,206   6,432,927 
Smartlinx Solutions, LLC
(7)
 Software & Tech Services Revolver 10.50% (S + 5.25%; 1.00% Floor) 03/04/2026  519,484   517,124   519,484 
Smartlinx Solutions, LLC
(1) (2) (4)
 Software & Tech Services Term Loan 10.35% (S + 5.25%; 1.00% Floor) 03/04/2026  5,591,430   5,540,152   5,591,430 
Smartlinx Solutions, LLC
(4)
 Software & Tech Services Term Loan 10.35% (S + 5.25%; 1.00% Floor) 03/04/2026  490,658   482,745   493,112 
Soladoc, LLC
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.62% (S + 5.25%; 0.75% Floor) 06/12/2028  —     (19,528  (53,003
Soladoc, LLC
(5) (6)
 Software & Tech Services Revolver 10.62% (S + 5.25%; 0.75% Floor) 06/12/2028  —     (9,773  (19,140
Soladoc, LLC
(1) (4)
 Software & Tech Services Term Loan 10.62% (S + 5.25%; 0.75% Floor) 06/12/2028  5,889,225   5,793,730   5,697,825 
SugarCRM, Inc.
(5) (6)
 Software & Tech Services Revolver 11.70% (S + 6.50%; 1.00% Floor) 07/31/2024  —     (1,016  (3,102
SugarCRM, Inc.
(1) (4)
 Software & Tech Services Term Loan 11.70% (S + 6.50%; 1.00% Floor) 07/31/2024  4,268,824   4,250,945   4,226,136 
Sundance Group Holdings, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 11.44% (S + 6.25%; 1.00% Floor) 07/02/2027  3,547,253   3,500,578   3,494,044 
Sundance Group Holdings, Inc.
(5)
 Software & Tech Services Revolver 11.52% (S + 6.25%; 1.00% Floor) 07/02/2027  331,077   311,892   309,793 
Sundance Group Holdings, Inc.
(3)
 Software & Tech Services Term Loan 11.61% (S + 6.25%; 1.00% Floor) 07/02/2027  463,790   451,584   456,833 
Sundance Group Holdings, Inc.
(1) (2)
 Software & Tech Services Term Loan 11.41% (S + 6.25%; 1.00% Floor) 07/02/2027  11,824,177   11,666,124   11,646,815 
Swiftpage, Inc.
(5) (6)
 Software & Tech Services Revolver 11.70% (S + 6.50%; 1.00% Floor) 12/13/2023  —     (343  (3,943
Swiftpage, Inc.
(3)
 Software & Tech Services Term Loan 11.70% (S + 6.50%; 1.00% Floor) 12/13/2023  221,672   222,130   217,793 
Swiftpage, Inc.
(2) (3)
 Software & Tech Services Term Loan 11.70% (S + 6.50%; 1.00% Floor) 12/13/2023  2,408,071   2,413,543   2,365,929 
Sysnet North America, Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 11.50% (S + 6.00%; 1.00% Floor) 12/01/2026  8,817,002   8,753,843   8,640,662 
Telesoft Holdings, LLC
(5) (7)
 Software & Tech Services Revolver 10.95% (P + 4.75%) 12/16/2025  115,394   109,801   101,965 
Telesoft Holdings, LLC
(2) (4)
 Software & Tech Services Term Loan 10.95% (S + 5.75%; 1.00% Floor) 12/16/2025  5,774,683   5,719,174   5,644,753 
TRGRP, Inc.
(5)
 Software & Tech Services Revolver 12.39% (S + 4.50%; 2.50% PIK; 1.00% Floor) 06/10/2024  33,333   32,881   33,333 
TRGRP, Inc.
(2) (4)
 Software & Tech Services Term Loan 9.89% (S + 4.50%; 2.50% PIK; 1.00% Floor) 06/10/2024  5,092,872   5,076,884   5,092,872 
TRGRP, Inc.
(1)
 Software & Tech Services Term Loan 9.89% (L + 4.50%; 2.50% PIK; 1.00% Floor) 06/10/2024  1,137,533   1,135,745   1,137,533 
TRGRP, Inc.
(2)
 Software & Tech Services Term Loan 9.89% (L + 4.50%; 2.50% PIK; 1.00% Floor) 06/10/2024  2,388,568   2,382,693   2,388,568 
Unanet, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  —     (34,475  (18,952
Unanet, Inc.
(5) (6)
 Software & Tech Services Revolver 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  —     (25,270  (18,952
Unanet, Inc.
(2) (4)
 Software & Tech Services Term Loan 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  12,003,044   11,784,600   11,822,998 
Ungerboeck Systems International,
LLC
(1)
 Software & Tech Services Delayed Draw Term Loan 11.86% (S + 6.50%; 1.00% Floor) 04/30/2027  322,391   319,217   316,749 
Ungerboeck Systems International,
LLC
(4)
 Software & Tech Services Delayed Draw Term Loan 11.86% (S + 6.50%; 1.00% Floor) 04/30/2027  690,794   690,794   678,705 
Ungerboeck Systems International,
LLC
(4) (5) (7)
 Software & Tech Services Delayed Draw Term Loan 11.83% (L + 6.50%; 1.00% Floor) 04/30/2027  432,770   428,491   424,416 
Ungerboeck Systems International,
LLC
(5)
 Software & Tech Services Revolver 11.70% (S + 6.50%; 1.00% Floor) 04/30/2027  48,936   46,263   44,922 
Ungerboeck Systems International,
LLC
(1) (4)
 Software & Tech Services Term Loan 11.86% (S + 6.50%; 1.00% Floor) 04/30/2027  2,717,277   2,690,974   2,669,724 
Ungerboeck Systems International,
LLC
(4)
 Software & Tech Services Term Loan 11.89% (S + 6.50%; 1.00% Floor) 04/30/2027  136,383   133,937   133,996 
Vectra AI, Inc.
(1)
 Software & Tech Services Delayed Draw Term Loan 11.50% (S + 6.25%; 1.00% Floor) 03/02/2028  1,163,793   1,148,427   1,140,517 
Vectra AI, Inc.
(5) (6)
 Software & Tech Services Revolver 11.56% (S + 6.25%; 1.00% Floor) 03/02/2028  —     (3,177  (4,655
Vectra AI, Inc.
(1) (4)
 Software & Tech Services Term Loan 11.56% (S + 6.25%; 1.00% Floor) 03/02/2028  5,552,870   5,463,921   5,441,813 
Vehlo Purchaser, LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.18% (S + 5.00%; 0.75% Floor) 05/24/2028  6,195,183   6,139,590   6,086,767 
Vehlo Purchaser, LLC
(5)
 Software & Tech Services Revolver 10.25% (S + 5.00%; 0.75% Floor) 05/24/2028  247,807   232,536   226,124 
Vehlo Purchaser, LLC
(1) (2) (4)
 Software & Tech Services Term Loan 10.18% (S + 5.00%; 0.75% Floor) 05/24/2028  22,302,658   22,026,713   21,912,362 
Velocity Purchaser Corporation
(5) (6)
 Software & Tech Services Revolver 11.70% (S + 6.50%; 1.00% Floor) 12/02/2024  —     (279  —   
Velocity Purchaser Corporation
(1)
 Software & Tech Services     Term Loan 11.70% (S + 6.50%; 1.00% Floor) 12/02/2024  577,329   576,374   577,329 
See Notes to Unaudited Consolidated Financial Statements
15

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Velocity Purchaser Corporation
(1) (2)
 Software & Tech Services Term Loan 11.70% (S + 6.50%; 1.00% Floor) 12/02/2024 $4,584,544  $4,571,441  $4,584,544 
Velocity Purchaser Corporation
(1)
 Software & Tech Services Term Loan 11.70% (S + 6.50%; 1.00% Floor) 12/02/2024  2,320,884   2,317,776   2,320,884 
Veracross LLC
(1)
 Software & Tech Services Delayed Draw Term Loan 12.20% (S + 2.00%; 5.00% PIK; 1.00% Floor) 12/28/2027  1,685,964   1,652,623   1,652,244 
Veracross LLC
(5) (6)
 Software & Tech Services Revolver 7.39% (S + 2.00%; 4.75% PIK; 1.00% Floor) 12/28/2027  —     (16,825  (22,251
Veracross LLC
(4)
 Software & Tech Services Term Loan 7.39% (S + 2.00%; 4.75% PIK; 1.00% Floor) 12/28/2027  13,230,829   13,045,725   12,966,213 
Vhagar Purchaser, LLC
(3)
 Software & Tech Services Term Loan 12.24% (S + 7.00%; 1.00% Floor) 06/11/2029  3,360,201   3,260,363   3,259,395 
Vhagar Purchaser, LLC.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 12.24% (S + 7.00%; 1.00% Floor) 06/11/2029  —     (11,092  (11,201
Vhagar Purchaser, LLC.
(5) (6)
 Software & Tech Services Revolver 12.24% (S + 7.00%; 1.00% Floor) 06/11/2029  —     (11,093  (11,201
Zendesk, Inc.
(5) (6)
 Software & Tech Services Delayed Draw Term Loan 8.75% (S + 3.50%; 3.50% PIK; 0.75% Floor) 11/22/2028  —     (30,058  (8,334
Zendesk, Inc.
(5) (6)
 Software & Tech Services Revolver 8.75% (S + 3.50%; 3.50% PIK; 0.75% Floor) 11/22/2028  —     (24,744  (17,158
Zendesk,
Inc.
(1) (2) (4)
 Software & Tech Services Term Loan 8.75% (S + 3.50%; 3.50% PIK; 0.75% Floor) 11/22/2028  13,450,775   13,200,739   13,282,640 
Dillon Logistics,
Inc.
(8)
 Transport & Logistics Revolver — (P + 6.00%; 2.00% Floor) 12/11/2023  880,789   776,403   —   
Dillon Logistics,
Inc.
(8)
 Transport & Logistics Term Loan — (P + 6.00%; 2.00% Floor) 12/11/2023  3,023,808   2,553,023   —   
             
Total U.S. 1st Lien/Senior Secured Debt
 
 
 
1,198,345,811
 
 
 
1,166,694,872
 
2nd Lien/Junior Secured Debt
- 2.16%
 
Conterra Ultra Broadband Holdings, Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 13.71% (S + 8.50%; 1.00% Floor) 04/30/2027  6,537,710   6,482,784   6,488,678 
Symplr Software, Inc.
(1) (3)
 Healthcare & HCIT Term Loan 13.02% (S + 7.88%; 0.75% Floor) 12/22/2028  3,130,634   3,086,999   2,778,438 
Brave Parent Holdings, Inc.
(1)
 Software & Tech Services Term Loan 12.95% (S + 7.50%) 04/17/2026  1,230,107   1,218,548   1,168,601 
             
Total U.S. 2nd Lien/Junior Secured Debt
  
 
10,788,331
 
 
 
10,435,717
 
             
Total U.S. Corporate Debt
  
 
1,209,134,142
 
 
 
1,177,130,589
 
Canadian Corporate Debt
- 4.95%
 
1st Lien/Senior Secured Debt
- 4.95%
 
McNairn Holdings Ltd.
(1) (9)
 Business Services Term Loan 11.73% (S + 6.50%; 0.50% PIK; 1.00% Floor) 11/25/2025  737,343   728,639   731,813 
Syntax Systems Ltd
(1) (2) (9)
 Digital Infrastructure & Services Term Loan 10.94% (L + 5.75%; 0.75% Floor) 10/29/2028  8,729,120   8,660,732   8,336,309 
Syntax Systems Ltd
(5) (9)
 Digital Infrastructure & Services Revolver 10.94% (L + 5.75%; 0.75% Floor) 10/29/2026  649,103   642,559   605,289 
Syntax Systems Ltd
(5) (6) (9)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.94% (L + 5.75%; 0.75% Floor) 10/29/2028  —     (18,702  (109,536
Banneker V Acquisition,
Inc.
(1) (2) (4) (9)
 Software & Tech Services Term Loan 12.70% (S + 7.50%; 1.00% Floor) 12/04/2025  13,258,433   13,034,565   12,926,972 
Banneker V Acquisition,
Inc.
(5) (9)
 Software & Tech Services Revolver 12.74% (S + 7.50%; 1.00% Floor) 12/04/2025  478,231   459,746   455,814 
Banneker V Acquisition,
Inc.
(2) (9)
 Software & Tech Services Delayed Draw Term Loan 12.70% (S + 7.50%; 1.00% Floor) 12/04/2025  1,024,233   1,014,117   998,627 
             
Total Canadian 1st Lien/Senior Secured Debt
 
 
 
24,521,656
 
 
 
23,945,288
 
             
Total Canadian Corporate Debt
 
 
 
24,521,656
 
 
 
23,945,288
 
Portfolio Company
 
Class/Series
 
        Industry        
 
                                                    
 
Initial Acquisition
Date 
(10)
 
      Shares      
  
        Cost        
  
   Fair Value   
 
U.S. Preferred Stock
- 2.02%
 
Ntiva Investments, LLC (MSP Global Holdings, Inc)
(11)
 Class A Digital Infrastructure & Services  01/24/2022  333,937  $272,826  $306,649 
Bowline Topco LLC
^^ (11) (12)
 LLC Units Energy  08/09/2021  2,946,390   —     264,486 
Alphasense,
Inc.
(9) (11)
 Series C Software & Tech Services  06/01/2021  23,961   369,843   633,076 
Concerto Health AI Solutions, LLC
(11) (12)
 Series B-1 Software & Tech Services  12/23/2019  65,614   349,977   353,458 
Datarobot, Inc.
(11)
 Series F Software & Tech Services  10/27/2020  6,715   88,248   74,963 
Datarobot, Inc.
(11)
 Series E Software & Tech Services  08/30/2019  38,190   289,278   329,334 
Degreed, Inc.
(11)
 Series D Software & Tech Services  04/30/2021  16,943   278,308   268,519 
Degreed, Inc.
(11)
 Series C-1 Software & Tech Services  06/25/2019  43,819   278,541   372,505 
Heap, Inc.
(11)
 Series C Software & Tech Services  05/21/2019  189,617   696,352   1,022,572 
Heap, Inc.
(11)
 Series D Software & Tech Services  11/24/2021  17,425   147,443   148,936 
Knockout Intermediate Holdings I, Inc. (Kaseya, Inc.)
(11)
 Perpetual Software & Tech Services  06/23/2022  1,345   1,311,760   1,485,833 
Netskope, Inc.
(11)
 Series G Software & Tech Services  01/27/2020  36,144   302,536   394,625 
Phenom People, Inc.
(11)
 Series C Software & Tech Services  01/08/2020  35,055   220,610   431,871 
Protoscale Rubrik, LLC
(11)
 Class B Software & Tech Services  01/04/2019  25,397   598,212   676,994 
Swyft Parent Holdings
LP
(11) (12)
 LP Interests Software & Tech Services  02/07/2022  850,470   758,389   891,266 
See Notes to Unaudited Consolidated Financial Statements
16
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
 
Class/Series
 
        Industry        
 
                                                    
 
Initial Acquisition
Date 
(10)
 
      Shares      
  
        Cost        
  
   Fair Value   
 
Symplr Software Intermediate Holdings, Inc.
(11)
    
 Series A Software & Tech Services  11/30/2018  1,196  $1,160,532  $2,007,282 
Vectra AI, Inc
(11)
 Series F Software & Tech Services  05/28/2021  17,064   131,095   104,677 
             
Total U.S. Preferred Stock
  
 
7,253,950
 
 
 
9,767,046
 
U.S. Common Stock
- 1.74%
 
Global Radar Holdings, LLC
(11) (12)
 Earn Out Business Services  11/08/2022  125   —     —   
AEG Holding Company, Inc.
(11)
 Class A Consumer Discretionary  11/20/2017  320   321,309   253,510 
Freddy’s Acquisition, LP (Freddy’s Frozen Custard, LLC)
(11)
 LP Interests Consumer Non-Cyclical  03/03/2021  72,483   72,483   134,437 
8x8, Inc.
(9) (11) (13)
 Common Units Digital Infrastructure & Services    7,886   170,890   33,358 
Avant Communications, LLC
(11) (12)
 Class A Digital Infrastructure & Services  11/30/2021  236,307   236,307   340,852 
MSP Global Holdings, Inc.
(11)
 Class A Digital Infrastructure & Services  01/24/2022  333,937   61,110   65,863 
NEPCORE Parent Holdings, LLC
(11)
 Class A Digital Infrastructure & Services  10/21/2021  98   97,884   74,828 
Neutral Connect, LLC
(11)
 LLC Units Digital Infrastructure & Services  10/21/2021  396,513   439,931   331,734 
Race Hometown Purchaser, LLC
(11)
 Class A Digital Infrastructure & Services  01/09/2023  705,827   705,827   750,196 
Thrive Parent, LLC
(11)
 Class L Digital Infrastructure & Services  01/22/2021  102,108   271,128   460,584 
Advantage AVP Parent Holdings, L.P. (Medical Management Resource Group, LLC)
(11)
 Class B Healthcare & HCIT  09/30/2021  34,492   34,492   35,735 
American Outcomes Management,
L.P.
(11) (12)
 Class A Healthcare & HCIT  02/17/2022  290,393   290,393   549,550 
Community Based Care Holdings, LP
(11)
 LP Interests Healthcare & HCIT  01/03/2022  179   178,916   224,553 
GSV MedSuite Investments, LLC (Millin Purchaser, LLC)
(11)
 Class A Healthcare & HCIT  03/31/2022  86,555   86,555   85,077 
INH Group Holdings, Inc.
(11)
 Class A Healthcare & HCIT  01/31/2019  484,552   484,552   8,229 
RCFN Parent, LP (People’s Care)
(11)
 Class A Healthcare & HCIT  06/18/2021  77   78,284   81,006 
REP Coinvest III AGP Blocker, L.P. (Agape Care Group)
(11)
 LP Interests Healthcare & HCIT  10/14/2021  590,203   590,203   960,517 
SBS Super Holdings, LLC
^^^ (11)
 Class A Healthcare & HCIT  05/12/2023  21   —     —   
SBS Super Holdings, LLC
^^^ (11)
 Class B Healthcare & HCIT  05/12/2023  100   10   —   
Brightspot Holdco, LLC
(11)
 LLC Units Software & Tech Services  11/16/2021  433,207   433,207   459,468 
GSV Vehlo Investments, LLC (Vehlo Purchaser, LLC)
(11)
 Class A Software & Tech Services  05/24/2022  150,297   150,297   165,054 
Human Security
(11)
 Common Shares Software & Tech Services  07/29/2022  329,116   953,133   908,762 
Moon Topco, L.P. (Radiant Logic,
Inc.)
(11)
 Class A Software & Tech Services  04/21/2021  3,600   35,999   36,603 
Mykaarma Acquisition LLC
(11)
 Class A Software & Tech Services  03/21/2022  257,031   257,031   302,245 
Ranger Lexipol Holdings, LLC
(11)
 Class A Software & Tech Services  11/18/2021  433   355,837   433,875 
Ranger Lexipol Holdings, LLC
(11)
 Class B Software & Tech Services  11/18/2021  433   77,371   172,446 
REP Coinvest III Tec, L.P. (American Safety Holdings Corp.)
(11)
 LP Interests Software & Tech Services  06/18/2020  167,509   190,658   260,283 
Stripe, Inc.
(11)
 Class B Software & Tech Services  05/17/2021  4,158   166,854   84,179 
Swyft Parent Holdings LP
(11) (12)
 LP Interests Software & Tech Services  02/07/2022  4,485   53,049   68,233 
REP Coinvest
III-A
Omni, L.P. (Omni Logistics, LLC)
(11)
 LP Interests Transport & Logistics  02/05/2021  193,770   53,301   281,012 
REP RO Coinvest IV A Blocker (Road One)
(11)
 Class A Transport & Logistics  12/28/2022  66,441,840   664,418   865,804 
             
Total U.S. Common Stock
    
 
7,511,429
 
 
 
8,427,993
 
U.S. Warrants
- 0.23%
             
Alphasense, Inc., expire
05/29/2027
(9) (11)
 Series B Software & Tech Services  06/02/2020  40,394   35,185   761,733 
Degreed, Inc., expire 04/11/2028
(11)
 Series D Software & Tech Services  04/11/2021  7,624   —     15,082 
Degreed, Inc., expire 05/31/2026
(11)
 Series C -1 Software & Tech Services  05/31/2019  26,294   46,823   107,168 
Degreed, Inc., expire 08/18/2029
(11)
 Common Shares Software & Tech Services  08/18/2022  9,374   —     45,253 
ScyllaDB, Inc., expire 09/08/2032
(11)
 Series C-1 Software & Tech Services  09/08/2022  239,984   43,880   87,088 
Vectra AI, Inc., expire 03/18/2031
(11)
 Series F Software & Tech Services  03/18/2021  35,156   58,189   76,767 
             
Total U.S. Warrants
    
 
184,077
 
 
 
1,093,091
 
United Kingdom Warrants
- 0.06%
             
GlobalWebIndex, Inc., expire 12/30/2027
(11)
 Preferred Units Software & Tech Services  12/30/2020  11,776   159,859   294,721 
 ��           
Total United Kingdom Warrants
  
 
159,859
 
 
 
294,721
 
Portfolio Company
 
Class/Series
       
Shares
  
Cost
  
Fair Value
 
Investment Companies
- 1.43%
     
Orangewood WWB
Co-Invest,

L.P.
(11) (14)
 LP Interests     829,314  $829,314  $995,177 
ORCP III Triton
Co-Investors,

L.P.
(11) (14)
 LP Interests     341,592   98,394   591,296 
AB Equity Investors, L.P.
(11) (14)
 LP Interests     2,059,293   2,059,292   2,337,165 
Falcon
Co-Investment
Partners,
L.P.
(11) (14)
 LP Interests     812,734   812,734   813,547 
GHP E Aggregator, LLC
(11) (14)
 LLC Units     417,813   186,588   626,719 
GHP SPV 2, L.P.
(9) (11) (14)
 LP Interests     271,942   271,942   272,703 
Magenta Blocker Aggregator,
LP
(11) (14)
 Class A     821,396   676,978   1,016,067 
See Notes to Unaudited Consolidated Financial Statements
17

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of June 30, 2023 (continued)
(Unaudited)
Portfolio Company
  
Class/Series
              
Shares
   
Cost
   
Fair Value
 
Palms
Co-Investment
Partners,
L.P.
(11) (14)
   LP Interests         261,450   $261,450   $261,450 
                   
  
 
5,196,692
 
  
 
6,914,124
 
Total Investment Companies
 
  
 
5,196,692
 
  
 
6,914,124
 
TOTAL INVESTMENTS - 253.7
5
%
(15)
 
       
$
1,253,961,805
 
  
$
1,227,572,852
 
                   
Portfolio Company
      
Industry
   
                    
   
                                            
  
Shares
   
Cost
   
Fair Value
 
Cash Equivalents
- 7.66%
 
           
U.S. Investment Companies
- 7.66%
 
           
Blackrock T Fund I
(13) (16)
   Money Market    Money Market Portfolio      4.98%
(17)
 
  29,934,343   $29,934,343   $29,934,343 
State Street Institutional US Government Money Market Fund
(13) (16)
   Money Market    Money Market Portfolio      5.03%
(17)
 
  7,129,923    7,129,923    7,129,923 
                   
Total U.S. Investment Companies
           
 
37,064,266
 
  
 
37,064,266
 
                   
Total Cash Equivalents
           
 
37,064,266
 
  
 
37,064,266
 
LIABILITIES IN EXCESS OF OTHER ASSETS - (161.41%)
             
$
(780,854,292
                
NET ASSETS - 100.00%
             
$
483,782,826
 
                
(++) 
Unless otherwise indicated, all securities represent
co-investments
made with the Fund’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Related Party Transactions”.
As of June 30, 2023, qualifying assets represented 96.79% of total assets. Under the 1940 Act we may not acquire any
non-qualifying
assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.
Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.
Percentages are based on net assets.
Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”), Secured Overnight Financing Rate including adjustment, if any (“SOFR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR and SOFR loans are typically indexed to
30-day,
60-day,
90-day
or
180-day
rates (1M, 3M or 6M, respectively) at the borrower’s option. LIBOR and SOFR loans may be subject to interest floors. As of June 30, 2023, rates for weekly 1M L, 3M L 6M L, 1M S, 3M S and 6M S are 5.22%, 5.55%, 5.76%, 5.14%, 5.27% and 5.39%, respectively. As of June 30, 2023, the U.S. Prime rate was 8.25%.
^^ Controlled affiliated investment. See Note 3 “Related Party Transactions”.
^^^ 
Non-controlled
affiliated investment. See Note 3 “Related Party Transactions”.
(2) Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO XIII Ltd..
(3) Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding IV, LLC.
(4) Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.
(5) Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date, that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.
(6) The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.
(7) 
This investment has multiple reference rates or alternate base rates. The
All-in
interest rate shown is the weighted average interest rate in effect at June 30, 2023.
(8) 
The investment is on
non-accrual
status. See Note 2 “Significant Accounting Policies.”
(9) 
Positions considered
non-qualified
assets therefore excluded from the qualifying assets calculation as noted in footnote + above.
(10) Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of June 30, 2023, the aggregate fair value of these securities is $19,549,493 or 4.04% of the Fund’s net assets. The initial acquisition dates have been included for such securities.
(11) 
Non-income
producing investment.
(12) Position or portion thereof is held through a consolidated subsidiary.
(13) Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.
(14) Excluded from the ASC 820 fair value hierarchy as fair value is measured using the net asset value per share practical expedient.
(15) Aggregate gross unrealized appreciation for federal income tax purposes is $9,521,439; aggregate gross unrealized depreciation for federal income tax purposes is $35,910,392. Net unrealized depreciation is $26,388,953 based upon a tax cost basis of $1,253,961,805.
(16) Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.
(17) 
The rate shown is the annualized
seven-day
yield as of June 30, 2023.
L -LIBOR
P -Prime
PIK -
Payment-In-Kind
S -SOFR
See Notes to Unaudited Consolidated Financial Statements
18
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Investments at Fair Value
—245.69% (++) + * # ^
 
U.S. Corporate Debt
—236.64%
 
1st Lien/Senior Secured Debt
—234.31%
 
AmerCareRoyal, LLC
(1)
 Business Services Delayed Draw Term Loan 9.98% (S + 5.00%; 0.50% PIK; 1.00% Floor) 11/25/2025 $496,745  $489,122  $488,052 
AmerCareRoyal, LLC
(2)
 Business Services Term Loan 9.98% (L + 5.00%; 0.50% PIK; 1.00% Floor) 11/25/2025  511,273   499,144   502,326 
AmerCareRoyal, LLC
(1)
 Business Services Term Loan 9.98% (L + 5.00%; 0.50% PIK; 1.00% Floor) 11/25/2025  4,118,091   4,014,301   4,046,024 
Cerifi, LLC
(3) (4)
 Business Services Revolver 10.07% (S + 5.75%; 1.00% Floor) 04/01/2027  —     (19,595  (33,234
Cerifi, LLC
(2) (5)
 Business Services Term Loan 10.07% (S + 5.75%; 1.00% Floor) 03/31/2028  16,066,537   15,771,511   15,584,541 
Engage2Excel, Inc.
(3) (6)
 Business Services Revolver 10.63% (L + 7.25%; 1.00% Floor) 03/07/2023  351,629   350,588   341,095 
Engage2Excel, Inc.
(1)
 Business Services Term Loan 11.98% (L + 7.25%; 1.00% Floor) 03/07/2023  1,026,967   1,025,881   998,726 
Engage2Excel, Inc.
(1)
 Business Services Term Loan 11.98% (L + 7.25%; 1.00% Floor) 03/07/2023  2,959,179   2,956,519   2,877,801 
Metametrics, Inc.
(3)
 Business Services Revolver 9.77% (L + 5.00%; 1.00% Floor) 09/10/2025  130,237   124,316   122,097 
Metametrics, Inc.
(1)
(2)
 Business Services Term Loan 9.73% (L + 5.00%; 1.00% Floor) 09/10/2025  4,731,059   4,683,677   4,671,920 
MSM Acquisitions, Inc.
(3)
 Business Services Delayed Draw Term Loan 10.75% (L + 6.00%; 1.00% Floor) 12/09/2026  368,247   355,038   240,389 
MSM Acquisitions, Inc.
(2)
 Business Services Delayed Draw Term Loan 10.75% (L + 6.00%; 1.00% Floor) 12/09/2026  3,005,143   2,961,347   2,869,912 
MSM Acquisitions, Inc.
(3) (6)
 Business Services Revolver 12.50% (P + 5.00%; 1.00% Floor) 12/09/2026  569,646   553,338   514,519 
MSM Acquisitions, Inc.
(1) (2) (5)
 Business Services Term Loan 10.75% (L + 6.00%; 1.00% Floor) 12/09/2026  8,212,239   8,108,554   7,842,688 
Rep Tec Intermediate Holdings, Inc.
(3)
 Business Services Revolver 11.23% (L + 6.50%; 1.00% Floor) 12/01/2027  302,547   293,240   276,896 
Rep Tec Intermediate Holdings, Inc.
(1) (2) (5)
 Business Services Term Loan 11.23% (L + 6.50%; 1.00% Floor) 12/01/2027  14,568,787   14,390,788   14,095,301 
Sako and Partners Lower Holdings LLC
(3)
 Business Services Delayed Draw Term Loan 10.73% (S + 6.00%; 1.00% Floor) 09/15/2028  710,250   649,364   665,859 
Sako and Partners Lower Holdings LLC
(3)
 Business Services Revolver 10.73% (S + 6.00%; 1.00% Floor) 09/15/2028  337,369   301,842   303,188 
Sako and Partners Lower Holdings LLC
(1) (2) (5)
 Business Services Term Loan 10.73% (S + 6.00%; 1.00% Floor) 09/15/2028  14,915,247   14,488,923   14,505,078 
Valcourt Holdings II, LLC
(1) (3)
 Business Services Delayed Draw Term Loan 9.87% (S + 5.25%; 1.00% Floor) 01/07/2027  1,436,481   1,416,480   1,436,481 
Valcourt Holdings II, LLC
(2)
 Business Services Term Loan 9.98% (S + 5.25%; 1.00% Floor) 01/07/2027  2,641,197   2,603,425   2,641,197 
Valcourt Holdings II, LLC
(1) (2)
 Business Services Term Loan 9.98% (S + 5.25%; 1.00% Floor) 01/07/2027  6,279,095   6,191,332   6,279,095 
Valcourt Holdings II, LLC
(2)
 Business Services Term Loan 9.98% (S + 5.25%; 1.00% Floor) 01/07/2027  1,155,228   1,135,675   1,155,228 
AEG Holding Company, Inc.
(1)
 Consumer Discretionary Delayed Draw Term Loan 10.23% (L + 5.50%; 1.00% Floor) 11/20/2023  1,045,702   1,042,174   1,045,702 
AEG Holding Company, Inc.
(3)
 Consumer Discretionary Revolver 9.89% (L + 5.50%; 1.00% Floor) 11/20/2023  446,746   442,684   446,746 
AEG Holding Company, Inc.
(1)
 Consumer Discretionary Term Loan 10.23% (L + 5.50%; 1.00% Floor) 11/20/2023  5,512,963   5,493,673   5,512,963 
AEG Holding Company, Inc.
(5)
 Consumer Discretionary Term Loan 10.23% (L + 5.50%; 1.00% Floor) 11/20/2023  1,819,685   1,811,922   1,819,685 
Ampler QSR Holdings, LLC
(2) (5)
 Consumer
Non-Cyclical
 Term Loan 10.60% (L + 5.875%; 1.00% Floor) 07/21/2027  12,346,801   12,157,380   11,451,658 
Blink Holdings, Inc. Consumer
Non-Cyclical
 Delayed Draw Term Loan 12.73% (L + 5.50%; 2.50% PIK; 1.00% Floor) 11/08/2024  906,057   902,381   776,944 
Blink Holdings, Inc.
(1)
 Consumer
Non-Cyclical
 Delayed Draw Term Loan 12.73% (L + 5.50%; 2.50% PIK; 1.00% Floor) 11/08/2024  1,129,978   1,125,457   968,956 
Blink Holdings, Inc.
(1)
 Consumer
Non-Cyclical
 Term Loan 12.73% (L + 5.50%; 2.50% PIK; 1.00% Floor) 11/08/2024  1,579,576   1,573,226   1,354,486 
Freddy’s Frozen Custard,
L.L.C
(3) (4)
 Consumer
Non-Cyclical
 Revolver 9.73% (L + 5.00%; 1.00% Floor) 03/03/2027  —     (3,622  (4,123
Freddy’s Frozen Custard,
L.L.C
(2) (5)
 Consumer
Non-Cyclical
 Term Loan 9.73% (L + 5.00%; 1.00% Floor) 03/03/2027  4,856,991   4,814,117   4,808,421 
Krispy Krunchy Foods, L.L.C
(2)
 Consumer
Non-Cyclical
 Term Loan 9.17% (S + 4.75%; 1.00% Floor) 11/17/2027  9,419,615   9,264,858   9,066,379 
Mathnasium LLC
(3)
 Consumer
Non-Cyclical
 Revolver 10.13% (L + 5.00%; 0.75% Floor) 11/15/2027  87,043   76,360   72,355 
Mathnasium LLC
(1)
(2)
 Consumer
Non-Cyclical
 Term Loan 10.13% (L + 5.00%; 0.75% Floor) 11/15/2027  5,399,401   5,311,094   5,277,914 
See Notes to Unaudited Consolidated Financial Statements
19

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
MMP Intermediate,
LLC
(3) (4)
 Consumer
Non-Cyclical
 Revolver 10.13% (L + 5.75%; 1.00% Floor) 02/15/2027 $—    $(9,184 $(19,351
MMP Intermediate,
LLC
(1) (2)
 Consumer
Non-Cyclical
 Term Loan 10.13% (L + 5.75%; 1.00% Floor) 02/15/2027  8,210,266   8,070,540   7,922,907 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 9.32% (S + 5.00%; 1.00% Floor) 07/11/2025  236,681   230,929   227,214 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 9.48% (S + 5.00%; 1.00% Floor) 07/11/2025  117,139   114,293   112,454 
PF Growth Partners, LLC
(1)
 Consumer
Non-Cyclical
 Term Loan 9.48% (S + 5.00%; 1.00% Floor) 07/11/2025  1,970,938   1,961,608   1,892,101 
TBG Food Acquisition Corp
(3) (4)
 Consumer
Non-Cyclical
 Delayed Draw Term Loan 10.39% (L + 6.00%; 0.75% Floor) 12/25/2027  —     (8,824  (84,488
TBG Food Acquisition Corp
(3) (4)
 Consumer
Non-Cyclical
 Revolver 10.39% (L + 6.00%; 0.75% Floor) 12/25/2027  —     (2,206  (21,122
TBG Food Acquisition Corp
(1) (2)
 Consumer
Non-Cyclical
 Term Loan 10.39% (L + 6.00%; 0.75% Floor) 12/25/2027  6,534,645   6,480,001   6,011,873 
5 Bars, LLC
(3)
 Digital Infrastructure & Services Delayed Draw Term Loan 8.99% (L + 4.75%; 1.00% Floor) 09/27/2024  603,543   585,333   594,921 
5 Bars, LLC
(3)
(4)
 Digital Infrastructure & Services Revolver 9.14% (L + 4.75%; 1.00% Floor) 09/27/2024  —     (3,414  (1,617
5 Bars, LLC
(5)
 Digital Infrastructure & Services Term Loan 9.14% (L + 4.75%; 1.00% Floor) 09/27/2024  4,742,121   4,715,064   4,730,266 
Airwavz Solutions, Inc
(3) (4)
 Digital Infrastructure & Services Delayed Draw Term Loan 9.23% (S + 4.50%; 1.00% Floor) 03/31/2027  —     (27,846  (40,796
Airwavz Solutions, Inc
(3) (4)
 Digital Infrastructure & Services Revolver 9.23% (S + 4.50%; 1.00% Floor) 03/31/2027  —     (9,752  (13,055
Airwavz Solutions, Inc
(5)
 Digital Infrastructure & Services Term Loan 9.23% (S + 4.50%; 1.00% Floor) 03/31/2027  5,221,919   5,143,907   5,117,480 
Avant Communications, LLC
(3) (4)
 Digital Infrastructure & Services Revolver 10.23% (S + 5.50%; 1.00% Floor) 11/30/2026  —     (8,944  —   
Avant Communications, LLC
(1) (2)
 Digital Infrastructure & Services Term Loan 10.23% (S + 5.50%; 1.00% Floor) 11/30/2026  11,226,016   11,037,593   11,226,016 
Bridgepointe Technologies, LLC
(1) (3)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.33% (S + 6.50%; 1.00% Floor) 12/31/2027  2,867,063   2,762,979   2,730,229 
Bridgepointe Technologies, LLC
(1) (2) (6)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.48% (S + 6.50%; 1.00% Floor) 12/31/2027  3,887,472   3,843,407   3,751,411 
Bridgepointe Technologies, LLC
(5)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.48% (S + 6.50%; 1.00% Floor) 12/31/2027  2,765,645   2,743,404   2,661,933 
Bridgepointe Technologies, LLC
(3) (4)
 Digital Infrastructure & Services Revolver 10.48% (S + 6.50%; 1.00% Floor) 12/31/2027  —     (13,012  (29,156
Bridgepointe Technologies, LLC
(1) (2)
 Digital Infrastructure & Services Term Loan 10.33% (S + 6.50%; 1.00% Floor) 12/31/2027  2,294,250   2,203,018   2,208,215 
Bridgepointe Technologies, LLC
(1) (2)
 Digital Infrastructure & Services Term Loan 10.48% (S + 6.50%; 1.00% Floor) 12/31/2027  4,753,445   4,671,568   4,575,191 
Coretelligent Intermediate LLC
(2) (3)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.23% (L + 5.50%; 1.00% Floor) 10/21/2027  1,918,917   1,894,363   1,824,177 
Coretelligent Intermediate LLC
(3)
 Digital Infrastructure & Services Revolver 12.00% (P + 4.50%; 1.00% Floor) 10/21/2027  126,642   111,317   91,816 
Coretelligent Intermediate LLC
(1) (2) (5)
 Digital Infrastructure & Services Term Loan 10.23% (L + 5.50%; 1.00% Floor) 10/21/2027  7,948,819   7,852,631   7,730,226 
EvolveIP, LLC Digital Infrastructure & Services Delayed Draw Term Loan 10.54% (S + 5.50%; 1.00% Floor) 06/07/2025  111,106   110,897   108,051 
EvolveIP, LLC
(3)
 Digital Infrastructure & Services Revolver 10.23% (S + 5.50%; 1.00% Floor) 06/07/2025  148,331   147,270   132,742 
EvolveIP, LLC
(1)
 Digital Infrastructure & Services Term Loan 10.54% (S + 5.50%; 1.00% Floor) 06/07/2025  6,434,309   6,420,987   6,257,365 
Fatbeam, LLC
(3) (4)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.14% (L + 5.75%; 1.00% Floor) 02/22/2026  —     (23,079  (8,048
Fatbeam, LLC Digital Infrastructure & Services Revolver 9.97% (L + 5.75%; 1.00% Floor) 02/22/2026  643,849   634,618   640,630 
Fatbeam, LLC
(2) (5)
 Digital Infrastructure & Services Term Loan 10.14% (L + 5.75%; 1.00% Floor) 02/22/2026  6,438,490   6,345,468   6,406,298 
Firstdigital Communications LLC
(3)
 Digital Infrastructure & Services Revolver 8.69% (L + 4.25%; 0.75% Floor) 12/17/2026  412,549   387,223   345,113 
Firstdigital Communications LLC
(2) (5)
 Digital Infrastructure & Services Term Loan 8.69% (L + 4.25%; 0.75% Floor) 12/17/2026  13,645,840   13,428,040   13,065,892 
FirstLight Holdco, Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 8.38% (L + 4.00%; 1.00% Floor) 07/23/2025  6,195,183   6,042,729   5,947,376 
Greenlight Intermediate II, Inc.
(3) (4)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.05% (S + 5.50%; 0.75% Floor) 06/01/2028  —     (66,688  (50,266
Greenlight Intermediate II, Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 10.05% (S + 5.50%; 0.75% Floor) 06/01/2028  5,331,605   5,230,201   5,238,302 
MBS Holdings, Inc.
(3) (4)
 Digital Infrastructure & Services Revolver 10.13% (L + 5.75%; 1.00% Floor) 04/16/2027  —     (14,092  (38,967
MBS Holdings, Inc.
(1) (2) (5)
 Digital Infrastructure & Services Term Loan 10.13% (L + 5.75%; 1.00% Floor) 04/16/2027  10,363,212   10,213,299   9,948,684 
MSP Global Holdings,
Inc.
(3) (5)
 Digital Infrastructure & Services Delayed Draw Term Loan 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027  614,779   593,150   572,537 
See Notes to Unaudited Consolidated Financial Statements
20
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
MSP Global Holdings, Inc.
(3) (4)
 Digital Infrastructure & Services Revolver 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027 $—    $(12,111 $(29,608
MSP Global Holdings, Inc.
(2) (5)
 Digital Infrastructure & Services Term Loan 8.40% (S + 5.25%; 1.00% Floor) 01/25/2027  7,871,107   7,755,826   7,595,618 
NI Topco, Inc
(1)
 Digital Infrastructure & Services Term Loan 10.48% (L + 5.75%; 0.75% Floor) 12/28/2028  1,230,554   1,204,841   1,190,561 
NI Topco, Inc
(2)
(5)
 Digital Infrastructure & Services Term Loan 10.48% (L + 5.75%; 0.75% Floor) 12/28/2028  6,639,365   6,507,375   6,423,586 
Single Digits, Inc.
(2)
 Digital Infrastructure & Services Delayed Draw Term Loan 11.73% (L + 6.00%; 0.50% PIK; 1.00% Floor) 12/21/2023  599,248   597,286   507,863 
Single Digits, Inc.
(3) (4)
 Digital Infrastructure & Services Revolver 11.23% (L + 6.00%; 0.50% PIK; 1.00% Floor) 12/21/2023  —     (821  (63,463
Single Digits, Inc.
(1)
 Digital Infrastructure & Services Term Loan 11.23% (L + 6.00%; 0.50% PIK; 1.00% Floor) 12/21/2023  3,208,390   3,196,684   2,719,110 
Stratus Networks, Inc.
(3) (7)
 Digital Infrastructure & Services Delayed Draw Term Loan 8.65% (L + 5.25%; 1.00% Floor) 12/15/2027  330,033   294,377   270,627 
Stratus Networks, Inc.
(3) (7)
 Digital Infrastructure & Services Revolver 9.64% (L + 5.25%; 1.00% Floor) 12/15/2027  976,896   960,427   952,144 
Stratus Networks, Inc.
(2) (7)
 Digital Infrastructure & Services Term Loan 9.64% (L + 5.25%; 1.00% Floor) 12/15/2027  7,920,781   7,785,668   7,722,762 
Thrive Buyer, Inc.
(1) (2)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.73% (L + 6.00%; 1.00% Floor) 01/22/2027  8,257,588   8,132,628   8,133,724 
Thrive Buyer, Inc.
(3)
 Digital Infrastructure & Services Revolver 12.50% (P + 5.00%; 2.00% Floor) 01/22/2027  147,963   131,922   131,317 
Thrive Buyer, Inc.
(1) (2) (5)
 Digital Infrastructure & Services Term Loan 10.73% (L + 6.00%; 1.00% Floor) 01/22/2027  11,765,473   11,599,744   11,588,991 
Towerco IV Holdings, LLC
(1) (2) (3) (6)
 Digital Infrastructure & Services Delayed Draw Term Loan 8.69% (S + 4.25%; 1.00% Floor) 04/23/2026  18,094,038   17,893,436   17,776,414 
Transtelco Holding, Inc.
(2)
 Digital Infrastructure & Services Term Loan 9.98% (L + 5.25%; 0.50% Floor) 03/26/2026  4,708,605   4,683,094   4,508,489 
Transtelco Holding, Inc.
(1) (2) (5)
 Digital Infrastructure & Services Term Loan 10.48% (L + 5.75%; 0.50% Floor) 03/26/2026  4,708,605   4,683,985   4,567,347 
Accelerate Resources Operating, LLC
(3) (4)
 Energy Revolver 9.88% (L + 5.50%; 1.00% Floor) 02/24/2026  —     (4,437  —   
Accelerate Resources Operating, LLC
(1)
 Energy Term Loan 9.88% (L + 5.50%; 1.00% Floor) 02/24/2026  3,684,022   3,644,714   3,684,022 
Foundation Risk Partners, Corp.
(3)
 Financials Delayed Draw Term Loan 10.68% (S + 6.00%; 0.75% Floor) 10/30/2028  1,889,450   1,855,507   1,841,927 
Foundation Risk Partners, Corp.
(5)
 Financials Delayed Draw Term Loan 10.68% (S + 6.00%; 0.75% Floor) 10/29/2028  2,122,119   2,108,360   2,084,982 
Foundation Risk Partners, Corp.
(3)
 Financials Revolver 10.32% (S + 6.00%; 0.75% Floor) 10/29/2027  427,437   417,074   409,271 
Foundation Risk Partners, Corp.
(2)
 Financials Term Loan 10.68% (S + 6.00%; 0.75% Floor) 10/30/2028  787,291   776,726   773,513 
Foundation Risk Partners, Corp.
(1) (2) (5)
 Financials Term Loan 10.68% (S + 6.00%; 0.75% Floor) 10/29/2028  9,757,328   9,656,553   9,586,574 
Galway Borrower, LLC
(3) (4)
 Financials Delayed Draw Term Loan 9.98% (L + 5.25%; 0.75% Floor) 09/29/2028  —     (324  (1,274
Galway Borrower, LLC
(3) (4)
 Financials Revolver 9.98% (L + 5.25%; 0.75% Floor) 09/30/2027  —     (4,314  (11,492
Galway Borrower, LLC
(1) (2)
 Financials Term Loan 9.98% (L + 5.25%; 0.75% Floor) 09/29/2028  4,251,002   4,193,362   4,070,335 
Higginbotham Insurance Agency, Inc.
(2) (3)
 Financials Delayed Draw Term Loan 9.63% (L + 5.25%; 0.75% Floor) 11/25/2026  1,418,215   1,400,872   1,376,500 
Higginbotham Insurance Agency,
Inc.
(1) (2) (5)
 Financials Term Loan 9.63% (L + 5.25%; 0.75% Floor) 11/25/2026  8,043,274   7,963,283   7,922,625 
Peter C. Foy & Associates Insurance Services, LLC
(3) (5)
 Financials Delayed Draw Term Loan 11.12% (S + 6.00%; 0.75% Floor) 11/01/2028  1,094,089   1,075,743   1,037,605 
Peter C. Foy & Associates Insurance Services, LLC
(1) (5)
 Financials Delayed Draw Term Loan 11.12% (S + 6.00%; 0.75% Floor) 11/01/2028  5,929,510   5,878,970   5,662,682 
Peter C. Foy & Associates Insurance Services, LLC
(1)
 Financials Term Loan 11.12% (S + 6.00%; 0.75% Floor) 11/01/2028  502,267   495,352   479,665 
RSC Acquisition, Inc. Financials Delayed Draw Term Loan 10.05% (S + 5.50%; 0.75% Floor) 11/02/2026  1,858,816   1,847,931   1,798,405 
RSC Acquisition, Inc.
(3)
 Financials Delayed Draw Term Loan 10.78% (S + 5.50%; 0.75% Floor) 10/30/2026  208,293   163,003   39,176 
Wealth Enhancement Group, LLC
(1) (8)
 Financials Delayed Draw Term Loan 9.41% (S + 6.00%; 1.00% Floor) 10/04/2027  6,294,610   6,279,281   6,184,455 
Wealth Enhancement Group, LLC
(3) (8)
 Financials Delayed Draw Term Loan 10.31% (S + 6.00%; 1.00% Floor) 10/04/2027  644,865   641,740   624,421 
Wealth Enhancement Group, LLC
(3) (4) (8)
 Financials Revolver 9.41% (S + 6.00%; 1.00% Floor) 10/04/2027  —     (1,587  (8,004
AAH Topco, LLC
(1) (2) (3) (5)
 Healthcare & HCIT Delayed Draw Term Loan 9.79% (L + 5.50%; 0.75% Floor) 12/22/2027  3,495,723   3,353,967   3,262,208 
AAH Topco, LLC
(3) (4)
 Healthcare & HCIT Revolver 9.89% (L + 5.50%; 0.75% Floor) 12/22/2027  —     (13,145  (31,491
AAH Topco, LLC
(1) (2) (5)
 Healthcare & HCIT Term Loan 9.89% (L + 5.50%; 0.75% Floor) 12/22/2027  6,485,381   6,369,535   6,225,966 
See Notes to Unaudited Consolidated Financial Statements
21

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
American Physician Partners, LLC
(3)
 Healthcare & HCIT Delayed Draw Term Loan 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023 $210,956  $207,763  $198,310 
American Physician Partners, LLC
(1) (2)
 Healthcare & HCIT Delayed Draw Term Loan 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023  1,044,619   1,033,760   885,314 
American Physician Partners, LLC
(3)
 Healthcare & HCIT Revolver 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023  346,322   344,287   278,612 
American Physician Partners, LLC Healthcare & HCIT Term Loan 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023  5,569,954   5,360,739   4,720,536 
American Physician Partners, LLC
(1) (2)
 Healthcare & HCIT Term Loan 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023  2,223,081   2,143,812   1,884,061 
American Physician Partners, LLC
(2)
 Healthcare & HCIT Term Loan 14.67% (S + 6.75%; 3.50% PIK; 1.00% Floor) 02/15/2023  1,197,659   1,156,370   1,015,016 
Analogic Corporation
(3)
 Healthcare & HCIT Revolver 9.66% (L + 5.25%; 1.00% Floor) 06/22/2023  189,444   189,049   181,958 
Analogic Corporation
(1) (5)
 Healthcare & HCIT Term Loan 9.66% (L + 5.25%; 1.00% Floor) 06/22/2024  2,074,722   2,063,433   2,002,107 
AOM Acquisition, LLC.
(3) (4)
 Healthcare & HCIT Revolver 9.48% (S + 4.75%; 1.00% Floor) 02/18/2027  —     (20,267  (9,140
AOM Acquisition, LLC.
(1) (2)
 Healthcare & HCIT Term Loan 9.48% (S + 4.75%; 1.00% Floor) 02/18/2027  7,052,170   6,932,469   6,999,279 
BAART Programs, Inc.
(1) (3) (9)
 Healthcare & HCIT Delayed Draw Term Loan 9.73% (L + 5.00%; 1.00% Floor) 06/11/2027  3,913,117   3,859,734   3,596,122 
BAART Programs, Inc.
(1) (2) (9)
 Healthcare & HCIT Term Loan 9.73% (L + 5.00%; 1.00% Floor) 06/11/2027  4,721,880   4,688,869   4,497,591 
BV EMS Buyer, Inc.
(3)
 Healthcare & HCIT Delayed Draw Term Loan 10.18% (S + 5.75%; 1.00% Floor) 11/23/2027  764,792   703,741   641,249 
BV EMS Buyer, Inc.
(2)
 Healthcare & HCIT Term Loan 10.17% (S + 5.75%; 1.00% Floor) 11/23/2027  3,520,986   3,420,849   3,397,752 
Caregiver 2, Inc.
(2)
 Healthcare & HCIT Delayed Draw Term Loan 10.01% (L + 5.25%; 1.00% Floor) 07/24/2025  1,558,643   1,537,782   1,469,021 
Caregiver 2, Inc.
(5)
 Healthcare & HCIT Term Loan 10.01% (L + 5.25%; 1.00% Floor) 07/24/2025  4,672,010   4,621,799   4,403,370 
Caregiver 2, Inc.
(5)
 Healthcare & HCIT Term Loan 10.01% (L + 5.25%; 1.00% Floor) 07/24/2025  670,584   663,377   632,026 
Caregiver 2, Inc.
(2)
 Healthcare & HCIT Term Loan 9.69% (L + 5.25%; 1.00% Floor) 07/24/2025  640,028   630,459   603,227 
Choice Health At Home, LLC,
(1) (3)
 Healthcare & HCIT Delayed Draw Term Loan 10.14% (L + 6.00%; 1.00% Floor) 12/29/2026  988,121   968,239   895,779 
Choice Health At Home, LLC,
(1) (2)
 Healthcare & HCIT Term Loan 10.14% (L + 6.00%; 1.00% Floor) 12/29/2026  2,677,708   2,644,479   2,557,211 
Coding Solutions Acquisition, Inc
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 9.82% (S + 5.50%; 0.75% Floor) 05/11/2028  —     (15,076  (62,111
Coding Solutions Acquisition, Inc
(3)
 Healthcare & HCIT Revolver 9.82% (S + 5.50%; 0.75% Floor) 05/11/2028  159,072   145,189   121,292 
Coding Solutions Acquisition, Inc
(2) (5)
 Healthcare & HCIT Term Loan 9.82% (S + 5.50%; 0.75% Floor) 05/11/2028  5,516,636   5,417,625   5,254,596 
Community Based Care Acquisition,
Inc.
(2) (3)
 Healthcare & HCIT Delayed Draw Term Loan 9.93% (S + 5.25%; 1.00% Floor) 09/16/2027  2,034,120   2,003,449   1,948,384 
Community Based Care Acquisition,
Inc.
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 9.93% (S + 5.75%; 1.00% Floor) 09/16/2027  —     (55,320  (87,363
Community Based Care Acquisition,
Inc.
(3) (4)
 Healthcare & HCIT Revolver 9.93% (S + 5.25%; 1.00% Floor) 09/16/2027  —     (13,669  (34,553
Community Based Care Acquisition,
Inc.
(1) (2)
 Healthcare & HCIT Term Loan 9.93% (S + 5.25%; 1.00% Floor) 09/16/2027  5,288,695   5,203,277   5,077,147 
Delaware Valley Management Holdings, Inc.
(10)
 Healthcare & HCIT Delayed Draw Term Loan —   (L + 6.25%; 1.00% Floor) 03/21/2024  368,816   336,057   236,964 
Delaware Valley Management Holdings, Inc.
(3) (4) (10)
 Healthcare & HCIT Delayed Draw Term Loan —   (L + 6.25%; 1.00% Floor) 03/21/2024  65,913   58,267   (178,955
Delaware Valley Management Holdings, Inc.
(10)
 Healthcare & HCIT Revolver —   (L + 6.25%; 1.00% Floor) 03/21/2024  537,691   534,876   345,466 
Delaware Valley Management Holdings, Inc.
(10)
 Healthcare & HCIT Term Loan —   (L + 6.25%; 1.00% Floor) 03/21/2024  3,457,825   3,438,961   2,221,653 
FH MD Buyer, Inc.
(1) (2)
 Healthcare & HCIT Term Loan 9.38% (L + 5.00%; 0.75% Floor) 07/22/2028  5,465,408   5,417,025   5,246,792 
GHA Buyer, Inc.
(2)
 Healthcare & HCIT Delayed Draw Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  810,317   801,655   775,879 
GHA Buyer, Inc.
(3) (4)
 Healthcare & HCIT Revolver 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  —     (4,821  (40,421
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  1,955,034   1,947,826   1,871,945 
GHA Buyer, Inc.
(1) (5)
 Healthcare & HCIT Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  5,347,734   5,290,225   5,120,455 
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  725,344   714,335   694,517 
GHA Buyer, Inc.
(5)
 Healthcare & HCIT Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  4,630,385   4,575,902   4,433,594 
GHA Buyer, Inc.
(1)
 Healthcare & HCIT Term Loan 12.98% (S + 4.50%; 3.75% PIK; 1.00% Floor) 06/24/2026  558,835   552,492   535,085 
See Notes to Unaudited Consolidated Financial Statements
22
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Honor HN Buyer, Inc
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 10.48% (S + 6.00%; 1.00% Floor) 10/15/2027 $—    $(22,762 $—   
Honor HN Buyer, Inc
(2) (3)
 Healthcare & HCIT Delayed Draw Term Loan 10.48% (S + 5.75%; 1.00% Floor) 10/15/2027  762,672   743,223   758,541 
Honor HN Buyer, Inc
(3) (4)
 Healthcare & HCIT Revolver 10.48% (S + 5.75%; 1.00% Floor) 10/15/2027  —     (4,878  (2,281
Honor HN Buyer, Inc
(1) (2)
 Healthcare & HCIT Term Loan 10.48% (S + 5.75%; 1.00% Floor) 10/15/2027  2,616,861   2,574,759   2,597,235 
Medbridge Holdings,
LLC
(3) (4)
 Healthcare & HCIT Revolver 10.73% (S + 6.00%; 1.00% Floor) 12/23/2026  —     (18,403  (30,965
Medbridge Holdings, LLC
(1)
 Healthcare & HCIT Term Loan 10.73% (S + 6.00%; 1.00% Floor) 12/23/2026  974,356   957,337   952,433 
Medbridge Holdings, LLC
(1) (2)
 Healthcare & HCIT Term Loan 10.73% (S + 6.00%; 1.00% Floor) 12/23/2026  15,367,872   15,156,980   15,022,094 
Medical Management Resource Group, LLC
(1)
 Healthcare & HCIT Delayed Draw Term Loan 9.83% (L + 5.75%; 0.75% Floor) 09/30/2027  1,574,165   1,530,370   1,515,134 
Medical Management Resource Group, LLC
(3) (4)
 Healthcare & HCIT Revolver 10.16% (L + 5.75%; 0.75% Floor) 09/30/2026  —     (4,784  (11,866
Medical Management Resource Group, LLC
(2)
 Healthcare & HCIT Term Loan 10.16% (L + 5.75%; 0.75% Floor) 09/30/2027  3,812,010   3,751,190   3,669,060 
Medsuite Purchaser,
LLC
(3) (4) (11)
 Healthcare & HCIT Delayed Draw Term Loan 9.48% (S + 4.75%; 1.00% Floor) 10/22/2026  —     (41,080  —   
Medsuite Purchaser,
LLC
(3) (4) (11)
 Healthcare & HCIT Revolver 9.48% (S + 4.75%; 1.00% Floor) 10/22/2026  —     (7,832  (5,103
Medsuite Purchaser,
LLC
(1) (2) (11)
 Healthcare & HCIT Term Loan 9.48% (S + 4.75%; 1.00% Floor) 10/22/2026  4,782,533   4,727,484   4,746,664 
OMH-HealthEdge
Holdings,
LLC
(3) (4)
 Healthcare & HCIT Revolver 10.03% (L + 5.25%; 1.00% Floor) 10/24/2024  —     (3,799  (1,147
OMH-HealthEdge
Holdings, LLC
(2)
 Healthcare & HCIT Term Loan 10.03% (L + 5.25%; 1.00% Floor) 10/24/2025  2,121,853   2,092,279   2,116,548 
OMH-HealthEdge
Holdings, LLC
(2)
 Healthcare & HCIT Term Loan 10.03% (L + 5.25%; 1.00% Floor) 10/24/2025  963,638   946,724   961,229 
OMH-HealthEdge
Holdings, LLC
(1)
 Healthcare & HCIT Term Loan 10.03% (L + 5.25%; 1.00% Floor) 10/24/2025  3,661,451   3,618,231   3,652,297 
Pace Health Companies, LLC
(3) (4)
 Healthcare & HCIT Revolver 9.23% (L + 4.50%; 1.00% Floor) 08/02/2024  —     (2,053  (1,542
Pace Health Companies, LLC
(1)
 Healthcare & HCIT Term Loan 9.23% (L + 4.50%; 1.00% Floor) 08/02/2024  5,140,906   5,122,407   5,128,053 
Pinnacle Dermatology Management, LLC
(3)
 Healthcare & HCIT Delayed Draw Term Loan 10.55% (S + 5.75%; 0.75% Floor) 12/08/2028  462,795   449,342   421,791 
Pinnacle Dermatology Management, LLC
(3) (6)
 Healthcare & HCIT Revolver 8.74% (L + 4.00%; 0.75% Floor) 12/08/2026  153,627   142,959   146,906 
Pinnacle Dermatology Management, LLC
(1) (2) (5)
 Healthcare & HCIT Term Loan 9.50% (L + 5.75%; 0.75% Floor) 12/08/2028  5,608,718   5,494,471   5,356,325 
Pinnacle Treatment Centers,
Inc.
(2)
 Healthcare & HCIT Delayed Draw Term Loan 10.57% (L + 6.50%; 1.00% Floor) 01/02/2026  343,635   342,065   335,904 
Pinnacle Treatment Centers,
Inc.
(3) (4)
 Healthcare & HCIT Revolver 10.57% (L + 6.50%; 1.00% Floor) 01/02/2026  —     (1,223  (6,591
Pinnacle Treatment Centers,
Inc.
(5)
 Healthcare & HCIT Term Loan 10.57% (L + 6.50%; 1.00% Floor) 01/02/2026  286,781   280,374   280,329 
Pinnacle Treatment Centers, Inc. Healthcare & HCIT Term Loan 10.57% (L + 6.50%; 1.00% Floor) 01/02/2026  147,916   147,916   144,588 
Pinnacle Treatment Centers,
Inc.
(2) (5)
 Healthcare & HCIT Term Loan 10.57% (L + 6.50%; 1.00% Floor) 01/02/2026  4,086,076   4,086,076   3,994,140 
Priority Ondemand Midco 2,L.P
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 10.26% (S + 5.50%; 1.00% Floor) 07/17/2028  —     (22,041  (30,472
Priority Ondemand Midco 2,L.P
(1) (2)
 Healthcare & HCIT Term Loan 10.26% (S + 5.50%; 1.00% Floor) 07/17/2028  7,617,883   7,493,551   7,465,525 
RCP Encore Acquisition,
Inc.
(10)
 Healthcare & HCIT Term Loan —   (L + 5.00%; 1.00% Floor) 06/07/2025  3,328,678   3,230,584   33,287 
Redwood Family Care Network, Inc.
(3)
 Healthcare & HCIT Delayed Draw Term Loan 10.23% (S + 5.50%; 1.00% Floor) 06/18/2026  681,697   590,071   573,016 
Redwood Family Care Network, Inc.
(1)
 Healthcare & HCIT Delayed Draw Term Loan 10.23% (S + 5.50%; 1.00% Floor) 06/18/2026  5,829,798   5,748,005   5,684,053 
Redwood Family Care Network, Inc.
(3) (4)
 Healthcare & HCIT Revolver 10.23% (S + 5.50%; 1.00% Floor) 06/18/2026  —     (8,245  (14,718
Redwood Family Care Network, Inc.
(5)
 Healthcare & HCIT Term Loan 10.23% (S + 5.50%; 1.00% Floor) 06/18/2026  6,668,555   6,575,155   6,501,841 
Salisbury House, LLC
(3)
 Healthcare & HCIT Revolver 9.24% (S + 5.00%; 1.00% Floor) 08/30/2025  179,337   173,206   162,524 
Salisbury House, LLC
(1) (2)
 Healthcare & HCIT Term Loan 10.20% (S + 5.50%; 1.00% Floor) 08/30/2025  3,934,410   3,874,710   3,786,869 
Salisbury House, LLC
(1)
 Healthcare & HCIT Term Loan 10.20% (S + 5.50%; 1.00% Floor) 08/30/2025  1,237,525   1,215,852   1,191,118 
Salisbury House, LLC
(1)
 Healthcare & HCIT Term Loan 10.20% (S + 5.50%; 1.00% Floor) 08/30/2025  1,137,143   1,125,353   1,094,500 
See Notes to Unaudited Consolidated Financial Statements
23

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Sandstone Care Holdings, LLC
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 9.69% (S + 5.50%; 1.00% Floor) 06/28/2028 $—    $(10,812 $(26,502
Sandstone Care Holdings, LLC
(3)
 Healthcare & HCIT Revolver 9.69% (S + 5.50%; 1.00% Floor) 06/28/2028  235,569   220,425   208,773 
Sandstone Care Holdings, LLC
(1) (5)
 Healthcare & HCIT Term Loan 9.69% (S + 5.50%; 1.00% Floor) 06/28/2028  4,687,823   4,591,008   4,535,469 
SCA Buyer, LLC
(3)
 Healthcare & HCIT Revolver 11.38% (S + 6.50%; 1.00% Floor) 01/20/2026  386,309   380,329   360,555 
SCA Buyer, LLC
(2)
 Healthcare & HCIT Term Loan 11.38% (S + 6.50%; 1.00% Floor) 01/20/2026  3,795,490   3,759,075   3,643,671 
SIS Purchaser, Inc.
(3) (4)
 Healthcare & HCIT Revolver 10.39% (L + 6.00%; 1.00% Floor) 10/15/2026  —     (12,996  (37,893
SIS Purchaser, Inc.
(2)
 Healthcare & HCIT Term Loan 10.39% (L + 6.00%; 1.00% Floor) 10/15/2026  2,405,941   2,374,979   2,327,748 
SIS Purchaser, Inc.
(1) (2) (5)
 Healthcare & HCIT Term Loan 10.39% (L + 6.00%; 1.00% Floor) 10/15/2026  12,568,947   12,422,981   12,160,456 
Smile Brands, Inc.
(5)
 Healthcare & HCIT Delayed Draw Term Loan 7.87% (L + 4.50%; 0.75% Floor) 10/12/2025  482,953   481,469   445,524 
Smile Brands, Inc.
(3)
 Healthcare & HCIT Revolver 11.00% (P + 3.50%; 0.75% Floor) 10/12/2025  88,025   87,613   68,277 
Smile Brands, Inc.
(1)
 Healthcare & HCIT Term Loan 7.87% (L + 4.50%; 0.75% Floor) 10/12/2025  1,590,621   1,585,335   1,467,348 
Spark DSO LLC
(3) (4)
 Healthcare & HCIT Revolver 9.99% (L + 6.25%; 1.00% Floor) 04/20/2026  —     (13,111  (38,702
Spark DSO LLC
(1) (2) (5)
 Healthcare & HCIT Term Loan 9.99% (L + 6.25%; 1.00% Floor) 04/19/2026  7,274,395   7,188,032   7,019,791 
The Center for Orthopedic and Research Excellence, Inc.
(3)
 Healthcare & HCIT Delayed Draw Term Loan 10.18% (S + 5.50%; 1.00% Floor) 08/15/2025  456,510   441,385   430,864 
The Center for Orthopedic and Research Excellence, Inc.
(2) (6)
 Healthcare & HCIT Delayed Draw Term Loan 10.18% (S + 6.00%; 1.00% Floor) 08/15/2025  1,735,098   1,716,275   1,700,396 
The Center for Orthopedic and Research Excellence, Inc.
(1) (2)
 Healthcare & HCIT Delayed Draw Term Loan 10.24% (S + 6.00%; 1.00% Floor) 08/15/2025  1,141,583   1,137,251   1,113,044 
The Center for Orthopedic and Research Excellence, Inc.
(3)
 Healthcare & HCIT Revolver 10.56% (S + 6.00%; 1.00% Floor) 08/15/2025  552,426   546,948   535,162 
The Center for Orthopedic and Research Excellence, Inc.
(2)
 Healthcare & HCIT Term Loan 10.41% (S + 6.00%; 1.00% Floor) 08/15/2025  3,232,332   3,186,733   3,151,523 
The Center for Orthopedic and Research Excellence, Inc.
(1) (5)
 Healthcare & HCIT Term Loan 10.24% (S + 6.00%; 1.00% Floor) 08/15/2025  4,843,650   4,802,458   4,722,559 
West Dermatology
(3) (4)
 Healthcare & HCIT Delayed Draw Term Loan 10.17% (S + 5.75%; 1.00% Floor) 03/17/2028  —     (33,915  (522,447
West Dermatology
(3) (4)
 Healthcare & HCIT Revolver 10.17% (S + 5.75%; 1.00% Floor) 03/17/2028  —     (22,620  (186,588
West Dermatology
(1) (2) (5)
 Healthcare & HCIT Term Loan 10.17% (S + 5.75%; 1.00% Floor) 03/17/2028  12,594,247   12,365,225   10,705,110 
Activ Software Holdings, LLC
(3) (4)
 Software & Tech Services Revolver 11.79% (L + 6.25%; 1.00% Floor) 05/04/2027  —     (9,501  (21,087
Activ Software Holdings, LLC
(1) (2) (5)
 Software & Tech Services Term Loan 11.79% (L + 6.25%; 1.00% Floor) 05/04/2027  7,988,807   7,871,886   7,729,171 
Admiral Buyer, Inc
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.08% (S + 5.50%; 0.75% Floor) 05/08/2028  —     (14,110  (15,770
Admiral Buyer, Inc
(3) (4)
 Software & Tech Services Revolver 10.08% (S + 5.50%; 0.75% Floor) 05/08/2028  —     (10,084  (11,264
Admiral Buyer, Inc
(1)
 Software & Tech Services Term Loan 10.08% (S + 5.50%; 0.75% Floor) 05/08/2028  5,842,640   5,738,028   5,725,787 
AMI US Holdings, Inc.
(3) (4)
 Software & Tech Services Revolver 9.63% (L + 5.25%) 04/01/2024  —     (5,893  —   
AMI US Holdings, Inc.
(1)
 Software & Tech Services Term Loan 9.63% (L + 5.25%; 1.00% Floor) 04/01/2025  8,007,035   7,938,572   8,007,035 
Avalara, Inc.
(3) (4)
 Software & Tech Services Revolver 11.83% (S + 7.25%; 0.75% Floor) 10/19/2028  —     (25,767  (26,634
Avalara, Inc.
(2) (5)
 Software & Tech Services Term Loan 11.83% (S + 7.25%; 0.75% Floor) 10/19/2028  10,653,748   10,396,078   10,387,404 
Avetta, LLC
(3) (4)
 Software & Tech Services Revolver 10.16% (L + 5.75%; 1.00% Floor) 04/10/2024  —     (2,142  (2,472
Avetta, LLC
(2)
 Software & Tech Services Term Loan 10.16% (L + 5.75%; 1.00% Floor) 04/10/2024  6,768,472   6,704,614   6,734,630 
Avetta, LLC
(1)
 Software & Tech Services Term Loan 10.16% (L + 5.75%; 1.00% Floor) 04/10/2024  4,196,029   4,171,041   4,175,049 
Avetta, LLC
(1) (5)
 Software & Tech Services Term Loan 10.16% (L + 5.75%; 1.00% Floor) 04/10/2024  3,187,003   3,161,068   3,171,068 
Bonterra, LLC
(3) (4) (12)
 Software & Tech Services Delayed Draw Term Loan 10.98% (L + 6.25%; 0.75% Floor) 09/08/2027  —     (17,010  (68,655
Bonterra, LLC
(3) (12)
 Software & Tech Services Revolver 10.98% (L + 6.25%; 0.75% Floor) 09/08/2027  428,359   414,759   390,927 
Bonterra, LLC
(1) (2) (5) (12)
 Software & Tech Services Term Loan 10.98% (L + 6.25%; 0.75% Floor) 09/08/2027  15,595,728   15,416,612   15,088,867 
See Notes to Unaudited Consolidated Financial Statements
24
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
             Industry             
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Brightspot Buyer, Inc
(3) (4)
 Software & Tech Services Revolver 10.18% (S + 5.50%; 0.75% Floor) 11/16/2027 $—    $(11,138 $(20,409
Brightspot Buyer, Inc
(2)
 Software & Tech Services Term Loan 10.18% (S + 5.50%; 0.75% Floor) 11/16/2027  5,215,571   5,130,177   5,059,104 
BSI2 Hold Nettle, LLC
(3) (4)
 Software & Tech Services Revolver 9.54% (S + 4.75%; 0.75% Floor) 06/30/2028  —     (8,123  (10,306
BSI2 Hold Nettle, LLC
(2) (5)
 Software & Tech Services Term Loan 9.54% (S + 4.75%; 0.75% Floor) 06/30/2028  4,699,602   4,634,781   4,617,359 
BusinesSolver.com, Inc.
(3)
 Software & Tech Services Delayed Draw Term Loan 9.88% (L + 5.50%; 0.75% Floor) 12/01/2027  169,881   160,968   120,219 
BusinesSolver.com, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.23% (L + 5.50%; 0.75% Floor) 12/01/2027  7,324,613   7,264,046   7,104,875 
Certify, Inc Software & Tech Services Delayed Draw Term Loan 9.89% (L + 5.50%; 1.00% Floor) 02/28/2024  399,689   397,724   396,692 
Certify, Inc
(5)
 Software & Tech Services Delayed Draw Term Loan 9.89% (L + 5.50%; 1.00% Floor) 02/28/2024  479,627   477,590   476,030 
Certify, Inc
(3)
 Software & Tech Services Revolver 9.89% (L + 5.50%; 1.00% Floor) 02/28/2024  39,969   39,838   38,770 
Certify, Inc
(1) (2)
(5)
 Software & Tech Services Term Loan 9.89% (L + 5.50%; 1.00% Floor) 02/28/2024  3,916,954   3,897,691   3,887,577 
Community Brands Parentco, LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.17% (S + 5.75%; 0.75% Floor) 02/24/2028  —     (7,196  (27,118
Community Brands Parentco, LLC
(3) (4)
 Software & Tech Services Revolver 10.17% (S + 5.75%; 0.75% Floor) 02/24/2028  —     (7,201  (17,731
Community Brands Parentco, LLC
(1) (2)
 Software & Tech Services Term Loan 10.17% (S + 5.75%; 0.75% Floor) 02/24/2028  7,039,335   6,915,224   6,740,163 
Datacor, Inc.
(3)
 Software & Tech Services Delayed Draw Term Loan 10.09% (S + 5.75%; 1.00% Floor) 12/29/2025  1,113,561   1,084,969   1,100,835 
Datacor, Inc.
(3) (4)
 Software & Tech Services Revolver 10.33% (S + 5.75%; 1.00% Floor) 12/29/2025  —     (7,696  (9,658
Datacor, Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 10.33% (S + 5.75%; 1.00% Floor) 12/29/2025  13,841,011   13,618,560   13,633,396 
Degreed, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.92% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  —     (4,052  (34,785
Degreed, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.92% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  —     (11,955  (26,433
Degreed, Inc.
(3) (4)
 Software & Tech Services Revolver 10.92% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  —     (1,544  (12,534
Degreed, Inc.
(2)
 Software & Tech Services Term Loan 10.92% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  2,793,161   2,776,565   2,709,367 
Degreed, Inc.
(1) (5)
 Software & Tech Services Term Loan 10.92% (S + 5.50%; 1.00% PIK; 1.00% Floor) 05/29/2026  5,172,233   5,138,480   5,017,066 
Dispatch Track, LLC
(3) (4)
 Software & Tech Services Revolver 8.86% (L + 4.50%; 1.00% Floor) 12/17/2026  —     (1,812  (3,019
Dispatch Track, LLC
(1) (2)
 Software & Tech Services Term Loan 8.86% (L + 4.50%; 1.00% Floor) 12/17/2026  9,849,936   9,777,608   9,751,437 
Drilling Info Holdings, Inc.
(1)
 Software & Tech Services Term Loan 8.63% (L + 4.25%) 07/30/2025  3,292,167   3,285,890   3,226,324 
EET Buyer, Inc.
(3) (4)
 Software & Tech Services Revolver 10.26% (L + 5.25%; 0.75% Floor) 11/08/2027  —     (11,261  (13,816
EET Buyer, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.26% (L + 5.25%; 0.75% Floor) 11/08/2027  6,856,127   6,744,365   6,719,005 
Exterro, Inc.
(3) (4)
 Software & Tech Services Revolver 10.27% (L + 5.50%; 1.00% Floor) 05/31/2024  —     (1,197  (1,238
Exterro, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.27% (L + 5.50%; 1.00% Floor) 05/31/2024  6,237,900   6,184,219   6,206,710 
Exterro, Inc.
(1) (2)
 Software & Tech Services Term Loan 10.27% (L + 5.50%; 1.00% Floor) 05/31/2024  5,809,123   5,752,695   5,780,077 
Exterro, Inc.
(1)
 Software & Tech Services Term Loan 10.27% (L + 5.50%; 1.00% Floor) 05/31/2024  2,793,450   2,779,059   2,779,483 
Faithlife, LLC
(1)
(2)
 Software & Tech Services Delayed Draw Term Loan 10.68% (S + 6.00%; 1.00% Floor) 09/18/2025  708,304   700,650   708,304 
Faithlife, LLC
(3) (4)
 Software & Tech Services Revolver 10.68% (S + 6.00%; 1.00% Floor) 09/18/2025  —     (3,059  —   
Faithlife, LLC
(1) (2)
 Software & Tech Services Term Loan 10.68% (S + 6.00%; 1.00% Floor) 09/18/2025  304,180   300,827   304,180 
Fusion Holding Corp
(3) (4)
 Software & Tech Services Revolver 10.78% (S + 6.25%; 0.75% Floor) 09/15/2027  —     (29,257  (34,480
Fusion Holding
Corp
(1) (2) (5)
 Software & Tech Services Term Loan 10.78% (S + 6.25%; 0.75% Floor) 09/15/2029  16,895,061   16,530,288   16,472,685 
Fusion Risk Management
Inc
(3) (4)
 Software & Tech Services Revolver 11.40% (S + 6.50%; 1.00% Floor) 08/30/2028  —     (18,154  (29,850
Fusion Risk Management
Inc
(1) (5)
 Software & Tech Services Term Loan 11.40% (S + 6.50%; 1.00% Floor) 08/30/2028  8,610,210   8,428,666   8,308,852 
Genesis Acquisition
Co.
(5)
 Software & Tech Services Revolver 8.48% (L + 3.75%) 07/31/2024  202,400   201,292   196,834 
Genesis Acquisition
Co.
(1) (2)
 Software & Tech Services Term Loan 7.92% (L + 3.75%) 07/31/2024  1,360,788   1,352,870   1,323,367 
Greenhouse Software,
Inc.
(3) (4)
 Software & Tech Services Revolver 11.58% (S + 7.00%; 1.00% Floor) 09/01/2028  —     (19,492  (30,806
See Notes to Unaudited Consolidated Financial Statements
25

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Greenhouse Software,
Inc.
(3) (4)
 Software & Tech Services Revolver 11.58% (S + 7.00%; 1.00% Floor) 09/01/2028 $—    $(14,303 $(15,112
Greenhouse Software,
Inc.
(2) (5)
 Software & Tech Services Term Loan 11.58% (S + 7.00%; 1.00% Floor) 09/01/2028  12,376,845   12,179,502   12,067,424 
Greenhouse Software,
Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 11.58% (S + 7.00%; 1.00% Floor) 09/01/2028  14,507,975   14,164,695   14,145,275 
Gryphon-Redwood Acquisition LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 14.58% (S + 4.00%; 6.00% PIK; 1.00% Floor) 09/16/2028  —     (26,449  (35,685
Gryphon-Redwood Acquisition LLC
(1)
 Software & Tech Services Term Loan 14.58% (S + 4.00%; 6.00% PIK; 1.00% Floor) 09/16/2028  3,521,435   3,463,723   3,442,202 
GS AcquisitionCo, Inc.
(3) (4)
 Software & Tech Services Revolver 9.92% (L + 5.75%; 1.00% Floor) 05/22/2026  —     (1,923  (18,268
GS AcquisitionCo,
Inc.
(1) (2) (5) (6)
 Software & Tech Services Term Loan 9.92% (L + 5.75%; 1.00% Floor) 05/22/2026  9,479,087   9,448,353   9,099,923 
Iodine Software, LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 11.42% (S + 7.00%; 1.00% Floor) 05/19/2027  —     (41,099  (25,771
Iodine Software, LLC
(2) (5)
 Software & Tech Services Delayed Draw Term Loan 11.42% (S + 7.00%; 1.00% Floor) 05/19/2027  7,956,211   7,838,340   7,797,087 
Iodine Software, LLC
(3) (4)
 Software & Tech Services Revolver 11.42% (S + 7.00%; 1.00% Floor) 05/19/2027  —     (16,085  (21,781
Iodine Software, LLC
(1) (2)
 Software & Tech Services Term Loan 11.42% (S + 7.00%; 1.00% Floor) 05/19/2027  5,281,749   5,203,738   5,176,114 
Kaseya Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.33% (S + 5.75%; 0.75% Floor) 06/25/2029  —     (8,852  (19,103
Kaseya Inc.
(3) (4)
 Software & Tech Services Revolver 10.33% (S + 5.75%; 0.75% Floor) 06/25/2029  —     (4,425  (23,879
Kaseya Inc.
(1) (2)
 Software & Tech Services Term Loan 10.33% (S + 5.75%; 0.75% Floor) 06/25/2029  10,506,804   10,360,743   10,112,799 
Mavenlink, Inc.
(3)
 Software & Tech Services Revolver 9.89% (L + 5.75%; 0.75% Floor) 06/03/2027  357,963   328,924   308,743 
Mavenlink, Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 9.14% (L + 5.75%; 0.75% Floor) 06/03/2027  15,034,451   14,790,523   14,621,004 
Moon Buyer, Inc. Software & Tech Services Delayed Draw Term Loan 9.49% (L + 4.75%; 1.00% Floor) 04/21/2027  581,896   578,330   580,442 
Moon Buyer, Inc.
(3) (4)
 Software & Tech Services Revolver 9.48% (L + 4.75%; 1.00% Floor) 04/21/2027  —     (12,657  (2,909
Moon Buyer, Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 9.48% (L + 4.75%; 1.00% Floor) 04/21/2027  6,304,848   6,236,280   6,289,086 
Mykaarma Acquisition
LLC
(3) (4)
 Software & Tech Services Revolver 10.88% (S + 3.00%; 3.75% PIK; 1.00% Floor) 03/21/2028  —     (10,357  (16,313
Mykaarma Acquisition
LLC
(2) (5)
 Software & Tech Services Term Loan 10.88% (S + 3.00%; 3.75% PIK; 1.00% Floor) 03/21/2028  6,103,707   5,997,612   5,935,855 
Navigate360, LLC
(2)
 Software & Tech Services Delayed Draw Term Loan 10.33% (S + 6.00%; 1.00% Floor) 03/17/2027  1,808,174   1,786,326   1,772,010 
Navigate360, LLC
(3) (4)
 Software & Tech Services Revolver 10.33% (S + 6.00%; 1.00% Floor) 03/17/2027  —     (10,211  (12,085
Navigate360, LLC
(2)
 Software & Tech Services Term Loan 10.33% (S + 6.00%; 1.00% Floor) 03/17/2027  2,265,796   2,221,961   2,220,480 
Navigate360, LLC
(5)
 Software & Tech Services Term Loan 10.33% (S + 6.00%; 1.00% Floor) 03/17/2027  4,197,924   4,125,548   4,113,965 
Netwrix Corporation And Concept Searching Inc.
(3)
 Software & Tech Services Delayed Draw Term Loan 9.70% (S + 5.00%; 0.75% Floor) 06/11/2029  548,139   543,652   521,729 
Netwrix Corporation And Concept Searching
Inc.
(3) (4)
 Software & Tech Services Revolver 9.70% (S + 5.00%; 0.75% Floor) 06/11/2029  —     (2,349  (7,748
Netwrix Corporation And Concept Searching
Inc.
(1) (2)
 Software & Tech Services Term Loan 9.70% (S + 5.00%; 0.75% Floor) 06/11/2029  9,204,116   9,181,651   9,112,075 
Ping Identity
Corporation
(3) (4)
 Software & Tech Services Revolver 11.32% (S + 7.00%; 0.75% Floor) 10/17/2028  —     (29,103  (30,084
Ping Identity
Corporation
(1) (2) (5)
 Software & Tech Services Term Loan 11.32% (S + 7.00%; 0.75% Floor) 10/17/2029  12,033,445   11,741,078   11,732,609 
Ranger Buyer, Inc.
(3) (4)
 Software & Tech Services Revolver 9.88% (L + 5.50%; 0.75% Floor) 11/18/2027  —     (19,742  (29,981
Ranger Buyer, Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 9.88% (L + 5.50%; 0.75% Floor) 11/17/2028  14,282,859   14,033,779   13,925,788 
Sauce Labs, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.31% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  —     (21,889  (35,512
Sauce Labs, Inc.
(5)
 Software & Tech Services Delayed Draw Term Loan 10.31% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  1,925,189   1,895,279   1,877,059 
Sauce Labs, Inc.
(3) (4)
 Software & Tech Services Revolver 10.31% (S + 5.50%; 1.00% Floor) 08/16/2027  —     (19,953  (32,046
Sauce Labs, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.31% (S + 5.50%; 0.50% PIK; 1.00% Floor) 08/16/2027  7,504,362   7,377,979   7,316,753 
Saviynt, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 11.42% (S + 7.00%; 1.00% Floor) 12/22/2027  —     (151,721  (152,450
Saviynt, Inc.
(3) (4)
 Software & Tech Services Revolver 11.42% (S + 7.00%; 1.00% Floor) 12/22/2027  —     (15,172  (15,245
See Notes to Unaudited Consolidated Financial Statements
26
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
    Facility Type    
 
                      Interest                      
 
  Maturity  
 
Funded

  Par Amount  
  
        Cost        
  
  Fair Value  
 
Saviynt, Inc.
(2) (5)
 Software & Tech Services Term Loan 11.42% (S + 7.00%; 1.00% Floor) 12/22/2027 $18,293,942  $17,838,779  $17,836,593 
ScyllaDB, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.82% (S + 6.50%; 1.00% Floor) 09/08/2027  —     (3,101  (8,260
ScyllaDB, Inc.
(3) (4)
 Software & Tech Services Revolver 10.82% (S + 6.50%; 1.00% Floor) 09/08/2027  —     (2,481  (4,626
ScyllaDB, Inc.
(5)
 Software & Tech Services Term Loan 10.82% (S + 6.50%; 1.00% Floor) 09/08/2027  2,643,348   2,577,310   2,597,089 
Securonix, Inc.
(3) (4)
 Software & Tech Services Revolver 10.10% (S + 6.50%; 0.75% Floor) 04/05/2028  —     (23,716  (69,225
Securonix, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.10% (S + 6.50%; 0.75% Floor) 04/05/2028  8,546,314   8,414,561   8,161,730 
Sirsi Corporation
(3) (4)
 Software & Tech Services Revolver 8.88% (L + 4.50%; 1.00% Floor) 03/15/2024  —     (2,145  (2,769
Sirsi Corporation
(1) (2)
 Software & Tech Services Term Loan 8.88% (L + 4.50%; 1.00% Floor) 03/15/2024  6,591,250   6,563,978   6,558,294 
Smartlinx Solutions, LLC
(3)
 Software & Tech Services Revolver 10.48% (L + 5.75%; 1.00% Floor) 03/04/2026  129,871   127,080   114,286 
Smartlinx Solutions, LLC Software & Tech Services Term Loan 10.48% (L + 5.75%; 1.00% Floor) 03/04/2026  493,137   484,961   478,342 
Smartlinx Solutions,
LLC
(1) (2) (5)
 Software & Tech Services Term Loan 10.48% (L + 5.75%; 1.00% Floor) 03/04/2026  5,620,327   5,559,389   5,451,717 
Soladoc, LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.07% (S + 5.25%; 0.75% Floor) 06/12/2028  —     (21,438  (53,003
Soladoc, LLC
(3) (4)
 Software & Tech Services Revolver 10.07% (S + 5.25%; 0.75% Floor) 06/12/2028  —     (10,724  (19,140
Soladoc, LLC
(1) (2)
 Software & Tech Services Term Loan 10.07% (S + 5.25%; 0.75% Floor) 06/12/2028  5,889,225   5,781,986   5,697,825 
SugarCRM, Inc.
(3) (4)
 Software & Tech Services Revolver 10.88% (L + 6.50%; 1.00% Floor) 07/31/2024  —     (1,483  (4,654
SugarCRM, Inc.
(1) (5)
 Software & Tech Services Term Loan 10.88% (L + 6.50%; 1.00% Floor) 07/31/2024  4,268,824   4,243,198   4,204,792 
Sundance Group Holdings,
Inc.
(5)
 Software & Tech Services Delayed Draw Term Loan 10.75% (S + 6.25%; 1.00% Floor) 07/02/2027  3,547,253   3,493,454   3,449,704 
Sundance Group Holdings,
Inc.
(3) (4)
 Software & Tech Services Revolver 10.75% (S + 6.25%; 1.00% Floor) 07/02/2027  —     (21,522  (39,020
Sundance Group Holdings,
Inc.
(2) (5)
 Software & Tech Services Term Loan 10.75% (S + 6.25%; 1.00% Floor) 07/02/2027  11,824,177   11,644,830   11,499,012 
Sundance Group Holdings, Inc. Software & Tech Services Term Loan 10.93% (S + 6.25%; 1.00% Floor) 07/02/2027  463,790   450,131   451,036 
Swiftpage, Inc.
(3) (4)
 Software & Tech Services Revolver 10.92% (S + 6.50%; 1.00% Floor) 06/13/2023  —     (414  (9,576
Swiftpage, Inc.
(2)
 Software & Tech Services Term Loan 10.92% (S + 6.50%; 1.00% Floor) 06/13/2023  222,833   222,285   213,363 
Swiftpage, Inc.
(2)
 Software & Tech Services Term Loan 10.92% (S + 6.50%; 1.00% Floor) 06/13/2023  2,420,745   2,416,550   2,317,863 
Sysnet North America,
Inc.
(1) (2) (5)
 Software & Tech Services Term Loan 11.50% (L + 5.00%; 1.00% Floor) 12/01/2026  8,862,217   8,790,246   8,552,039 
Telcor Buyer, Inc.
(3) (4)
 Software & Tech Services Revolver 9.64% (L + 4.50%; 1.00% Floor) 08/20/2027  —     (3,400  (7,996
Telcor Buyer, Inc.
(1) (2)
 Software & Tech Services Term Loan 9.64% (L + 4.50%; 1.00% Floor) 08/20/2027  9,304,625   9,195,815   9,048,748 
Telesoft Holdings, LLC
(3)
 Software & Tech Services Revolver 10.14% (L + 5.75%; 1.00% Floor) 12/16/2025  49,739   43,024   36,309 
Telesoft Holdings, LLC
(2) (5)
 Software & Tech Services Term Loan 10.13% (L + 5.75%; 1.00% Floor) 12/16/2025  5,804,526   5,737,622   5,673,924 
TRGRP, Inc.
(3) (4)
 Software & Tech Services Revolver 11.73% (L + 4.50%; 2.50% PIK; 1.00% Floor) 11/01/2023  —     (1,126  —   
TRGRP, Inc.
(2) (5)
 Software & Tech Services Term Loan 11.73% (L + 4.50%; 2.50% PIK; 1.00% Floor) 11/01/2023  5,052,223   5,025,591   5,052,223 
TRGRP, Inc.
(2)
 Software & Tech Services Term Loan 11.73% (L + 4.50%; 2.50% PIK; 1.00% Floor) 11/01/2023  2,370,051   2,355,364   2,370,051 
TRGRP, Inc.
(1)
 Software & Tech Services Term Loan 11.73% (L + 4.50%; 2.50% PIK; 1.00% Floor) 11/01/2023  1,128,534   1,124,106   1,128,534 
Unanet, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  —     (37,535  (37,904
Unanet, Inc.
(3) (4)
 Software & Tech Services Revolver 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  —     (25,270  (25,270
Unanet, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.97% (S + 6.25%; 0.75% Floor) 12/08/2028  12,003,044   11,764,925   11,762,983 
Ungerboeck Systems International, LLC
(3)
 Software & Tech Services Delayed Draw Term Loan 11.22% (L + 6.50%; 1.00% Floor) 04/30/2027  272,766   268,398   267,992 
Ungerboeck Systems International, LLC
(5)
 Software & Tech Services Delayed Draw Term Loan 11.23% (L + 6.50%; 1.00% Floor) 04/30/2027  690,794   690,794   676,978 
Ungerboeck Systems International, LLC
(1)
 Software & Tech Services Delayed Draw Term Loan 11.23% (L + 6.50%; 1.00% Floor) 04/30/2027  322,391   318,814   315,943 
Ungerboeck Systems International, LLC
(3) (4)
 Software & Tech Services Revolver 11.23% (L + 6.50%; 1.00% Floor) 04/30/2027  —     (3,012  (4,588
See Notes to Unaudited Consolidated Financial Statements
27

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
            Industry            
 
        Facility Type        
 
                        Interest                    
 
  Maturity  
 
Funded

  Par Amount  
  
      Cost      
  
  Fair Value  
 
                  
Ungerboeck Systems International, LLC Software & Tech Services Term Loan 11.28% (L + 6.50%; 1.00% Floor) 04/30/2027 $136,383  $133,886  $133,655 
Ungerboeck Systems International, LLC
(2) (5)
 Software & Tech Services Term Loan 11.23% (L + 6.50%; 1.00% Floor) 04/30/2027  2,717,277   2,687,154   2,662,931 
Vectra AI, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 10.49% (L + 5.75%; 1.00% Floor) 03/18/2026     (18,778  (34,914
Vectra AI, Inc.
(3) (4)
 Software & Tech Services Revolver 10.49% (L + 5.75%; 1.00% Floor) 03/18/2026     (3,756  (6,983
Vectra AI, Inc.
(2) (5)
 Software & Tech Services Term Loan 10.49% (L + 5.75%; 1.00% Floor) 03/18/2026  3,258,620   3,204,291   3,160,862 
Vehlo Purchaser,
LLC
(2) (5)
 Software & Tech Services Delayed Draw Term Loan 9.98% (S + 5.00%; 0.75% Floor) 05/24/2028  6,195,183   6,133,560   6,148,719 
Vehlo Purchaser,
LLC
(3) (4)
 Software & Tech Services Revolver 9.69% (S + 5.00%; 0.75% Floor) 05/24/2028     (16,782  (18,586
Vehlo Purchaser,
LLC
(1) (2) (5)
 Software & Tech Services Term Loan 9.69% (S + 5.00%; 0.75% Floor) 05/24/2028  22,302,658   22,000,883   21,968,118 
Velocity Purchaser Corporation
(3) (4)
 Software & Tech Services Revolver 10.24% (S + 6.00%; 1.00% Floor) 12/01/2023     (611  (483
Velocity Purchaser Corporation
(1)
 Software & Tech Services Term Loan 10.24% (S + 6.00%; 1.00% Floor) 12/01/2023  2,412,446   2,405,375   2,406,415 
Velocity Purchaser Corporation
(1) (2)
 Software & Tech Services Term Loan 10.24% (S + 6.00%; 1.00% Floor) 12/01/2023  4,765,411   4,735,630   4,753,497 
Velocity Purchaser Corporation
(1)
 Software & Tech Services Term Loan 10.24% (S + 6.00%; 1.00% Floor) 12/01/2023  600,106   597,933   598,605 
Veracross LLC
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 11.23% (S + 2.00%; 5.00% PIK; 1.00% Floor) 12/28/2027     (13,965  (37,549
Veracross LLC
(3) (4)
 Software & Tech Services Revolver 11.23% (S + 2.00%; 5.00% PIK; 1.00% Floor) 12/28/2027     (18,636  (36,158
Veracross LLC
(5)
 Software & Tech Services Term Loan 11.23% (S + 2.00%; 5.00% PIK; 1.00% Floor) 12/28/2027  12,906,513   12,701,489   12,487,052 
Zendesk, Inc.
(3) (4)
 Software & Tech Services Delayed Draw Term Loan 11.04% (S + 6.50%; 0.75% Floor) 11/22/2028     (32,741  (33,335
Zendesk, Inc.
(3) (4)
 Software & Tech Services Revolver 11.04% (S + 6.50%; 0.75% Floor) 11/22/2028     (26,961  (27,453
Zendesk, Inc.
(2) (5)
 Software & Tech Services Term Loan 11.04% (S + 6.50%; 0.75% Floor) 11/22/2028  13,334,101   13,072,194   13,067,419 
Dillon Logistics, Inc.
(10)
 Transport & Logistics Revolver —  (P + 6.00%; 1.00% Floor) 12/11/2023  834,642   750,748   54,586 
Dillon Logistics, Inc.
(10)
 Transport & Logistics Term Loan —  (L + 7.00%; 1.00% Floor) 12/11/2023  3,079,544   2,673,820   201,402 
             
Total U.S. 1st Lien/Senior Secured Debt
   
 
1,097,596,835
 
 
 
1,070,520,769
 
2nd Lien/Junior Secured Debt
-
2.33
%
 
Conterra Ultra Broadband Holdings,
Inc.
(1) (2)
 Digital Infrastructure & Services Term Loan 13.01% (L + 8.50%; 1.00% Floor) 04/30/2027  6,537,710   6,476,655   6,521,366 
Brave Parent Holdings,
Inc.
(1)
 Software & Tech Services Term Loan 11.88% (L + 7.50%) 04/17/2026  1,230,107   1,216,529   1,199,354 
Symplr Software,
Inc.
(1) (2)
 Software & Tech Services Term Loan 12.07% (S + 7.88%; 0.75% Floor) 12/22/2028  3,130,634   3,083,175   2,919,316 
             
Total U.S. 2nd Lien/Junior Secured Debt
   
 
10,776,359
 
 
 
10,640,036
 
             
Total U.S. Corporate Debt
   
 
1,108,373,194
 
 
 
1,081,160,805
 
Canadian Corporate Debt - 3.87%
 
1st
Lien
/Senior Secured Debt
- 3.87%
 
McNairn Holdings
Ltd.
(1) (13)
 Business Services Term Loan 9.98% (L + 5.00%; 0.50% PIK; 1.00% Floor) 11/25/2025 $739,507  $730,174  $726,566 
Syntax Systems
Ltd
(1) (2) (13)
 Digital Infrastructure & Services Term Loan 10.13% (L + 5.75%; 0.75% Floor) 10/29/2028  8,773,543   8,699,024   8,334,866 
Syntax Systems
Ltd
(3) (13)
 Digital Infrastructure & Services Revolver 10.04% (L + 5.75%; 0.75% Floor) 10/29/2026  649,103   641,599   600,420 
Syntax Systems
Ltd
(3) (4) (13)
 Digital Infrastructure & Services Delayed Draw Term Loan 10.13% (L + 5.50%; 0.75% Floor) 10/29/2028  —     (20,396  (121,707
Banneker V Acquisition,
Inc.
(2) (5) (13)
 Software & Tech Services Term Loan 10.39% (L + 6.00%; 1.00% Floor) 12/04/2025  7,105,235   7,011,398   7,105,235 
Banneker V Acquisition,
Inc.
(3) (4) (13)
 Software & Tech Services Revolver 10.39% (L + 6.00%; 1.00% Floor) 12/04/2025  —     (3,068  —   
Banneker V Acquisition,
Inc.
(2) (13)
 Software & Tech Services Delayed Draw Term Loan 10.39% (L + 6.00%; 1.00% Floor) 12/04/2025  1,024,233   1,012,076   1,024,233 
             
Total Canadian 1st Lien/Senior Secured Debt
   
 
18,070,807
 
 
 
17,669,613
 
             
Total Canadian Corporate Debt
   
 
18,070,807
 
 
 
17,669,613
 
Portfolio Company
 
        Class/Series        
 
            Industry            
   
    Initial Acquisition Date 
(14)
   
 
      Shares      
  
      Cost      
  
  Fair Value  
 
                  
U.S. Preferred Stock
- 2.02%
      
Ntiva Investments, LLC (MSP Global Holdings, Inc)
(15)
 Class A Digital Infrastructure & Services  01/24/2022  333,937  $272,826  $234,701 
Bowline Topco
LLC^^
(15) (16)
 LLC Units Energy  08/09/2021  2,946,390   —     173,837 
See Notes to Unaudited Consolidated Financial Statements
28
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
        Class/Series        
 
            Industry            
   
    Initial Acquisition Date 
(14)
   
 
      Shares      
  
      Cost      
  
  Fair Value  
 
SBS Ultimate Holdings, LP
(15)
 Class A Healthcare & HCIT  09/18/2020  217,710  $861,878  $266 
Alphasense, Inc.
(13) (15)
 Series C Software & Tech Services  06/01/2021  23,961   369,843   474,027 
Concerto Health AI Solutions, LLC
(15) (16)
 Series B-1 Software & Tech Services  12/23/2019  65,614   349,977   351,172 
Datarobot, Inc.
(15)
 Series F Software & Tech Services  10/27/2020  6,715   88,248   80,863 
Datarobot, Inc.
(15)
 Series E Software & Tech Services  08/30/2019  38,190   289,278   364,025 
Degreed, Inc.
(15)
 Series D Software & Tech Services  04/30/2021  16,943   278,308   260,465 
Degreed, Inc.
(15)
 Series C-1 Software & Tech Services  06/25/2019  43,819   278,541   358,800 
Heap, Inc.
(15)
 Series D Software & Tech Services  11/24/2021  17,425   147,443   148,351 
Heap, Inc.
(15)
 Series C Software & Tech Services  05/21/2019  189,617   696,351   1,032,478 
Knockout Intermediate Holdings I, Inc.
(Kaseya, Inc.)
(15)
 Perpetual Software & Tech Services  06/23/2022  1,345   1,311,760   1,377,730 
Netskope, Inc.
(15)
 Series G Software & Tech Services  01/27/2020  36,144   302,536   377,701 
Phenom People, Inc.
(15)
 Series C Software & Tech Services  01/08/2020  35,055   220,610   444,061 
Protoscale Rubrik,
LLC
(15)
 Class B Software & Tech Services  01/04/2019  25,397   598,212   687,828 
Swyft Parent Holdings LP
(15) (16)
 LP Interests Software & Tech Services  02/07/2022  850,470   811,438   840,825 
Symplr Software Intermediate Holdings, Inc.
(15)
 Series A Software & Tech Services  11/30/2018  1,196   1,160,532   1,901,763 
Vectra AI, Inc
(15)
 Series F Software & Tech Services  05/28/2021  17,064   131,095   109,329 
             
Total U.S. Preferred Stock
    
 
8,168,876
 
 
 
9,218,222
 
U.S. Common Stock
- 1.71%
 
Global Radar Holdings,
LLC
(15) (16)
 Earn Out Business Services  11/08/2022  125   —    2,179 
AEG Holding Company, Inc.
(15)
 Class A Consumer Discretionary  11/20/2017  320   321,309   338,179 
Freddy’s Acquisition, LP (Freddy’s Frozen
Custard, LLC)
(15)
 LP Interests Consumer Non-Cyclical  03/03/2021  72,483   72,483   122,100 
8x8, Inc.
(13) (15) (17)
 Common Units Digital Infrastructure & Services    7,886   170,890   34,068 
Avant Communications, LLC
(15) (16)
 Class A Digital Infrastructure & Services  11/30/2021  236,307   236,307   300,030 
NEPCORE Parent Holdings, LLC
(15)
 Class A Digital Infrastructure & Services  10/21/2021  95   95,249   74,585 
Nepcore  Parent Holdings, LLC (Coretelligent Intermediate,
LLC)
(15)
 LLC Units Digital Infrastructure & Services  10/21/2021  396,513  
439,932  
332,454 
Ntiva Investments, LLC (MSP Global Holdings, Inc)
(15)
 Class A Digital Infrastructure & Services  01/24/2022  333,937   61,111   52,571 
Thrive Parent, LLC
(15)
 Class L Digital Infrastructure & Services  01/22/2021  100,219   263,195   406,456 
Advantage AVP Parent Holdings, L.P. (Medical Management Resource Group, LLC)
(15)
 Class B Healthcare & HCIT  09/30/2021  34,492   34,492   38,533 
American Outcomes Management,
L.P.
(15) (16)
 Class A Healthcare & HCIT  02/17/2022  290,393   290,393   515,299 
Community Based Care Holdings,
LP
(15)
 LP Interests Healthcare & HCIT  01/03/2022  179   178,916   191,113 
See Notes to Unaudited Consolidated Financial Statements
29

AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
(Unaudited)
Portfolio Company
 
        Class/Series        
 
            Industry            
   
    Initial Acquisition Date 
(14)
   
 
      Shares      
  
      Cost      
  
  Fair Value  
 
GSV MedSuite Investments, LLC (Millin Purchaser, LLC)
(15)
 Class A Healthcare & HCIT  03/31/2022  86,555  $86,555  $81,204 
Health Platform Group, Inc
(15)
 Earn Out Healthcare & HCIT  10/31/2020  16,502   —     —   
INH Group Holdings, Inc.
(15)
 Class A Healthcare & HCIT  01/31/2019  484,552   484,552   6,249 
RCFN Parent, LP (People’s Care)
(15)
 Class A Healthcare & HCIT  06/18/2021  77   78,284   83,644 
REP Coinvest III AGP Blocker, L.P. (Agape Care Group)
(15)
 LP Interests Healthcare & HCIT  10/14/2021  590,203   590,203   830,544 
Brightspot Holdco, LLC
(15)
 LLC Units Software & Tech Services  11/16/2021  433,207   433,207   427,682 
GSV Vehlo Investments, LLC (Vehlo Purchaser, LLC)
(15)
 Class A Software & Tech Services  05/24/2022  150,297   150,297   162,814 
Human Security
(15)
 Common Shares Software & Tech Services  07/29/2022  339,568   953,134   953,127 
Moon Topco, L.P. (Radiant Logic, Inc.)
(15)
 Class A Software & Tech Services  04/21/2021  3,600   35,999   55,819 
Mykaarma Acquisition LLC
(15)
 Class A Software & Tech Services  03/21/2022  257,031   257,031   277,758 
Ranger Lexipol Holdings, LLC
(15)
 Class B Software & Tech Services  11/18/2021  433   —     175,219 
Ranger Lexipol Holdings, LLC
(15)
 Class A Software & Tech Services  11/18/2021  433   433,207   404,565 
REP Coinvest III Tec, L.P. (American Safety Holdings Corp.)
(15)
 LP Interests Software & Tech Services  06/18/2020  167,509   190,658   253,338 
Samsara Networks, Inc.
(13) (15) (17)
 Class A Software & Tech Services    33,451   369,998   415,796 
Stripe, Inc.
(15)
 Class B Software & Tech Services  05/17/2021  4,158   166,854   123,181 
Swyft Parent Holdings LP
(15) (16)
 LP Interests Software & Tech Services  02/07/2022  4,485   —     76,262 
REP Coinvest
III-A
Omni, L.P. (Omni Logistics, LLC)
(15)
 LP Interests Transport & Logistics  02/05/2021  193,770   120,614   471,569 
REP RO Coinvest IV A Blocker (Road One)
(15)
 Class A Transport & Logistics  12/28/2022  66,441,840   664,418   664,418 
             
Total U.S. Common Stock
    
 
7,179,288
 
 
 
7,870,756
 
U.S. Warrants
- 0.17%
 
SBS Ultimate Holdings, LP, expire 09/18/2030
(15)
 Class A Healthcare & HCIT  09/18/2020  17,419   —     —   
Alphasense, Inc., expire 05/29/2027(13)
(15)
 Series B Software & Tech Services  06/02/2020  40,394   35,185   480,369 
Degreed, Inc., expire 04/11/2028
(15)
 Series D Software & Tech Services  04/11/2021  7,624   —     17,163 
Degreed, Inc., expire 05/31/2026
(15)
 Series C
-1
 Software & Tech Services  05/31/2019  26,294   46,823   109,950 
Degreed, Inc., expire 08/18/2029
(15)
 Common Shares Software & Tech Services  08/18/2022  9,374   —     45,483 
ScyllaDB, Inc., expire 09/08/2032
(15)
 Series
C-1
 Software & Tech Services  09/08/2022  239,984   43,880   44,046 
Vectra AI, Inc., expire 03/18/2031
(15)
 Series F Software & Tech Services  03/18/2021  35,156   58,189   79,903 
             
Total U.S. Warrants
    
 
184,077
 
 
 
776,914
 
United Kingdom Warrants
- 0.05%
 
GlobalWebIndex, Inc., expire 12/30/2027
(15)
 Preferred Units Software & Tech Services    8,832   159,859   217,181 
             
Total United Kingdom Warrants
    
 
159,859
 
 
 
217,181
 
Portfolio Company
 
        Class/Series        
 
                    
 
                        
 
                                  
 
      Shares      
  
      Cost      
  
Fair Value  
 
U.S. Investment Companies
- 1.22%
 
Orangewood WWB
Co-Invest,

L.P.
(15) (18)
 LP Interests     829,314  $829,314  $829,314 
ORCP III Triton
Co-Investors,

L.P.
(15) (18)
 LP Interests     341,592   98,394   420,500 
AB Equity Investors,
L.P.
(15) (18)
 LP Interests     984,786   984,786   1,307,429 
Portfolio Company
 
Class/Series
 
        
 
                        
   
Shares
  
Cost
  
Fair Value
 
Falcon
Co-Investment
Partners,
L.P.
(15) (18)
 LP Interests     812,734  $812,734  $813,547 
GHP E Aggregator, LLC
(15) (18)
 LLC Units     417,813   186,588   614,185 
GHP SPV 2, L.P.(13)
(15) (18)
 LP Interests     244,920   244,920   230,225 
See Notes to Unaudited Consolidated Financial Statements
30
AB Private Credit Investors Corporation
Consolidated Schedule of Investments as of December 31, 2022 (continued)
Portfolio Company
 
Class/Series
 
        
 
                                
   
Shares
  
Cost
  
Fair Value
 
Magenta Blocker Aggregator, LP
(15) (18)
 Class A        821,396  $676,978  $1,126,955 
Palms
Co-Investment
Partners, L.P.
(15) (18)
 LP Interests        261,449   261,449   261,449 
                     
Total U.S. Investment Companies
           
 
4,095,163
 
 
 
5,603,604
 
   
TOTAL INVESTMENTS - 245.69%
(19)
 
 
$
1,146,231,264
 
 
$
1,122,517,095
 
          
        
Portfolio Company
   
Industry
     
Shares
  
Cost
  
Fair Value
 
Cash Equivalents
- 6.34%
 
U.S. Investment Companies
- 6.34%
 
Blackrock T Fund I
(17) (20)
 Money Market Money Market Portfolio   4.03% (21)  14,121,193  $14,121,193  $14,121,193 
State Street Institutional US Government Money Market Fund
(17) (20)
 Money Market Money Market Portfolio   4.12% (21)  14,850,792   14,850,792   14,850,792 
                     
Total U.S. Investment Companies
 
 
 
28,971,985
 
 
 
28,971,985
 
                     
Total Cash Equivalents
 
 
 
28,971,985
 
 
 
28,971,985
 
LIABILITIES IN EXCESS OF OTHER ASSETS - (152.03%)
 
 
$
(694,610,587
NET ASSETS - 100.00%
 
 
$
456,878,493
 
                     
(++) 
Unless otherwise indicated, all securities represent
co-investments
made with the Fund’s affiliates in accordance with the terms of the exemptive relief received from the U.S. Securities and Exchange Commission. See Note 3 “Related Party Transactions”.
As of December 31, 2022, qualifying assets represented 96.90% of total assets. Under the 1940 Act we may not acquire any
non-qualifying
assets unless, at the time the acquisition is made, qualifying assets represent at least 70% of our total assets.
Unless otherwise indicated, all securities are valued using significant unobservable inputs, which are categorized as Level 3 assets under the definition of Financial Accounting Standards Board’s Accounting Standards Codification 820 fair value hierarchy.
Percentages are based on net assets.
Generally, the interest rate on floating interest rate investments is at benchmark rate plus spread. The borrower has an option to choose the benchmark rate, such as the London Interbank Offered Rate (“LIBOR”), Secured Overnight Financing Rate including adjustment, if any (“SOFR”) or the U.S. Prime rate. The spread may change based on the type of rate used. The terms in the Consolidated Schedule of Investments disclose the actual interest rate in effect as of the reporting period. LIBOR and SOFR loans are typically indexed to
30-day,
60-day,
90-day
or
180-day
rates (1M, 3M or 6M, respectively) at the borrower’s option. LIBOR and SOFR loans may be subject to interest floors. As of December 31, 2022, rates for weekly 1M L, 3M L 6M L, 1M S, 3M S and 6M S are 4.39%, 4.73%, 5.15%, 4.42%, 4.73% and 4.98%, respectively. As of December 31, 2022, the U.S. Prime rate was 7.50%.
^^ As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Fund because the Fund owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. See Note 3 “Related Party Transactions”.
(1) Position, or a portion thereof, has been segregated to collateralize ABPCI Direct Lending Fund CLO VI Ltd.
(2) Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding III, LLC.
(3) Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. The unfunded loan commitment may be subject to a commitment termination date, that may expire prior to the maturity date stated. See Note 6 “Commitments and Contingencies”.
(4) The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan.
(5) Position, or a portion thereof, has been segregated to collateralize ABPCIC Funding II, LLC.
(6) 
This investment has multiple reference rates or alternate base rates. The
All-in
interest rate shown is the weighted average interest rate in effect at
December 31, 2022
.
(7) Saturn Borrower Inc. has been renamed to Stratus Networks, Inc. in 2022.
(8) TA/WEG Holdings, LLC has been renamed to Wealth Enhancement Group, LLC in 2022.
(9) MedMark Services, Inc. has been renamed to BAART Programs, Inc. in 2022.
(10) 
The investment is on
non-accrual
status. See Note 2 “Significant Accounting Policies.”
(11) Millin Purchaser LLC. has been renamed to Medsuite Purchaser, LLC in 2022.
(12) Cybergrants Holdings, LLC has been renamed to Bonterra LLC in 2022.
(13) 
Positions considered
non-qualified
assets therefore excluded from the qualifying assets calculation as noted in footnote + above.
(14) Securities exempt from registration under the Securities Act of 1933, and may be deemed to be “restricted securities”. As of December 31, 2022, the aggregate fair value of these securities is $17,633,209 or 3.86% of the Fund’s net assets. The initial acquisition dates have been included for such securities.
(15) 
Non-income
producing investment.
(16) Position or portion thereof is held through a consolidated subsidiary.
(17) Categorized as Level 1 assets under the definition of ASC 820 fair value hierarchy.
(18) Excluded from the ASC 820 fair value hierarchy as fair value is measured using the net asset value per share practical expedient.
(19) Aggregate gross unrealized appreciation for federal income tax purposes is $7,142,498; aggregate gross unrealized depreciation for federal income tax purposes is $30,898,346. Net unrealized depreciation is $23,755,848 based upon a tax cost basis of $1,146,272,943.
(20) Included within ‘Cash and cash equivalents’ on the Consolidated Statements of Assets and Liabilities.
(21) 
The rate shown is the annualized
seven-day
yield as of December 31, 2022.
L-LIBOR
P-Prime
PIK-
Payment-In-Kind
S-SOFR
See Notes to Unaudited Consolidated Financial Statements
31

AB Private Credit Investors Corporation
Notes to Unaudited Consolidated Financial Statements
June 30, 2023
1. Organization

AB Private Credit Investors Corporation (the “Fund”“Fund,” “we,” “our,” and “us”), an externally managed,
non-diversified,
closed-end,non-diversified
management investment company that iselected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), was incorporated under the laws of the state of Maryland on February 6, 2015. The Fund was formed to invest in primary-issue middle-market credit opportunities that are directly sourced and privately negotiated.

AB Private Credit Investors LLC serves as the Fund’s external investment adviser (the “Adviser”).

The Fund is conducting private offerings (each a “Private Offering”) of its common stock to investors in reliance on an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). At the closing of any Private Offering, each investor will make a capital commitment (a “Capital Commitment”) to purchase shares of the Fund’s common stockShares pursuant to a subscription agreement entered into with the Fund. All investors will be committed to the Fund for at least three years from the date of their initial Capital Commitment, subject to the terms described in the Fund’s Private Placement Memorandum. Investors will be required to fund drawdowns to purchase shares of the Fund’s common stockShares up to the amount of their respective Capital Commitment on an
as-needed
basis each time the Fund delivers a capital draw-down notice to its investors. The Fund anticipates commencing its loan origination and investment activities contemporaneously with the initial drawdown from investors in the initial Private Offering.

As of September 30, 2017, no significant operations other than the sale and issuance of (i) 100 shares of common stock, par value $0.01, on June 27, 2016, at an aggregate purchase price of $1,000 ($10.00 per share) and (ii) 2,400 shares of common stock, par value $0.01, on May 26, 2017 to AB Private Credit Investors LLC, the Fund’s external investment adviser (the “Adviser”) have occurred. The sale of common shares was approved by the unanimous consent of the Fund’s board of directors on both occasions.

On September 29, 2017, the Fund completed the initial closing (“Initial Closing”) of its Private Offering after entering into subscription agreements (collectively, the “Subscription Agreements”) with several investors, providing for the private placement of the Fund’s common shares. Under the termsShares. As of the Subscription Agreements, investors are required to fund drawdowns to purchase the Fund’s common shares up to the amount of their respective Capital Commitments on anas-needed basis upon the issuance of a capital drawn-down notice. At SeptemberJune 30, 20172023, the Fund had total Capital Commitments of $70,928,060,$611,970,154, of which 100%14% or $88,163,879 is unfunded. Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including
follow-on
investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement (as defined below), and/or maintaining a reserve account for the payment of future expenses or liabilities.

As of September 30, 2017, the Fund had not commenced significant operational or investment activities.

The Fund’s fiscal year ends on December 31.

On June 14, 2019, the Adviser established ABPCI Direct Lending Fund CLO VI Ltd (“CLO VI”), an exempted company incorporated with limited liability under the laws of the Cayman Islands. CLO VI is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements. CLO VI issued
Class B-R
Notes,
Class C-R
Notes and Subordinated Notes to the Fund through AB PCI Direct Lending Fund CLO VI Depositor LLC, a wholly-owned subsidiary of the Fund established on June 28, 2019.
On February 7, 2020, the Fund and an affiliate of Abbott Capital Management, LLC (“Abbott”) became members of, ABPCIC Equity Holdings, LLC (“ABPCICE”), a Delaware limited liability company and a special purpose vehicle designed to invest in private equity investments sourced by Abbott. The Fund is the managing member and owns 100% of the Class L Units and 93% of the Class A Units of ABPCICE. As a result, the Fund consolidates ABPCICE in its consolidated financial statements and records a
non-controlling
interest of the equity interests in ABPCICE not held by the Fund.
On July 30, 2020, February 11, 2021 and January 13, 2023, the Adviser established ABPCIC Funding II LLC (“ABPCIC Funding II”), ABPCIC Funding III LLC (“ABPCIC Funding III”) and ABPCIC Funding IV LLC (“ABPCIC Funding IV”), respectively, Delaware limited liability companies. ABPCIC Funding II, ABPCIC Funding III and ABPCIC Funding IV are 100% owned by the Fund and are consolidated in the Fund’s consolidated financial statements commencing from the date of their formation.
On January 5, 2023, the Adviser established ABPCIC Direct Lending Fund CLO XIII LTD (“CLO XIII”), a private company limited by shares incorporated under the laws of Jersey. CLO XIII is 100% owned by the Fund and is consolidated in the Fund’s consolidated financial statements commencing from the date of its formation. CLO XIII issued Class D Notes and Subordinated Notes to the Fund through ABPCI Direct Lending Fund CLO XIII Depositor LLC, a wholly-owned subsidiary of the Fund established on April 3, 2023.
The Adviser has established certain additional consolidated subsidiaries that are subject to U.S. federal and state corporate level income taxes to hold certain equity or equity-like investments in portfolio companies.
2. Significant Accounting Policies

The Fund is an investment company under accounting principles generally accepted in the United States of America (“U.S. GAAP”) and follows the accounting and reporting guidance applicable to investment companies in the Financial Accounting Standards Board (“FASB”) ASCAccounting Standards Codification (“ASC”) 946,
Financial Services – Investment Companies. Actual
The Fund has prepared the consolidated financial statements and related financial information pursuant to the requirements for reporting on Form
10-Q
and Articles 6 and 10 of Regulation
S-X.
Accordingly, we have not included in this quarterly report all of the information and notes required by GAAP for annual financial statements. In the opinion of management, the unaudited financial information for the interim period presented in this report reflects all normal and recurring adjustments necessary for a fair statement of financial position and results could differ from those estimates.

operations. Operating results for interim periods are not necessarily indicative of operating results for an entire year.

32

The functional currency of the Fund is U.S. dollars and these consolidated financial statements have been prepared in conformity with U.S. GAAP, which requiresthat currency.
Consolidation
The Fund will generally consolidate any wholly or substantially owned subsidiary when the usedesign and purpose of estimatesthe subsidiary is to act as an extension of the Fund’s investment operations and assumptions that affectto facilitate the reported amounts and disclosuresexecution of the Fund’s investment strategy. Accordingly, the Fund consolidated the results of its wholly or substantially owned subsidiaries in theits consolidated financial statements. ActualThe portion of net assets that is attributable to
non-controlling
interest in ABPCICE is presented as
“Non-Controlling
Interest in ABPCIC Equity Holdings, LLC”, a component of total equity, on the Fund’s consolidated statements of assets and liabilities. All intercompany balances and transactions have been eliminated in consolidation.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current presentation, with no significant effect on our financial condition, results of operations or cash flows.
Valuation of Investment Companies
Investments in investment companies are valued at fair value. Fair values are generally determined utilizing the net asset value (“NAV”) supplied by, or on behalf of, management of each investment company, which is net of management and results could differ from these estimates, and such differences could be material.

The following is a summary of significant accounting policies followedincentive fees or allocations charged by the Fund.

investment company and is in accordance with the “practical expedient”, as defined by ASC 820. NAVs received by, or on behalf of, management of each investment company are based on the fair value of the investment company’s underlying investments in accordance with policies established by management of each investment company, as described in each of their financial statements and offering memorandum.

Cash and Cash Equivalents
Cash consists of demand deposits.deposits and money market accounts. Cash is carried at cost, which approximates fair value. The Fund maintains deposits of its cash with financial institutions, and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation insured limit.

The Fund intendsconsiders all highly liquid investments, with original maturities of less than ninety days and money market mutual funds as cash equivalents.

Revenue Recognition
Investment transactions are recorded on a trade-date basis. Interest income is recognized on an accrual basis. Interest income on debt instruments is accrued and recognized for those issuers who are currently paying in full or expected to electpay in full. For those issuers who are in default or expected to default, interest is not accrued and is only recognized when received. Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on
non-accrual
status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores
non-accrual
loans to accrual status when past due principal and interest is paid and, in the management’s judgment, is likely to remain current. Interest income and expense include discounts accreted and premiums amortized on certain debt instruments as determined in good faith by the Adviser and calculated using the effective interest method. Loan origination fees, original issue discounts and market discounts or premiums are capitalized as part of the underlying cost of the investments and accreted or amortized over the life of the investment as interest income.
Realized gains and losses on investment transactions are determined on the specific identification method.
Certain investments in debt securities may contain a contractual
payment-in-kind
(“PIK”) interest provision. The PIK provisions generally feature the obligation, or the option, at each interest payment date of making interest payments in (i) cash, (ii) additional debt or (iii) a combination of cash and additional debt. PIK interest, computed at the contractual rate specified in the investment’s credit agreement, is accrued as interest income and recorded as interest receivable up to the interest payment date. On the interest payment date, the accrued interest receivable attributable to PIK is added to the principal balance of the investment. When additional debt is received on the interest payment date, it typically has the same terms, including maturity dates and interest rates, as the original loan. PIK interest generally becomes due on the investment’s maturity date or call date.
33

The Fund may earn various fees during the life of the loans. Such fees include, but are not limited to, syndication, commitment, administration, prepayment and amendment fees, some of which are paid to the Fund on an ongoing basis. These fees and any other income are recognized as earned. Upon prepayment of a loan or debt security, any prepayment premiums, unamortized upfront loan origination fees and unamortized discounts are recorded as interest income.
Costs associated with entering into an investment are included in the cost of the investment, and any costs incurred relating to an unconsummated investment are expensed.
Distributions received from an equity interest, limited liability company or a limited partnership investment are evaluated to determine if the distribution should be recorded as dividend income or a return of capital.
Non-Accrual
Investments
Investments are placed on
non-accrual
status when it is probable that principal, interest or dividends will not be collected according to the contractual terms. Accrued interest or dividends generally are reversed when an investment is placed on
non-accrual
status. Interest or dividend payments received on
non-accrual
investments may be recognized as income or applied to principal depending upon management’s judgment.
Non-accrual
investments are restored to accrual status when past due principal and interest or dividends are paid and, in management’s judgment, principal and interest or dividend payments are likely to remain current. The Fund may make exceptions to this treatment if an investment has sufficient collateral value and is in the process of collection. As of June 30, 2023, the Fund had certain investments held in four portfolio companies on
non-accrual
status, which represented 1.83% and 0.29% of the total investments (excluding investments in cash equivalents, if any) at amortized cost and at fair value. As of December 31, 2022, the Fund had certain investments held in three portfolio companies on
non-accrual
status, which represented 0.96% and 0.26% of the total investments (excluding investments in cash equivalents, if any) at amortized cost and at fair value.
Credit Facility Related Costs, Expenses and Deferred Financing Costs
The Revolving Credit Facilities (as defined in Note 4) are recorded at carrying value, which approximates fair value. Interest expense and unused commitment fees on the Revolving Credit Facilities are recorded on an accrual basis. Unused commitment fees are included in interest and borrowing expenses in the consolidated statements of operations. Deferred financing costs include capitalized expenses related to the closing of the Revolving Credit Facilities. Amortization of deferred financing costs is computed on the straight-line basis over the contractual term. The amortization of such costs is included in interest and borrowing expenses in the consolidated statements of operations, with any unamortized amounts included in deferred financing costs on the consolidated statements of assets and liabilities.
Notes Payable Related Costs, Expenses and Unamortized Debt Issuance Costs
The Notes (as defined in Note 4) are recorded at carrying value. Interest expense on notes payable is recorded on an accrual basis. Debt issuance costs relating to notes payable are amortized on a straight-line basis over the contractual term and included in interest and borrowing expenses in the consolidated statements of operations. The unamortized debt issuance costs are included as a direct reduction of the carrying value of the notes payable (i.e. a contra liability).
Upon early termination or partial principal pay down of the Notes, the unamortized costs related to the Notes are accelerated into interest and borrowing expenses on the Fund’s consolidated statements of operations.    
Secured Borrowings
The Fund may finance the purchase of certain investments through
sale/buy-back
agreements. In a
sale/buy-back
agreement, the Fund enters into a trade to sell an investment and contemporaneously enters into a trade to buy the same investment back on a specified date in the future with the same counterparty. The Fund uses
sale/buy-back
agreements as a short-term financing alternative to its existing Revolving Credit Facilities. The Fund accounts for its
sale/buy-back
agreements (the “Secured Borrowings”) as secured borrowings and continues to present the investment as an asset and the obligation to return the cash received as a liability within secured borrowings on the consolidated statements of assets and liabilities. Interest income earned on investments pledged under
sale/buy-back
agreements and financing charges associated with the
sale/buy-back
agreements are included within interest income and interest and borrowing expenses, respectively, on the consolidated statements of operations. Accrued interest receivable on investments and accrued financing charges on the
sale/buy-back
agreements are included within interest receivable and interest and borrowing expenses payable, respectively, on the consolidated statements of assets and liabilities.
34

Income Taxes
ASC 740, “Accounting for Uncertainty in Income Taxes” (“ASC 740”) provides guidance on the accounting for and disclosure of uncertainty in tax positions. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are
“more-likely-than-not”
of being sustained by the applicable tax authority. Tax positions deemed to meet the
more-likely-than-not
threshold are recorded as a tax benefit or expense in the current year. Based on its analysis of its tax position for all open tax years (the current and prior two years), the Fund has concluded that it does not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740. Such open tax years remain subject to examination and adjustment by tax authorities.
The Fund has elected to be treated and intends to continue to be treated for federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended.amended (the “Code”). So long as the Fund is able to maintain its status as a RIC, it intends not to be subject to U.S. federal income tax on the portion of its taxable income and gains distributed to stockholders, if any. To qualify for RIC tax treatment, the Fund is required to distribute at least 90% of its investment company taxable income annually, meet diversification and income requirements quarterly, meet gross income requirements annually and file Form
1120-RIC,
as definedprovided by the Internal Revenue Code.

In the normal course of business,order for the Fund entersnot to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into general business contractsaccount certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the

one-year
period ending on October 31 of the calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that containwere not distributed during such years. The Fund, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a variety4% nondeductible U.S. federal excise tax on this income. The Fund will accrue excise tax on estimated undistributed taxable income as required. As of representationsJune 30, 2023, and warrantiesDecember 31, 2022, $0 and $0, respectively, of accrued excise taxes remained payable. For the three and six months ended June 30, 2023, the Fund accrued income taxes of $260,725 and $278,026, respectively. For the three and six months ended June 30, 2022, the Fund accrued income taxes of $258,256 and $567,083, respectively. As of June 30, 2023 and December 31, 2022, $320,348 and $1,303,918, respectively, of accrued income taxes remained payable.
The Fund may be subject to taxes imposed by countries in which the Fund invests. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued and applied to net investment income, net realized gains and net unrealized gain (loss) as such income and/or gains are earned.
The Fund remains subject to examination by U.S. federal and state jurisdictions, as well as international jurisdictions, and upon completion of these examinations (if undertaken by the taxing jurisdiction) tax adjustments may be necessary and retroactive to all open tax years.
Certain of the Fund’s consolidated subsidiaries are subject to U.S. federal and state corporate-level income taxes.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities, if any, at the date of the consolidated financial statements, and the reported amounts of revenues and expenses recorded during the reporting period. Actual results could differ from those estimates and such differences could be material.
Distributions
Distributions from net investment income and net realized capital gains are determined in accordance with U.S. federal income tax regulations, which may providediffer from those amounts determined in accordance with GAAP. The Fund may pay distributions in excess of its taxable net investment income. This excess would be a
tax-free
return of capital in the period and reduce the stockholder’s tax basis in its Shares. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent they are charged or credited to
paid-in
capital in excess of par or distributable earnings, as appropriate, in the period that the differences arise. Temporary and permanent differences are primarily attributable to differences in the tax treatment of certain loans and the tax characterization of income and
non-deductible
expenses. These differences are generally determined in conjunction with the preparation of the Fund’s annual RIC tax return. Distributions to common stockholders are recorded on the
ex-dividend
date. The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by the Adviser. The Fund may pay distributions to its stockholders in a year in excess of its net ordinary income and capital gains for indemnification.that year and, accordingly, a portion of such distributions may constitute a return of capital for U.S. federal income tax purposes. The Fund’s maximum exposure under these arrangements is unknown. However,Fund intends to timely distribute to its stockholders substantially all of its annual taxable income for each year, except that the Fund expectsmay retain certain net capital gains for reinvestment and, depending upon the risklevel of material lossthe Fund’s taxable income earned in a year, the Fund may choose to carry forward taxable income for distribution in the following year and pay any applicable U.S. federal excise tax. The specific tax characteristics of the Fund’s distributions will be remotereported to stockholders after the end of the calendar year. All distributions will be subject to available funds, and no amounts have been recorded in the financial statement for such arrangements.

In November 2016, the FASB issued ASU2016-18,Statement of Cash Flows (Topic 230): Restricted Cash (a Consensus of the Emerging Issues Task Force)(“ASU2016-18”), which requiresassurance can be given that the statementFund will be able to declare such distributions in future periods.

35

The Fund has adopted a dividend reinvestment plan that provides for stockholders to receive dividends or other distributions declared by the Board in cash flows explainunless a stockholder elects to “opt in” to the change duringdividend reinvestment plan. As a result, if the period inBoard declares a cash distribution, then the total of cash, cash equivalents, and amounts generally describes as restricted cash or restricted cash equivalents. ASU2016-18 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within those fiscal years, with early adoption permitted.

Management does not believe this accounting standard, which is not yet effective, if currently adopted, wouldstockholders who have a material effect on“opted in” to the accompanying financial statements. The Adviser is assessing the impact this accounting standarddividend reinvestment plan will have oncetheir cash distributions automatically reinvested in additional Shares, rather than receiving the cash distribution.

3. Related Party Transactions
Advisory Agreement
On November 13, 2019, the Fund commences investment activities.

3. Agreementsentered into the amended and Related Party Transactions

Advisory Agreement

On July 5, 2017, the Fund’s board of directors approved the investmentrestated advisory agreement (the “Amended and Restated Advisory Agreement”), replacing the advisory agreement the Fund entered into with the Adviser on July 27, 2017 (the “Advisory Agreement”), pursuant to which the Fund will pay the Adviser, quarterly in arrears, a base management fee calculated at an annual rate of 1.50%. The base management fee is calculated based on a percentage of the average outstanding assets of the Fund (which equals the gross value of equity and debt instruments, including investments made utilizing leverage), excluding cash and cash equivalents, during such fiscal quarter. The average outstanding assets will beis calculated by taking the average of the amount of assets of the Fund at the beginning and end of each month that occurs during the calculation period. The base management fee will beis calculated and paid quarterly in arrears but will be accrued monthly by the Fund over the fiscal quarter for which such base management fee is paid. The

On March 24, 2022, the Fund entered into the second amended and restated investment advisory agreement (the “Second Amended and Restated Advisory Agreement”), replacing the Amended and Restated Advisory Agreement pursuant to which effective March 24, 2022 the base management fee shall be calculated at an annual rate of 1.375%. On March 24, 2022, the Fund and the Adviser also entered into a fee waiver letter pursuant to which the Adviser has agreed to waive a portion of the management fee in excess of the base management fee calculated at the reduced annual rate of 1.375% for any partial month or quarter will be appropriately prorated.

the period January 1, 2022 through March 24, 2022.

For the three and six months ended June 30, 2023, the Fund incurred a management fee of $4,204,038 and $8,142,942, respectively. For the three and six months ended June 30, 2022, the Fund incurred a management fee of $3,391,227 and $6,794,019, respectively, of which $0 and $283,566, respectively, were voluntarily waived by the Adviser. As of June 30, 2023 and December 31, 2022, $4,204,038 and $3,778,123, respectively, of accrued management fee remained payable.
The Fund will also pay the Adviser an incentive fee that provides the Adviser with a share of the income that the Adviser generates for the Fund. The incentive fee will consist of an income-based incentive fee component and a capital-gains component, which are largely independent of each other, with the result that one component may be payable even if the other is not.

Income-Based Incentive Fee: The income-based incentive fee is calculated and payable quarterly in arrears based on the Fund’s net investment income prior to any deductions with respect to such income-based incentive fees and capital gains incentive fees
(“Pre-incentive
Fee Net Investment Income” or “PIFNII”) for the quarter, as further described below.Pre-incentive fee net investment income PIFNII means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or

other fees the Fund receives from portfolio companies) that the Fund accrues during the fiscal quarter, minus the Fund’s operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement (the “Administration Agreement”) we havethe Fund has entered into with State Street Bank and Trust Company (the “Administrator”), and any interest expense and dividends paid on any issued and outstanding indebtedness or preferred stock, respectively, but excluding, for avoidance of doubt, the income-based incentive fee, as well as the capital gains incentive fee (described below), accrued under U.S. GAAP).Pre-incentive fee net investment income PIFNII also includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay in kind

pay-in-kind
interest and zero coupon
zero-coupon
securities), accrued income that the Fund has not yet received in cash. The Adviser is not under any obligation to reimburse the Fund for any part of the income-based incentive fees it received that was based on accrued interest that the Fund never actually received.

Pre-incentive Fee Net Investment Income

PIFNII does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Because of the structure of the income-based incentive fee, it is possible that the Fund may accrue such income-based incentive fee in a quarter where the Fund incurs a net loss. For example, if the Fund receivesPre-incentive Fee Net Investment Income PIFNII in excess of a hurdle rate (as defined below) for a quarter, the Fund will accrue the applicable income-based incentive fee even if the Fund has incurred a realized and/or unrealized capital loss in that quarter. However, cash payment of the income-based incentive fee may be deferred in this situation, subject to the restrictions detailed at the end of this section.

Pre-incentive Fee Net Investment Income,
36

PIFNII, expressed as a rate of return on the average value of the Fund’s net assets (defined as total assets, less indebtedness and before taking into account any incentive fees payable during the period) atas of the endfirst day of each month during the course of the immediately preceding fiscalcalendar quarter, will be compared to various “hurdle rates,” with the income-based incentive fee rate of return increasing at each hurdle rate.

LOGO

Description of Quarterly Incentive Fee Calculations

We pay

The Fund pays the Adviser an income-based incentive fee with respect toPre-incentive Fee Net Investment Income PIFNII in each calendar quarter as follows:

No income-based incentive fee in any calendar quarter in whichPre-incentive Fee Net Investment Income PIFNII does not exceed 1.5% per quarter (approximately 6%(6% per annum), the “6% Hurdle Rate”;

100% ofPre-incentive Fee Net Investment Income PIFNII with respect to that portion of suchPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds the 6% Hurdle Rate but is less than 1.67% in any calendar quarter (the “6%
Catch-up
Cap”), approximately 6.67% per annum. This portion ofPre-incentive Fee Net Investment Income PIFNII (which exceeds the 6% Hurdle Rate but is less than the 6%
Catch-up
Cap) is referred to as the “6%
Catch-up.”
The 6%
Catch-up
is meant to provide the Adviser with 10.0% of thePre-incentive Fee Net Investment Income PIFNII as if hurdle rate did not apply if this net investment income exceeded 1.67% but was less than 1.94% in any calendar quarter; and

10.0% of the amount ofPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds the 6%
Catch-up
Cap, but is less than 1.94% (the “7% Hurdle Rate”), approximately 7.78% per annum. The 7% Hurdle Rate is meant to limit the Adviser to 10% of thePre-incentive Fee Net Investment Income PIFNII until the amount ofPre-incentive Fee Net Investment Income PIFNII exceeds 1.94%, approximately 7.78% per annum; and

100% ofPre-incentive Fee Net Investment Income PIFNII with respect to that portion of suchPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds the 7% Hurdle Rate but is less than 2.06% in any calendar quarter (the “7%
Catch-up
Cap”), approximately 8.24% per annum. This portion ofPre-incentive Fee Net Investment Income PIFNII (which exceeds the 7% Hurdle Rate but is less than the 7%
Catch-up
Cap) is referred to as the “7%
Catch-up.”
The 7%
Catch-up
is meant to provide the Adviser with 15.0% of thePre-incentive Fee Net Investment Income PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.06% but was less than 2.35% in any calendar quarter; and

15.0% of the amount ofPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds the 7%
Catch-up
Cap, but is less than 2.35% (the “8% Hurdle Rate”, approximately 9.41% per annum). The 8% Hurdle Rate is meant to limit the Adviser to 15% of thePre-incentive Fee Net Investment Income PIFNII until the amount ofPre-incentive Fee Net Investment Income PIFNII exceeds 2.06%2.35%, approximately 9.41% per annum; and

100% ofPre-incentive Fee Net Investment Income PIFNII with respect to that portion of suchPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds the 8% Hurdle Rate but is less than 2.50% in any calendar quarter (the “8%
Catch-up
Cap”), approximately 10% per annum. This portion ofPre-incentive Fee Net Investment Income PIFNII (which exceeds the 8% Hurdle Rate but is less than the 8%
Catch-up
cap) is referred to as the “8%
Catch-up”.
The 8%
Catch-up
is meant to provide the Adviser with 20.0% of thePre-incentive Fee Net Investment Income PIFNII as if a hurdle rate did not apply if this net investment income exceeded 2.50% in any calendar quarter; and

20.0% of the amount ofPre-incentive Fee Net Investment Income, PIFNII, if any, that exceeds 2.50% in any calendar quarter.

Capital Gains Incentive Fee:

For the three and six months ended June 30, 2023, the Fund incurred income-based incentive fees of $2,600,473 and $5,355,077, respectively. For the three and six months ended June 30, 2022, the Fund incurred income-based incentive fees of $951,206 and $2,883,145, respectively. As of June 30, 2023 and December 31, 2022, $2,600,473 and $2,534,935, respectively, of accrued income-based incentive fees remained payable.
The capital gains incentive fee isshall be determined and payable atin arrears as of the end of each fiscalcalendar year (or upon termination of this Agreement as 17.5%set forth below), and will equal 20.0% of the Fund’s aggregate cumulative realized capital gains, if any, from the date of the Fund’s election to be regulated as a BDC through the end of thateach calendar year, computed net of all aggregate cumulative realized capital losses and aggregate cumulative unrealized capital depreciation, through the end of such year, less the aggregate amount of any previously paid capital gain incentive fees. Forfees, with respect to each of the foregoing purpose,investments in the Fund’s portfolio. The Fund’s “aggregate cumulative realized capital gains” will not include any unrealized appreciation. It should be noted, however, that the Fund will accrue an incentive fee for accounting purposes taking into account any unrealized appreciation in accordance with U.S. GAAP. For accounting purposes only, in order to reflect the theoretical capital gains incentive fee that would be payable for a given period as if all unrealized gains were realized, the Fund will accrue a capital gains incentive fee based upon net realized gains and unrealized depreciation for that calendar year (in accordance with the terms of the Advisory Agreement), plus unrealized appreciation on investments held at the end of the period. The capital gains incentive fee is not subject to any minimum return to stockholders. If such amount is negative, then no capital gains incentive fee will be payable for such year. Additionally, ifIn the Advisoryevent that this Agreement is terminatedshall terminate as of a date that is not a calendar year end, the termination date willshall be treated as though it were a calendar year end for purposes of calculating and paying a capital gains fee.
While the capital gains fee to be paid is determined above, GAAP requires such fee to be accrued as if the Fund were to be terminated and liquidated at period end hypothetical liquidation. There was no capital gains incentive fee.

fee under GAAP recognized for the three and six months ended June 30, 2023. For the three and six months ended June 30, 2022, the Fund reduced the previously recognized capital gains incentive fee under GAAP by $

(237,304
) and $(784,037
), which was not realized. As of June 30, 2023 and December 31, 2022, $0 and $0, respectively, of capital gains incentive fee remained payable.
37

The amount of capital gains incentive fee expense related to a hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

The Fund will defer cash payment of any income-based incentive fee and/or any capital gains incentive fee otherwise earned by the Adviser if during the most recent four full fiscal quarter periodperiods ending on or prior to the date such payment is to be made, the sum of (a) thepre-incentive fee net investment income, PIFNII, and (b) the realized capital gain / loss and (c) unrealized capital appreciation/ depreciation expressed as a rate of return on the value of our net assets, is less than 6.0%. Any such deferred fees are carried over for payment in subsequent calculation periods to the extent such payment is payable under the Amended and Restated Advisory Agreement.

Administration Agreement and Expense Reimbursement Agreement

We have

The Fund has entered into the Administration Agreement with the Administrator and a separate expense reimbursement agreement with the Adviser (the “Expense Reimbursement Agreement”) under which any allocable portion of the cost of ourits Chief Compliance Officer and Chief Financial Officer and their respective staffs will be reimbursed by the Fund. Under the Administration Agreement, the Administrator will be responsible for providing usthe Fund with clerical, bookkeeping, recordkeeping and other administrative services. WeThe Fund will reimburse the Adviser an amount equal to ourthe Fund’s allocable portion (subject to the review of ourits Board) of its overhead resulting from its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of ourits Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Expense Support and Conditional Reimbursement Agreement

On September 29, 2017, the Fund and the Adviser entered into an agreement (the “Expense Support and Conditional Reimbursement Agreement”) to limit certain of the Fund’s Operating Expenses, as defined in the Expense Support and Conditional Reimbursement Agreement,below, to no more than 1.5% of the Fund’s average quarterly gross assets. To achieve this percentage limitation, the Adviser has agreed to reimburse the Fund for certain Operating Expenses on a quarterly basis (any such payment by the Adviser, an “Expense Payment”) and the Fund has agreed to later repay such amounts (any such payment by the Fund, a “Reimbursement Payment”), pursuant to the terms of the Expense Support and Conditional Reimbursement Agreement. The actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets, is referred to as the “Percentage Limit.”

Any Expense Payment by the Adviser pursuant to the Expense Support and Conditional Reimbursement Agreement will be subject to repayment by the Fund on a quarterly basis within the three years following the fiscal quarter of the Fund in which the Operating Expenses were paid or absorbed, if the total Operating Expenses for the current quarter, including Reimbursement Payments, expressed as a percentage of the Fund’s average gross assets during such quarter is less than the then-current Percentage Limit, if any, and the Percentage Limit that was in effect at the time when the AdvisorAdviser reimbursed the Operating Expenses that are the subject of the repayment, subject to certain provisions of the Expense Support and Conditional Reimbursement Agreement, as described below. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Operating Expenses” means the Fund’s Total Operating Expenses (as defined below), excluding base management fees, incentive fees, distribution and shareholderstockholder servicing fees, financing fees and costs, interest expense, brokerage commissions and extraordinary expenses and “Total Operating Expenses” means all of the Fund’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies. The calculation of average net assets will be consistent with such periodic calculations of average net assets in the Fund’s financial statements.

However, no Reimbursement Payment for any quarter will be made if: (1) the Effective Rate of Distributions Per Share (as defined below) declared by the Fund at the time of such Reimbursement Payment is less than or equal to the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than or equal to the Operating Expense Ratio (as defined below) at the time the Expense Payment was made to which such Reimbursement Payment relates. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Effective Rate of Distributions Per Share” means the annualized rate (based on a
365-
day year) of regular cash distributions per shareShare exclusive of returns of capital, distribution rate reductions due to distribution and shareholderstockholder fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses in any quarter by the Fund’s average net assets in such quarter.

The specific amount of expenses paid by the Adviser, if any, will be determined at the end of each quarter. The Fund or the Adviser may terminate the Expense Support and Conditional Reimbursement Agreement at any time,

with or without notice. The Expense Support and Conditional Reimbursement Agreement will automatically terminate in the event of (a) the termination of the Amended and Restated Advisory Agreement, or (b) the board of directorsBoard of the Fund makesmaking a determination to dissolve or liquidate the Fund. Upon termination of the Expense Support and Conditional Reimbursement Agreement, the Fund will be required to fund any Expense Payments, subject to the aforementioned requirements per the Expense Support and Conditional Reimbursement Agreement, that have not been reimbursed by the Fund to the Adviser.

As

38

Transfer Agency Agreement

On September 26, 2017, the Fund and AllianceBernsteinAlliance Bernstein Investor Services, Inc. (“ABIS”), an affiliate of the Fund, entered into an agreement pursuant to which ABIS will provide transfer agent services to the Fund. The Fund bears the expenses related to the agreement with ABIS.

For the three and six months ended June 30, 2023, the Fund accrued $36,215 and $71,487, respectively, in transfer agent fees. For the three and six months ended June 30, 2022, the Fund accrued $29,841 and $55,517, respectively, in transfer agent fees. As of June 30, 2023 and December 31, 2022, $36,214 and $34,224, respectively, of accrued transfer agent fees remained payable.
Co-investment
Activity
The Fund may be prohibited under the 1940 Act from participating in certain transactions with its affiliates without prior approval of the directors who are not interested persons, and in some cases, the prior approval of the SEC. The Fund, the Adviser and certain of their affiliates have been granted exemptive relief by the SEC for the Fund to
co-invest
with other funds managed by the Adviser or its affiliates in a manner consistent with the Fund’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors. Pursuant to such exemptive relief, the Fund generally is permitted to
co-invest
with certain of its affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Board make certain conclusions in connection with a
co-investment
transaction, including that (1) the terms of the transaction, including the consideration to be paid, are reasonable and fair to the Fund and its shareholders and do not involve overreaching of the Fund or its shareholders on the part of any person concerned, (2) the transaction is consistent with the interests of the Fund’s shareholders and is consistent with its investment objective and strategies, (3) the investment by its affiliates would not disadvantage the Fund, and the Fund’s participation would not be on a basis different from or less advantageous than that on which its affiliates are investing and (4) the proposed investment by the Fund would not benefit the Adviser or its affiliates or any affiliated person of any of them (other than the parties to the transaction), except to the extent permitted by the exemptive relief and applicable law, including the limitations set forth in Section 57(k) of the 1940 Act. As a result of exemptive relief, there could be significant overlap in the Fund’s investment portfolio and the investment portfolio of other funds managed by the Adviser or its affiliates that could avail themselves of the exemptive relief and that have an investment objective similar to the Fund’s.
Affiliates
As defined in the Investment Company Act, the investment is deemed to be a “controlled affiliated person” of the Fund because the Fund owns, either directly or indirectly, 25% or more of the portfolio company’s outstanding voting securities or has the power to exercise control over management or policies of such portfolio company. The table below presents the Fund’s affiliated investments:
   
Beginning
Fair Value
Balance
   
Gross
Additions
(1)
   
Gross
Reductions
(2)
  
Net Realized
Gain/Loss
   
Net Change in
Unrealized
Appreciation
(Depreciation)
  
Ending Fair
Value
Balance
   
Dividend,
Interest, PIK
and Other
Income
 
For the Six Months Ended June 30, 2023
 
                            
Non-Controlled
Affiliates
                                 
SBS Super Holdings, LLC (Class B Units)  $—     $10     $  $—     $(10 $—     $—   
Controlled Affiliates
                                 
Bowline Topco LLC  $173,837   $—     $—    $—     $90,649  $264,486   $—   
                                  
   $173,837   $10     $  $—     $90,639  $264,486   $—   
For the Six Months Ended June 30, 2022
 
                       
Controlled Affiliates
                                 
Bowline Energy, LLC  $3,501,384   $6,012   $(111,258 $—     $(6,012 $3,390,126   $130,234 
Bowline Topco LLC   2,600,575    —      —     —      1,858,488   4,459,063    —   
                                  
   $6,101,959   $6,012   $(111,258 $—     $1,852,476  $7,849,189   $130,234 
(1)Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.
(2)Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.
39

4. OrganizationalBorrowings
Credit Facilities
HSBC Credit Facility
On July 8, 2021, the Fund entered into Joinder and Offering Expenses

OrganizationThird Amendment to Revolving Credit Agreement (the “HSBC Joinder”), with HSBC as administrative agent and a lender, and each of the parties listed thereto, pursuant to which the Fund became party to a subscription financing facility (the “2021 HSBC Credit Facility”) evidenced by Revolving Credit Agreement, dated as of June 14, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “2021 HSBC Credit Agreement”), by and among

AB-Abbott
Private Equity Investors 2019 (Delaware) Fund L.P.,
AB-Abbott
Private Equity Investors 2020 (Delaware) Fund L.P.,
AB-Abbott
Private Equity Solutions 2021 (Delaware) Fund L.P., AB Private Credit Investors Middle Market Direct Lending Fund L.P.,
AB-Abbott
Private Equity Solutions 2022 (Delaware), affiliates of the Fund, the banks and financial institutions from time to time party thereto as lenders, and HSBC as administrative agent. The Fund Group Facility Sublimit (as defined in the 2021 HSBC Credit Agreement) applicable to the Fund under the 2021 HSBC Credit Facility is $50 million. Borrowings under the 2021 HSBC Credit Facility bear interest at a rate per annum equal to (i) with respect to SOFR Loans, Adjusted Term SOFR (as defined in the 2021 HSBC Credit Agreement) plus the Applicable Margin (as defined in the 2021 HSBC Credit Agreement) for the applicable Interest Period (as defined in the 2021 HSBC Credit Agreement) and (ii) with respect to Reference Rate Loans (as defined in the 2021 HSBC Credit Agreement), the Reference Rate (as defined in the 2021 HSBC Credit Agreement) in effect from day to day. The Fund will also pay an unused commitment fee of 0.35%. Proceeds under the 2021 HSBC Credit Agreement may be used for any purpose permitted under the Fund’s organizational documents, including general corporate purposes such as the making of investments. The 2021 HSBC Credit Agreement contains certain customary covenants and events of default, with customary cure and notice provisions. As of
June 30
, 2023, the Fund is in compliance with these covenants. The Fund’s obligations under the 2021 HSBC Credit Agreement are secured by the Capital Commitments and capital contributions.
On June 10, 2022, the Fund entered into amendment no. 6 to the 2021 HSBC Credit Agreement. The 2021 HSBC Credit Agreement Amendment no. 6 (i) extended the maturity date of the 2021 HSBC Credit Facility from June 10, 2022 to June 9, 2023 and (ii) reduced the Fund’s sublimit commitment from $50,000,000 to $33,000,000.
On November 10, 2022, the Fund entered into amendment no. 7 to the 2021 HSBC Credit Agreement. The 2021 HSBC Credit Agreement Amendment no. 7 (i) temporarily increased the 2021 HSBC Credit Facility’s maximum commitment from $135,000,000 to $200,000,000 until March 31, 2023 (the “Temporary Increase Maturity Date”) and (ii) temporarily increased the Fund’s sublimit commitment from $33,000,000 to $50,000,000 until the Temporary Increase Maturity Date.
On March 30, 2023, the Fund entered into amendment no. 8 to the 2021 HSBC Credit Agreement. The 2021 HSBC Credit Agreement Amendment no. 8 extended the Temporary Increase Maturity Date from March 31, 2023 until June 9, 2023.
On June 9, 2023, the Fund entered into amendment no. 9 to the 2021 HSBC Credit Agreement. The 2021 HSBC Credit Agreement Amendment no. 9 (i) extended the maturity date of the 2021 HSBC Credit Facility from June 9, 2023 to June 7, 2024 and (ii) reduced the Fund’s sublimit commitment from $33,000,000 to $31,000,000.
Synovus Credit Facility
On October 15, 2020, ABPCIC Funding II entered into a revolving credit facility (the “Synovus Credit Facility”) with Synovus Bank, Specialty Finance Division (“Synovus”), as facility agent, and U.S. Bank, National Association (“U.S. Bank”), as collateral agent (in such capacity, the “Synovus Collateral Agent”), collateral custodian (in such capacity, the “Synovus Collateral Custodian”) and securities intermediary (in such capacity, the “Synovus Securities Intermediary”). On April 16, 2021, pursuant to an amendment to the loan financing and servicing agreement (the “Synovus Loan Agreement”), the Fund increased the commitment of the existing lender by $20,000,000 from $100,000,000 to $120,000,000 and added WebBank as an additional lender with a commitment of $30,000,000.
On December 31, 2021, pursuant to an amendment to the Synovus Loan Agreement, ABPCIC Funding II added Axos Bank as an additional lender with a commitment of $50,000,000.
40

The Synovus Credit Facility provides for borrowings in an aggregate amount up to $200,000,000. Borrowings under the Synovus Credit Facility bear interest based on an annual adjusted SOFR for the relevant interest period, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Synovus Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) October 15, 2025 (or such later date mutually agreed to by ABPCIC Funding II and Synovus) or (ii) upon certain events which result in accelerated maturity under the agreements establishing the Synovus Credit Facility. Borrowing under the Synovus Credit Facility is subject to certain restrictions contained in the 1940 Act.
Borrowings under the Synovus Credit Facility are secured by all of the assets held by ABPCIC Funding II. Pursuant to the agreements establishing the Synovus Credit Facility, the Adviser will perform certain duties with respect to the purchase and management of the assets securing the Synovus Credit Facility. The Adviser will not receive a fee for these services so long as the Adviser or an affiliate thereof continues providing such services. ABPCIC Funding II will reimburse all reasonable expenses, disbursements and advances incurred or made by the Adviser in the performance of its obligations relating to the Synovus Credit Facility.
All of the collateral pledged to the lenders by ABPCIC Funding II under the Synovus Credit Facility is held in the custody of the Synovus Collateral Custodian or the Synovus Securities Intermediary. The Synovus Collateral Custodian will maintain and perform certain custodial services with respect to the collateral pledged to support the Synovus Credit Facility. As compensation for the services rendered by U.S. Bank in its capacities as Synovus Collateral Custodian and Synovus Collateral Agent, ABPCIC Funding II will pay U.S. Bank, on a quarterly basis, customary fee amounts and reimburse U.S. Bank for its reasonable
out-of-pocket
expenses. The Synovus Credit Facility contains certain customary covenants and events of default, with customary cure and notice provisions. As of June 30, 2023, the Fund is in compliance with these covenants.
Natixis Credit Facility
On March 24, 2021, ABPCIC Funding III entered into a warehouse financing transaction (the “2021 Natixis Credit Facility”) with Natixis, New York Branch, as administrative agent and U.S. Bank as collateral agent, collateral administrator and custodian. The reinvestment period of ABPCIC Funding III expired on March 24, 2023. On May 3, 2023, ABPCIC Funding III merged with CLO XIII (the “ABPCIC Funding III Merger”) as part of the closing of the CLO XIII Transaction (as defined below). The 2021 Natixis Credit Facility was terminated in connection with the ABPCIC Funding III Merger.
On April 21, 2023, ABPCIC Funding IV entered into a warehouse financing transaction (the “Natixis Credit Facility,” and together with the 2021 HSBC Credit Facility and the Synovus Credit Facility, the “Revolving Credit Facilities”) with Natixis, New York Branch, as administrative agent (in such capacity, the “Natixis Administrative Agent”) and U.S. Bank Trust Company, National Association, as collateral agent (in such capacity, the “Natixis Collateral Agent”), collateral administrator (in such capacity, the “Natixis Collateral Administrator”). In connection with the Natixis Credit Facility, ABPCIC Funding IV entered into, among other agreements, (i) the credit agreement (the “Natixis Credit Agreement”) among ABPCIC Funding IV, the lenders referred to therein, the Natixis Administrative Agent, the Natixis Collateral Agent and the Natixis Collateral Administrator, (ii) the account control agreement (the “Natixis Account Control Agreement”) among ABPCIC Funding IV, as debtor, the Natixis Collateral Agent, as secured party, and U.S. Bank National Association, as securities intermediary (in such capacity, the “Natixis Securities Intermediary”), (iii) the collateral management agreement (the “Natixis Collateral Management Agreement”), between ABPCIC Funding IV and the Adviser, as collateral manager (in such capacity, the “Natixis Collateral Manager”), (iv) the collateral administration agreement (the “Natixis Collateral Administration Agreement”), among ABPCIC Funding IV, the Natixis Collateral Manager and the Natixis Collateral Administrator and (v) the master loan sale and contribution agreement between ABPCIC Funding IV and the Fund.
The Natixis Credit Agreement provides for borrowings in an aggregate amount up to $200,000,000. Borrowings under the Natixis Credit Agreement will bear interest based on an adjusted term standard overnight financing rate for the relevant interest period or the applicable replacement thereto provided for in the Natixis Credit Agreement, in each case, plus an applicable spread. Interest is payable quarterly in arrears. Any amounts borrowed under the Natixis Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 21, 2033 (or such later date mutually agreed to by ABPCIC Funding IV and the Natixis Administrative Agent) or (ii) upon certain other events which result in accelerated maturity under the Natixis Credit Facility. Borrowing under the Natixis Credit Facility is subject to certain restrictions contained in the 1940 Act.
Borrowings under the Natixis Credit Agreement are secured by all of the assets held by ABPCIC Funding IV. Pursuant to the Natixis Collateral Management Agreement, the Natixis Collateral Manager will perform certain duties with respect to the purchase and management of the assets securing the Natixis Credit Facility. There is no collateral management fee charged as long as Advisor serves as a collateral manager. ABPCIC Funding IV will reimburse the expenses incurred by the Natixis Collateral Manager in the performance of its obligations under the Natixis Collateral Management Agreement other than any ordinary overhead expenses, which shall not be reimbursed. ABPCIC Funding IV has made customary representations and warranties under the Natixis Collateral Management Agreement and is required to comply with various covenants, reporting requirements and other customary requirements for similar credit facilities. As of June 30, 2023, the Fund is in compliance with these covenants.
41

All of the collateral pledged to the lenders by ABPCIC Funding IV under the Natixis Credit Agreement is held in the custody of the Natixis Securities Intermediary under the Natixis Account Control Agreement. The Natixis Collateral Administrator will maintain and perform certain collateral administration services with respect to the collateral pursuant to the Natixis Collateral Administration Agreement. As compensation for the services rendered by the Natixis Collateral Administrator, ABPCIC Funding IV will pay the Natixis Collateral Administrator, on a quarterly basis, customary fee amounts and reimburse the Natixis Collateral Administrator for its reasonable
out-of-pocket
expenses. The Natixis Collateral Administration Agreement and the obligations of the Natixis Collateral Administrator will continue until the earlier of (i) the liquidation of the collateral and the final distribution of the proceeds of such liquidation, (ii) the date on which all obligations have been paid in full or (iii) the termination of the Natixis Collateral Management Agreement.
The Fund’s outstanding borrowings through the Revolving Credit Facilities as of June 30, 2023 were as follows:
   
Aggregate Borrowing

Amount Committed
   
Outstanding

Borrowing
   
Amount

Available
   
Carrying

Value
 
HSBC  $31,000,000   $—     $31,000,000   $—   
Synovus   200,000,000    200,000,000    —      200,000,000 
Natixis   200,000,000    53,400,000    146,600,000    53,400,000 
                    
Total
  $431,000,000   $253,400,000   $177,600,000   $253,400,000 
                    
The Fund’s outstanding borrowings through the Revolving Credit Facilities as of December 31, 2022 were as follows:
   
Aggregate Borrowing

Amount Committed
   
Outstanding

Borrowing
   
Amount

Available
   
Carrying

Value
 
HSBC  $50,000,000   $—     $50,000,000   $—   
Synovus   200,000,000    180,000,000    20,000,000    180,000,000 
Natixis   300,000,000    268,000,000    32,000,000    268,000,000 
                    
Total
  $550,000,000   $448,000,000   $102,000,000   $448,000,000 
                    
As of June 30, 2023 and December 31, 2022, deferred financing costs include,were $1,367,187 and $1,146,619, respectively, which remain to be amortized, and are reflected on the consolidated statements of assets and liabilities.
Collateralized Loan Obligations
CLO VI
On August 9, 2019, CLO VI (the “VI Issuer”) and ABPCI Direct Lending Fund CLO VI LLC, a limited liability company organized under the laws of the State of Delaware (the “VI
Co-Issuer,”
and together with the VI Issuer, the “VI
Co-Issuers”),
each a newly formed special purpose vehicle, completed a $300,500,000 term debt securitization (the “CLO VI Transaction”). The stated reinvestment date was August 9, 2022.
The CLO VI indenture was refinanced under terms of the first supplemental indenture dated April 28, 2022 among the VI Issuer and U.S. Bank National Association, as trustee. As a result of the refinancing, the outstanding notes (other than the Subordinated Notes) under the indenture dated August 9, 2019 in the amount of $246,900,000 were paid off, and the unamortized debt discount and debt issuance costs were accelerated into interest and borrowing expenses on the consolidated statements of operations. The VI Issuer issued new notes as listed below, as well as additional Subordinated Notes in the amount of $7,720,000.
42

The CLO VI Transaction was executed through a private placement and the notes offered (the “VI Notes”) that remain outstanding as of June 30, 2023 and December 31, 2022 were as follows:
   
June 30, 2023
 
   
Principal
Amount
   
Interest Rate
  
Carrying
Value
(1)
 
Class A-1-R
Senior Secured Floating Rate Note
(“Class A-1-R”)
  $98,250,000    Term SOFR + 1.83 $97,456,247 
Class A-1-L
Senior Secured Floating Rate Loan
(“Class A-1-L”)
  $75,000,000    Term SOFR + 1.83 $74,705,937 
Class A-1-F
Senior Secured Fixed Rate Note
(“Class A-1-F”)
  $30,000,000    4.305 $29,882,375 
Class A-2-R
Senior Secured Floating Rate Note
(“Class A-2-R”)
  $43,500,000    Term SOFR + 2.25 $43,329,463 
Class B-R
Secured Deferrable Floating Rate Note
(“Class B-R”)
  $19,250,000    Term SOFR + 3.10 $—  
Class C-R
Secured Deferrable Floating Rate Note
(“Class C-R”)
  $20,125,000    Term SOFR + 4.15 $—  
Subordinated Notes  $61,320,000    N/A  $—  
*
Class
B-R,
Class C-R
and Subordinated Notes are held by the Fund and have been eliminated in consolidation.
(1)Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the VI Notes totaled $408,664 and $967,314, respectively, as of June 30, 2023 and are reflected on the consolidated statements of assets and liabilities.
   
December 31, 2022
 
   
Principal
Amount
   
Interest Rate
  
Carrying
Value
(1)
 
Class A-1-R
Senior Secured Floating Rate Note
(“Class A-1-R”)
  $98,250,000    Term SOFR + 1.83 $97,345,789 
Class A-1-L
Senior Secured Floating Rate Loan
(“Class A-1-L”)
  $75,000,000    Term SOFR + 1.83 $74,626,138 
Class A-1-F
Senior Secured Fixed Rate Note
(“Class A-1-F”)
  $30,000,000    4.305 $29,850,455 
Class A-2-R
Senior Secured Floating Rate Note
(“Class A-2-R”)
  $43,500,000    Term SOFR + 2.25 $43,283,185 
Class B-R
Secured Deferrable Floating Rate Note
(“Class B-R”)
  $19,250,000    Term SOFR + 3.10 $—  
Class C-R
Secured Deferrable Floating Rate Note
(“Class C-R”)
  $20,125,000    Term SOFR + 4.15 $—  
Subordinated Notes  $61,320,000    N/A  $—  
*
Class
B-R,
Class C-R
and Subordinated Notes are held by the Fund and have been eliminated in consolidation.
(1)Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the VI Notes totaled $414,624 and $1,229,809, respectively, as of December 31, 2022 and are reflected on the consolidated statements of assets and liabilities.
The CLO VI indenture provides that the holders of the VI Notes are to receive quarterly interest payments, in arrears, on the 27th day in January, April, July and October of each year, commencing in July 2022. The VI Notes will mature on April 27, 2034.
The VI N
o
tes are the secured
o
bligations of the VI
Co-Issuers,
and the indenture governing the VI Notes includes customary covenants and events of default. The VI Notes have not been, and will not be, registered under the Securities Act or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.
The Adviser serves as collateral manager to the VI Issuer pursuant to a collateral management agreement between the Adviser and the VI Issuer (the “CLO VI Collateral Management Agreement”). For so long as the Adviser serves as collateral manager to the VI Issuer, the Adviser will elect to irrevocably waive any base management fee or subordinated interest to which it may be entitled under the CLO VI Collateral Management Agreement. For the three and six months ended June 30, 2023, the Fund did not incur any collateral management fees. For the three and six months ended June 30, 2022, the Fund incurred collateral management fees of $131,978 and $588,476, respectively, which were voluntarily waived by the Adviser. Pursuant to a new CLO notes issuance, a collateral management fee is no longer charged as long as the Adviser serves as a collateral manager.
43

CLO XIII
On May 3, 2023, CLO XIII (the “XIII Issuer”), ABPCI Direct Lending Fund CLO XIII LLC, a limited liability company organized under the laws of the State of Delaware (the “XIII
Co-Issuer,”
and together with the XIII Issuer, the “XIII
Co-Issuers”),
ABPCI Direct Lending Fund CLO XIII First Static Subsidiary Ltd (the “First Static Subsidiary”) and ABPCI Direct Lending Fund CLO XIII Second Static Subsidiary Ltd (the “Second Static Subsidiary” and together with the First Static Subsidiary, the “Static Subsidiaries”, and together with the XIII
Co-Issuers,
the “XIII Issuer Entities”), each a newly formed special purpose vehicle, completed a $395,000,000 term debt securitization (the “CLO XIII Transaction”). The stated reinvestment date was April 27, 2027.
The CLO XIII Transaction was executed through a private placement and the notes offered (the “XIII Notes”) that remain outstanding as of June 30, 2023 were as follows:
   
June 30, 2023
 
   
Principal
Amount
   
Interest Rate
  
Carrying
Value
(1)
 
Class A Senior Secured Floating Rate Note (“Class A”)  $228,000,000    Term SOFR + 2.60 $225,391,149 
Class B Senior Secured Floating Rate Note (“Class B”)  $36,000,000    Term SOFR + 3.65 $35,588,076 
Class C Secured Deferrable Floating Rate Note (“Class C”)  $36,000,000    Term SOFR + 4.55 $35,588,076 
Class D Secured Deferrable Floating Rate Note (“Class D”)  $28,000,000    Term SOFR + 6.90 $—  
Subordinated Notes  $67,000,000    N/A  $—  
*Class D and Subordinated Notes are held by the Fund and have been eliminated in consolidation.
(1)Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the XIII Notes totaled $0 and $3,432,699, respectively, as of June 30, 2023 and are reflected on the consolidated statements of assets and liabilities.
The CLO XIII indenture provides that the holders of the XIII Notes are to receive quarterly interest payments, in arrears, on the 27th day in January, April, July and October of each year, commencing in October 2023. The XIII Notes will mature on April 27, 2035.
The XIII Notes are the secured obligations of the XIII Issuer Entities, and the indenture governing the XIII Notes includes customary covenants and events of default. The XIII Notes have not been, and will not be, registered under the Securities Act or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.
The Adviser serves as collateral manager to the XIII Issuer pursuant to a collateral management agreement between the Adviser and the XIII Issuer (the “CLO XIII Collateral Management Agreement”). For so long as the Adviser serves as collateral manager to the XIII Issuer, a collateral management fee shall not be charged.
Secured Borrowings
From time to time, the Fund may engage in
sale/buy-back
agreements, with Macquarie US Trading LLC (the “Macquarie Sale/Buy Back”), which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a
transaction-by-transaction
basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the
sale/buy-back
counterparty for the duration of the agreement.
There were no Secured Borrowings outstanding as of June 30, 2023.
Secured Borrowings outstanding as of December 31, 2022, were as follows:
Loan Name Trade Date  Maturity Date bps Daily Rate  Amount 
Saviynt, Inc.  12/22/2022  90 days or less from trade date  2.27  $5,917,275 
               
            $5,917,275 
               
44

As of June 30, 2023 and December 31, 2022 total outstanding borrowings, net of unamortized discount and debt issuance costs, under the Revolving Credit Facilities, Notes, and Secured Borrowings were $795,341,323 and $699,022,842, respectively.
Interest Expense on Borrowings
For the three and six months ended June 30, 2023 and June 30, 2022, the components of interest and other debt expenses related to the borrowings were as follows:
   
For the three months ended
June 30,
  
For the six months ended
June 30,
 
   
2023
  
2022
  
2023
  
2022
 
Interest and borrowing expenses  $15,739,753  $5,356,327  $28,661,398  $9,200,934 
Commitment fees   158,849   148,583   245,381   279,999 
Amortization of discount, debt issuance and deferred financing costs   1,361,520   1,541,308   2,135,003   2,706,070 
                 
Total  $17,260,122  $7,046,218  $31,041,782  $12,187,003 
                 
Weighted average interest rate
(1)
   7.74  3.37  7.50  3.03
Average outstanding balance  $815,524,585  $637,643,911  $770,484,167  $612,778,229 
(1)Calculated as the amount of the stated interest and borrowing expenses divided by average borrowings during the period.
5. Fair Value Measurement
In accordance with ASC 820, fair value is defined as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a framework for measuring fair value and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability as of the reporting date.
Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation.
The three-tier hierarchy of inputs is summarized below:
Level 1 – Quoted prices in active markets for identical investments.
Level 2 – Other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).
Level 3 – Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments at the reporting date).
The level in the fair value hierarchy within which the fair value measurement is categorized in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. If a fair value measurement uses price data vendors or observable market price quotations, that measurement is usually a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.
The determination of what constitutes “observable” requires significant judgment by the Fund. The Fund considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market.
For certain investments, the Fund uses the net asset value of these investments as a practical expedient to determine their fair value. Due to the uncertainty inherent in valuing such positions, their estimated values could differ significantly from the values that could have been used had a ready market for such positions existed.
45

Valuation of Investments
Pursuant to the amended SEC Rule
2a-5
of the 1940 Act, the Board designated the Adviser as the Fund’s “valuation designee.” In this capacity, the Adviser is responsible, among other things, the cost of organizing as a Maryland corporation, including the cost of legal services and other fees pertainingfor making all fair value determinations relating to the Fund’s organization, all of which are expensed as incurred. Offering costs include, among other things, legal fees and other costs pertainingportfolio investments, subject to the preparationBoard’s oversight. Investments are valued at fair value as determined in good faith by our Adviser, as valuation designee, based on input of management, the audit committee and independent valuation firms that have been engaged to assist in the valuation of each portfolio investment without a readily available market quotation under a valuation policy. The Adviser principally carries out its fair value responsibilities through its Valuation
Sub-Committee.
This valuation process is conducted at the end of each fiscal quarter.
The fair values of loan investments based upon pricing data vendors or observable market price quotations are generally categorized as Level 2; however, those priced using models with significant unobservable inputs are categorized as Level 3.
In determining the fair value of the Fund’s private placement memorandumLevel 3 debt and other offering documents, including travel-related expenses. As of September 30, 2017, total organization expenses incurred amounted to $467,000. Offering expenses, which are being deferred, totaled $236,000, which is being amortized on a straight line basis over a one year period starting from September 29, 2017.

For the quarter ended September 30, 2017, the Adviser had reimbursed the above expenses as part of its Expense Payment, amounting to $467,647.

5. Fund Expenses

As of September 30, 2017,equity positions, the Adviser and its affiliatesthe independent valuation firms use the following factors where relevant: loan to value (“LTV”) based on an enterprise value determined using the original purchase price, public equity comparable, recent M&A transaction, and a discounted cash flow (“DCF”) analysis, and yields from comparable loans, comparable high yield bonds, high yield indexes and loan indexes (“comparable yields”).

Due to the inherent uncertainty of valuations, however, estimated fair values may differ from the values that would have incurred expenses of approximately $534,500 on behalfbeen used had a readily available market for the securities existed and the differences could be material.
The following table summarizes the valuation of the Fund in relation to professional feesFund’s investments as of June 30, 2023:
Assets*
  
Level 1
   
Level 2
   
Level 3
   
Total
 
Cash Equivalents        
Investment Companies  $37,064,266   $—     $—     $37,064,266 
                    
Total Cash Equivalents
  $37,064,266   $—     $—     $37,064,266 
                    
Assets*
  
Level 1
   
Level 2
   
Level 3
   
Total
 
1st Lien/Senior Secured Debt  $—     $—     $1,190,640,160   $1,190,640,160 
2nd Lien/Junior Secured Debt   —      —      10,435,717    10,435,717 
Preferred Stock   —      —      9,767,046    9,767,046 
Common Stock   33,358    —      8,394,635    8,427,993 
Warrants   —      —      1,387,812    1,387,812 
                    
Total
  $33,358   $0   $1,220,625,370   $1,220,658,728 
                    
Investments valued at NAV as a practical expedient
#
         6,914,124 
           
Total assets
#
        $1,227,572,852 
           
*See consolidated schedule of investments for industry classifications.
#Certain investments that are measured at fair value using NAV have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the consolidated statements of assets and liabilities.
The following table summarizes the valuation of the Fund’s investments as of December 31, 2022:
Assets*
  
Level 1
   
Level 2
   
Level 3
   
Total
 
Cash Equivalents        
Investment Companies  $28,971,985   $—     $—     $28,971,985 
                    
Total Cash Equivalents
  $28,971,985   $—     $—     $28,971,985 
                    
Assets*
  
Level 1
   
Level 2
   
Level 3
   
Total
 
1st Lien/Senior Secured Debt  $—     $—     $1,088,190,382   $1,088,190,382 
2nd Lien/Junior Secured Debt   —      —      10,640,036    10,640,036 
Preferred Stock   —      —      9,218,222    9,218,222 
Common Stock   449,864    —      7,420,892    7,870,756 
Warrants   —      —      994,095    994,095 
                    
Total
  $449,864   $—     $1,116,463,627   $1,116,913,491 
                    
Investments valued at NAV as a practical expedient
#
         5,603,604 
           
Total assets
#
        $1,122,517,095 
           
*See consolidated schedule of investments for industry classifications.
#Certain investments that are measured at fair value using NAV have not been categorized in the fair value hierarchy. The fair value amounts presented in the table are intended to permit reconciliation of the fair value hierarchy to the amount presented in the consolidated statements of assets and liabilities.
46
The following is a reconciliation of Level 3 assets for insurance, legal, audit and tax services and board of directors’ compensation costs.

the six months ended June 30, 2023:

  
1st

Lien/Senior

Secured

Debt
  
2nd

Lien/Junior

Secured Debt
  
Preferred

Stock
  
Common

Stock
  
Warrants
  
Total
 
Balance as of January 1, 2023 $ 1,088,190,382  $ 10,640,036  $ 9,218,222  $ 7,420,892  $994,095  $ 1,116,463,627 
Purchases (including PIK)  151,415,892   —        769,444   —     152,185,336 
Sales and principal payments  (47,322,894  —     (53,047)  (72,758  —     (47,448,699
Realized Gain (Loss)  20,919   —     (861,879  5,453   —     (835,507
Net Amortization of Premium/Discount  3,085,908   11,972   —     —     —     3,097,880 
Transfers In  —     —     —     —     —     —   
Transfers Out  —     —     —     —     —     —   
Net Change in Unrealized Appreciation (Depreciation)  (4,750,047  (216,291  1,463,750   271,604   393,717   (2,837,267
                         
Balance as of June 30, 2023 $1,190,640,160  $10,435,717  $9,767,046  $8,394,635  $1,387,812  $1,220,625,370 
                         
Change in Unrealized Appreciation (Depreciation) for Investments Still Held $(4,781,809) $(216,291 $602,140  $271,602  $393,717  $(3,730,641)
For the quartersix months ended SeptemberJune 30, 2017,2023, there were no transfers into or out of Level 3.
The following is a reconciliation of Level 3 assets for the year ended December 31, 2022:
  
1st

Lien/Senior

Secured

Debt
  
2nd

Lien/Junior

Secured Debt
  
Preferred

Stock
  
Common

Stock
  
Warrants
  
Total
 
Balance as of January 1, 2022 $859,412,243  $10,677,299  $12,563,914  $4,695,735  $1,111,543  $888,460,734 
Purchases (including PIK)  447,434,086   220,045   2,396,024   2,683,623   43,880   452,777,658 
Sales and principal payments  (196,946,622  —     (8,919,847  (159,711  (299,962  (206,326,142
Realized Gain (Loss)  (19,544  —     5,415,842   (46  275,999   5,672,251 
Net Amortization of Premium/Discount  6,629,933   21,713   —     —     —     6,651,646 
Transfers In  —     —     —     426,294   —     426,294 
Transfers Out  —     —     —     (802,902  —     (802,902
Net Change in Unrealized Appreciation (Depreciation)  (28,319,714  (279,021  (2,237,711  577,899   (137,365  (30,395,912
                         
Balance as of December 31, 2022 $ 1,088,190,382  $ 10,640,036  $9,218,222  $ 7,420,892  $994,095  $ 1,116,463,627 
                         
Change in Unrealized Appreciation (Depreciation) for Investments Still Held $(25,834,883 $(279,021 $(2,018,945 $577,899  $89,851  $(27,465,099
47

For the year ended December 31, 2022, amounts of $426,294 of Common Stock were transferred into Level 3 from Investments valued at net asset value as a practical expedient due to the decreased transparency of the price inputs used in the valuation of these positions. Further, amounts of $802,902 of Common Stock were transferred out of Level 3 as these positions are now valued using their net asset values as a practical expedient and therefore are excluded from levels 1, 2 or 3.
The following tables present the ranges of significant unobservable inputs used to value the Fund’s Level 3 investments as of June 30, 2023 and December 31, 2022, respectively. These ranges represent the significant unobservable inputs that were used in the valuation of each type of investment. These inputs are not representative of the inputs that could have been used in the valuation of any one investment. Accordingly, the ranges of inputs presented below do not represent uncertainty in, or possible ranges of, fair value measurements of the Fund’s Level 3 investments.
Fair Value as of
June 30,
2023
Valuation
Techniques
Unobservable
Input
Range/Input (Weighted
Average)
(1)
Impact to
Valuation from an
Increase in Input
Assets:
1st Lien/Senior
Secured
Debt
1,132,612,538Market Yield AnalysisMarket Yield8.9% - 34.1% (11.3%)Decrease
273,794Market ApproachEBITDA Multiple2.9xIncrease
33,287Liquidation ValueAsset ValueN/AIncrease
3,317,093Recent TransactionTransaction PriceN/AN/A
54,403,448Recent PurchasePurchase PriceN/AN/A
2nd Lien/Junior Secured Debt10,435,717Market Yield AnalysisMarket Yield11.3% - 14.8% (13.0%)Decrease
Common Stock6,535,023Market ApproachEBITDA Multiple8.3x - 42.0x (16.4x)Increase
1,019,175Market ApproachRevenue Multiple0.8x - 36.1x (9.6x)Increase
331,734Market ApproachNetwork Cashflow Multiple25.8xIncrease
508,703Market ApproachMarket Yield
12.75% - 14.07% (13.88%)

Decrease
Preferred Stock6,297,363Market ApproachRevenue Multiple4.5x - 11.0x (8.5x)Increase
3,205,197Market Yield AnalysisDividend Yield12.5% - 15.1% (14.3%)
De
crease
264,486Expected RepaymentRedemption PriceN/AN/A
Warrants1,387,812Market ApproachRevenue Multiple7.1x - 9.9x (9.0x)Increase
Total Assets1,220,625,370
(1) Weighted averages are calculated based on fair value of investments.
48

   
Fair Value as of
December 31,
2022
  
Valuation
Techniques
  
Unobservable
Input
  
Range/Input (Weighted
Average)
(1)
  
Impact to
Valuation from an
Increase in Input
Assets:          
1st Lien/Senior Secured Debt  1,017,673,836  Market Yield Analysis  Market Yield  9.1% - 24.5% (11.5%)  Decrease
  3,196,797  Market Approach  EBITDA Multiple  4.6x - 10.0x (9.9x)  Increase
  2,625,128  Market Approach  Revenue Multiple  0.5x  Increase
  255,988  Liquidition Value  Asset Value  N/A  Increase
  64,438,633  Recent Purchase  Purchase Price  N/A  N/A
2nd Lien/Junior Secured Debt  10,640,036  Market Yield Analysis  Market Yield  13.7% - 14.6% (14.3%)  Decrease
Common Stock  4,066,465  Market Approach  EBITDA Multiple  8.0x - 30.0x (13.5x)  Increase
  997,684  Market Approach  Revenue Multiple  0.8x - 36.1x (10.8x)  Increase
  332,454  Market Approach  Network Cashflow Multiple  33.0x  Increase
  404,565  Market Approach  Dividend Yield  14.3%  Decrease
  1,619,724  Recent Purchase  Purchase Price  N/A  N/A
Preferred Stock  4,689,366  Market Approach  Revenue Multiple  0.5x - 12.0x (8.2x)  Increase
  4,355,019  Market Yield Analysis  Dividend Yield  12.5% - 17.5% (15.6%)  Decrease
  173,837  Expected Repayment  Redemption Price  N/A  N/A
Warrants  994,095  Market Approach  Revenue Multiple  0.5x - 8.5x (8.2x)  Increase
               
Total Assets  1,116,463,627        
(1) Weighted averages are calculated based on fair value of investments.
Financial Instruments Disclosed, But Not Carried, At Fair Value
The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of June 30, 2023 and the level of each financial liability within the fair value hierarchy.
   
Carrying

Value
(1)
   
Fair

Value
   
Level 1
   
Level 2
   
Level 3
 
Class A-1-R
Senior Secured Floating Rate Note
  $97,456,247   $96,285,000   $—     $—     $96,285,000 
Class A-1-L
Senior Secured Floating Rate Note
   74,705,937    73,500,000    —      —      73,500,000 
Class A-1-F
Senior Secured Fixed Rate Note
   29,882,375    27,300,000    —      —      27,300,000 
Class A-2-R
Senior Secured Deferrable Floating Rate
   43,329,463    41,325,000    —      —      41,325,000 
Class A Note   225,391,149    228,000,000    —      —      228,000,000 
Class B Note   35,588,076    36,000,000    —      —      36,000,000 
Class C Note   35,588,076    36,000,000    —      —      36,000,000 
                         
Total  $541,941,323   $538,410,000   $—     $—     $538,410,000 
                         
(1)Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $408,664 and $4,400,013 as of June 30, 2023 and are reflected on the consolidated statements of assets and liabilities.
49

The following table presents the carrying value and fair value of the Fund’s financial liabilities disclosed, but not carried, at fair value as of December 31, 2022 and the level of each financial liability within the fair value hierarchy.
   
Carrying

Value
(1)
   
Fair

Value
   
Level 1
   
Level 2
   
Level 3
 
Class A-1-R
Senior Secured Floating Rate Note
  $97,345,789   $96,039,375   $—     $—     $96,039,375 
Class A-1-L
Senior Secured Floating Rate Note
   74,626,138    73,312,500    —      —      73,312,500 
Class A-1-F
Senior Secured Fixed Rate Note
   29,850,455    28,275,000    —      —      28,275,000 
Class A-2-R
Senior Secured Deferrable Floating Rate
   43,283,185    41,216,250    —      —      41,216,250 
                         
Total  $245,105,567   $238,843,125   $—     $—     $238,843,125 
                         
(1)Carrying value is net of unamortized discount and debt issuance costs. Unamortized discount and debt issuance costs associated with the Notes totaled $414,624 and $1,229,809 as of December 31, 2022 and are reflected on the consolidated statements of assets and liabilities.
The Revolving Credit Facilities and Secured Borrowings are recorded at carrying value, which approximates fair value.
6. Commitments & Contingencies
Commitments
The Fund may enter into commitments to fund investments. As of June 30, 2023 and December 31, 2022 the Adviser believed that the Fund had reimbursedadequate financial resources to satisfy its unfunded commitments. The amounts associated with unfunded commitments to provide funds to portfolio companies are not recorded in the above expensesFund’s consolidated statements of assets and liabilities. Since these commitments and the associated amounts may expire without being drawn upon, the total commitment amount does not necessarily represent a future cash requirement. The Fund had the following unfunded commitments by investment types as part of its Expense Payment, amountingJune 30, 2023 and December 31, 2022:
      
06/30/2023
  
12/31/2022
 
Investment Type
 
Facility Type
 
Commitment
Expiration
Date (1)
 
Unfunded
Commitment
(2)
  
Fair Value
(3)
  
Unfunded
Commitment
(2)
  
Fair
Value (3)
 
1st Lien/Senior Secured Debt 5 Bars, LLC Delayed Draw Term Loan 02/28/2023  —     —     2,845,273   (7,113
5 Bars, LLC Revolver 09/27/2024  —     —     646,653   (1,617
AAH Topco, LLC Delayed Draw Term Loan 12/22/2023  1,250,622   (59,405  3,689,335   (119,903
AAH Topco, LLC Revolver 12/22/2027  787,273   (39,364  787,273   (31,491
Accelerate Resources Operating, LLC Revolver 02/24/2026  —     —     414,764   —   
Accelerate Resources Operating, LLC Revolver 02/24/2027  414,764   —     —     —   
Activ Software Holdings, LLC Revolver 05/04/2027  648,837   (19,465  648,837   (21,087
Admiral Buyer, Inc Delayed Draw Term Loan 05/06/2024  1,576,961   —     1,576,961   (15,770
Admiral Buyer, Inc Revolver 05/08/2028  563,200   —     563,200   (11,264
AEG Holding Company, Inc. Revolver 11/20/2023  —     —     670,119   —   
Airwavz Solutions, Inc. Delayed Draw Term Loan 03/31/2024  652,740   (11,423  3,263,699   (40,796
Airwavz Solutions, Inc. Delayed Draw Term Loan 03/31/2024  5,206,136   (52,061  —     —   
Airwavz Solutions, Inc. Revolver 03/31/2027  652,740   (13,055  652,740   (13,055
American Physician Partners, LLC Revolver 02/15/2023  —     —     97,681   (14,896
American Physician Partners, LLC Delayed Draw Term Loan 02/15/2023  —     —     421,339   (8,427
50

AMI US Holdings, Inc. Revolver 04/01/2024  963,252   —     1,094,605   —   
Analogic Corporation Revolver 06/22/2023  —     —     24,444   (856
Analogic Corporation Revolver 06/24/2024  55,460   (277  —     —   
AOM Acquisition, LLC. Revolver 02/18/2027  1,218,605   (3,047  1,218,605   (9,140
Avalara, Inc. Revolver 10/19/2028  1,065,375   (21,308  1,065,375   (26,634
Avant Communications, LLC Revolver 11/30/2026  566,910   (9,921  566,910   —   
Avetta, LLC Revolver 04/10/2024  494,396   (4,944  494,396   (2,472
BAART Programs, Inc. Delayed Draw Term Loan 06/11/2023  —     —     2,750,974   (130,671
Banneker V Acquisition, Inc. Revolver 12/04/2025  418,452   (10,461  259,300   —   
Bonterra, LLC Delayed Draw Term Loan 09/08/2023  2,420,233   (42,354  2,746,215   (68,655
Bonterra, LLC Revolver 09/08/2027  18,521   (463  723,392   (23,510
Bridgepointe Technologies, LLC Delayed Draw Term Loan 09/23/2024  1,430,817   (28,616  2,108,716   (57,990
Bridgepointe Technologies, LLC Revolver 12/31/2027  660,870   (14,870  777,494   (29,156
Brightspot Buyer, Inc Revolver 11/16/2027  680,292   (17,007  680,292   (20,409
BSI2 Hold Nettle, LLC Revolver 06/30/2028  294,461   (5,153  588,922   (10,306
BusinesSolver.com, Inc. Delayed Draw Term Loan 12/01/2023  1,816,606   (31,791  1,816,606   (45,415
BV EMS Buyer, Inc. Delayed Draw Term Loan 03/21/2024  1,706,075   (42,652  2,765,018   (96,776
Cerifi, LLC Revolver 04/01/2027  738,528   (12,924  1,107,792   (33,234
Certify, Inc Revolver 02/28/2024  119,907   —     119,907   (899
Choice Health At Home, LLC, Delayed Draw Term Loan 12/29/2023  1,320,427   (66,021  1,320,427   (52,817
Coding Solutions Acquisition, Inc Delayed Draw Term Loan 05/10/2024  1,482,772   (44,483  1,656,288   (62,111
Coding Solutions Acquisition, Inc Revolver 05/11/2028  636,288   (25,452  636,288   (30,224
Community Based Care Acquisition, Inc. Delayed Draw Term Loan 09/16/2023  109,272   (2,185  109,272   (4,371
Community Based Care Acquisition, Inc. Delayed Draw Term Loan 03/29/2024  2,912,094   (36,401  2,912,094   (87,363
Community Based Care Acquisition, Inc. Revolver 09/16/2027  863,813   (17,276  863,813   (34,553
Community Brands Parentco, LLC Delayed Draw Term Loan 02/24/2024  834,415   (20,860  834,415   (27,118
Community Brands Parentco, LLC Revolver 02/24/2028  417,208   (14,602  417,208   (17,731
Coretelligent Intermediate LLC Delayed Draw Term Loan 10/21/2023  1,870,703   (42,091  1,870,703   (46,768
Coretelligent Intermediate LLC Revolver 10/21/2027  1,203,100   (30,078  1,139,779   (31,344
Coupa Holdings,LLC Delayed Draw Term Loan 08/27/2024  948,020   (11,850  —     —   
Coupa Holdings,LLC Revolver 02/27/2029  725,890   (18,147  —     —   
Datacor, Inc. Delayed Draw Term Loan 03/31/2024  1,431,722   (17,897  1,431,722   (7,159
Datacor, Inc. Revolver 12/29/2025  643,849   (14,487  643,849   (9,658
Degreed, Inc. Delayed Draw Term Loan 08/18/2023  1,391,394   (31,306  1,391,394   (34,785
Degreed, Inc. Delayed Draw Term Loan 08/18/2024  1,321,674   (23,129  1,321,674   (26,433
Degreed, Inc. Revolver 05/29/2026  417,813   (11,490  417,813   (12,534
Delaware Valley Management Holdings, Inc. Delayed Draw Term Loan 09/18/2023  144,839   (42,438  619,031   (221,304
51

Dispatch Track, LLC Revolver 12/17/2026  301,930   (3,019  301,930   (3,019
EET Buyer, Inc. Revolver 11/08/2027  1,036,629   (28,507  690,794   (13,816
Engage2Excel, Inc. Revolver 03/07/2023  —     —     31,409   (864
EvolveIP, LLC Revolver 06/07/2025  94,478   (4,015  418,538   (11,510
Exterro, Inc. Revolver 05/31/2024  738,562   —     247,500   (1,238
Faithlife, LLC Revolver 09/18/2025  279,053   —     279,053   —   
Fatbeam, LLC Delayed Draw Term Loan 02/22/2023  —     —     1,609,623   (8,048
Firstdigital Communications LLC Revolver 12/17/2026  1,174,177   (46,967  1,174,177   (49,903
Foundation Risk Partners, Corp. Delayed Draw Term Loan 04/14/2024  1,278,703   (38,361  1,278,703   (19,181
Foundation Risk Partners, Corp. Revolver 10/29/2027  1,038,062   (33,737  610,625   (10,686
Freddy’s Frozen Custard, L.L.C Revolver 03/03/2027  —     —     412,270   (4,123
Fusion Holding Corp Revolver 09/15/2027  1,379,193   (20,688  1,379,193   (34,480
Fusion Risk Management Inc Revolver 08/30/2028  —     —     852,848   (29,850
Fusion Risk Management, Inc. Revolver 05/22/2029  840,050   (16,801  —     —   
G Treasury SS, LLC Delayed Draw Term Loan 01/02/2024  2,439,257   (18,294  —     —   
G Treasury SS, LLC Delayed Draw Term Loan 06/30/2025  1,524,536   (11,434  —     —   
G Treasury SS, LLC Revolver 07/03/2029  914,721   (18,294  —     —   
Galway Borrower, LLC Delayed Draw Term Loan 09/29/2023  39,209   (980  39,209   (1,274
Galway Borrower, LLC Revolver 09/30/2027  270,410   (9,464  270,410   (11,492
GHA Buyer, Inc. Revolver 06/24/2026  951,077   (35,665  951,077   (40,421
Greenhouse Software, Inc. Revolver 09/01/2028  1,232,251   (21,564  1,232,251   (30,806
Greenhouse Software, Inc. Revolver 09/01/2028  604,499   (10,579  604,499   (15,112
Greenlight Intermediate II, Inc. Delayed Draw Term Loan 05/30/2025  4,336,642   —     6,702,083   (50,266
Gryphon-Redwood Acquisition LLC Delayed Draw Term Loan 09/16/2024  1,586,009   (11,895  1,586,009   (35,685
GS AcquisitionCo, Inc. Revolver 05/22/2026  304,465   (9,895  456,698   (18,268
Higginbotham Insurance Agency, Inc. Delayed Draw Term Loan 12/22/2023  —     —     1,918,951   (23,987
Hirevue, Inc. Revolver 05/03/2029  1,646,176   (41,154  —     —   
Honor HN Buyer, Inc Delayed Draw Term Loan 10/16/2023  —     —     889,740   (2,224
Honor HN Buyer, Inc Delayed Draw Term Loan 08/26/2024  1,421,307   —     2,437,025   —   
Honor HN Buyer, Inc Revolver 10/15/2027  266,081   —     304,093   (2,281
Iodine Software, LLC Delayed Draw Term Loan 10/18/2023  3,436,155   —     3,436,155   (25,771
Iodine Software, LLC Revolver 05/19/2027  1,089,030   (13,613  1,089,030   (21,781
Kaseya Inc. Delayed Draw Term Loan 06/24/2024  597,933   (14,948  636,776   (19,103
Kaseya Inc. Revolver 06/25/2029  477,582   (15,521  636,776   (23,879
Mathnasium LLC Revolver 11/15/2027  565,781   (9,901  565,781   (12,730
Mavenlink, Inc. Revolver 06/03/2027  1,073,889   (21,478  1,431,852   (39,376
MBS Holdings, Inc. Revolver 04/16/2027  818,302   (28,641  974,169   (38,967
Medbridge Holdings, LLC Revolver 12/23/2026  1,376,227   (20,643  1,376,227   (30,965
52
Medical Management Resource Group, LLC Revolver 09/30/2026  189,849   (8,543  316,415   (11,866
Medsuite Purchaser, LLC Delayed Draw Term Loan 10/23/2023  7,144,203   —     7,144,203   —   
Medsuite Purchaser, LLC Revolver 10/22/2026  680,400   (1,701  680,400   (5,103
Metametrics, Inc. Revolver 09/10/2025  651,183   —     520,946   (6,512
MMP Intermediate, LLC Revolver 02/15/2027  552,880   (15,204  552,880   (19,351
Moon Buyer, Inc. Revolver 04/21/2027  698,276   (33,168  1,163,793   (2,909
Mr. Greens Intermediate, LLC Delayed Draw Term Loan 11/01/2024  2,630,169   (78,905  —     —   
Mr. Greens Intermediate, LLC Revolver 05/01/2029  1,052,068   (31,562  —     —   
MSM Acquisitions, Inc. Delayed Draw Term Loan 01/30/2023  —     —     2,828,188   (113,128
MSM Acquisitions, Inc. Revolver 12/09/2026  226,633   (10,198  655,399   (29,493
MSP Global Holdings, Inc. Delayed Draw Term Loan 01/24/2024  592,150   (13,323  592,150   (20,725
MSP Global Holdings, Inc. Revolver 01/25/2027  845,929   (19,033  845,929   (29,608
Mykaarma Acquisition LLC Revolver 03/21/2028  593,215   (8,898  593,215   (16,313
Navigate360, LLC Revolver 03/17/2027  —     —     604,235   (12,085
Netwrix Corporation And Concept Searching Inc. Delayed Draw Term Loan 06/10/2024  2,845,286   (21,340  2,973,121   (22,298
Netwrix Corporation And Concept Searching Inc. Revolver 06/11/2029  581,067   (5,811  774,755   (7,748
OMH-HealthEdge
Holdings, LLC
 Revolver 10/24/2024  458,721   —     458,721   (1,147
Pace Health Companies, LLC Revolver 08/02/2024  616,682   —     616,682   (1,542
Peter C. Foy & Associates Insurance Services, LLC Delayed Draw Term Loan 12/15/2023  —     —     161,112   (7,250
Ping Identity Corporation Revolver 10/17/2028  1,203,345   (24,067  1,203,344   (30,084
Pinnacle Dermatology Management, LLC Delayed Draw Term Loan 12/08/2023  606,828   (28,824  798,862   (25,963
Pinnacle Dermatology Management, LLC Revolver 12/08/2026  215,078   (2,688  384,068   (4,801
Pinnacle Treatment Centers, Inc. Revolver 01/02/2026  146,477   (2,930  292,954   (6,591
Priority Ondemand Midco 2,L.P Delayed Draw Term Loan 07/15/2024  2,600,963   (13,005  2,720,672   (30,472
Race Finco LLC Delayed Draw Term Loan 01/09/2025  3,658,788   (45,735  —     —   
Race Finco LLC Revolver 01/09/2028  609,798   (16,769  —     —   
Ranger Buyer, Inc. Revolver 11/18/2027  1,199,233   (26,983  1,199,232   (29,981
Redwood Family Care Network, Inc. Delayed Draw Term Loan 04/15/2024  3,379,752   (33,798  3,665,540   (91,638
Redwood Family Care Network, Inc. Revolver 06/18/2026  588,705   (10,302  588,705   (14,718
Rep Tec Intermediate Holdings, Inc. Revolver 12/01/2027  407,781   (10,195  486,706   (15,818
RSC Acquisition, Inc. Delayed Draw Term Loan 05/31/2024  686,250   (17,156  4,995,303   (162,347
Sako and Partners Lower Holdings LLC Delayed Draw Term Loan 09/16/2024  1,633,575   (20,420  2,840,999   (35,512
Sako and Partners Lower Holdings LLC Revolver 09/15/2028  1,242,937   (24,859  905,569   (24,903
Salisbury House, LLC Revolver 08/30/2025  448,343   (11,209  269,006   (10,088
Sandstone Care Holdings, LLC Delayed Draw Term Loan 06/28/2024  1,077,728   —     1,177,845   (26,502
Sandstone Care Holdings, LLC Revolver 06/28/2028  630,147   (3,151  588,923   (19,140
Sauce Labs, Inc. Delayed Draw Term Loan 02/09/2024  2,367,500   (29,594  2,367,499   (35,512
53

Sauce Labs, Inc. Revolver 08/16/2027  1,281,821   (28,841  1,281,821   (32,046
Saviynt, Inc. Delayed Draw Term Loan 12/22/2024  4,268,586   (96,043  6,097,981   (152,450
Saviynt, Inc. Revolver 12/22/2027  609,798   (13,720  609,798   (15,245
SCA Buyer, LLC Revolver 01/20/2026  128,770   (5,473  257,540   (10,302
ScyllaDB, Inc. Delayed Draw Term Loan 03/08/2024  660,837   (4,956  660,837   (8,260
ScyllaDB, Inc. Revolver 09/08/2027  264,335   (3,304  264,335   (4,626
Securonix, Inc. Revolver 04/05/2028  1,538,337   (84,609  1,538,337   (69,225
Serrano Parent, LLC Revolver 05/13/2030  2,085,981   (52,150  —     —   
Single Digits, Inc. Revolver 12/21/2023  —     —     416,149   (63,463
Single Digits, Inc. Revolver 06/21/2026  416,149   (52,019  —     —   
Sirsi Corporation Revolver 03/15/2024  553,741   (1,384  553,741   (2,769
SIS Purchaser, Inc. Revolver 10/15/2026  1,165,951   (20,404  1,165,950   (37,893
Smartlinx Solutions, LLC Revolver 03/04/2026  —     —     389,613   (11,688
Smile Brands, Inc. Revolver 10/12/2025  16,987   (1,444  166,783   (12,926
Soladoc, LLC Delayed Draw Term Loan 06/10/2024  2,355,690   (53,003  2,355,690   (53,003
Soladoc, LLC Revolver 06/12/2028  588,923   (19,140  588,922   (19,140
Spark DSO LLC Revolver 04/20/2026  856,964   (49,275  1,105,760   (38,702
Stratus Networks, Inc. Delayed Draw Term Loan 12/15/2023  2,442,241   (18,317  3,630,358   (54,455
Stratus Networks, Inc. Revolver 12/15/2027  198,019   (3,465  13,201   (330
SugarCRM, Inc. Revolver 07/31/2024  310,244   (3,102  310,244   (4,654
Sundance Group Holdings, Inc. Revolver 07/02/2027  1,087,824   (16,317  1,418,901   (39,020
Swiftpage, Inc. Revolver 06/13/2023  —     —     225,317   (9,576
Swiftpage, Inc. Revolver 12/13/2023  225,317   (3,943  —     —   
Syntax Systems Ltd Delayed Draw Term Loan 10/30/2023  2,434,137   (109,536  2,434,137   (121,707
Syntax Systems Ltd Revolver 10/29/2026  324,552   (14,605  324,552   (16,228
TBG Food Acquisition Corp Delayed Draw Term Loan 12/25/2023  1,056,104   (60,726  1,056,104   (84,488
TBG Food Acquisition Corp Revolver 12/25/2027  264,026   (15,182  264,026   (21,122
Telcor Buyer, Inc. Revolver 08/20/2027  290,770   (5,815  290,770   (7,996
Telesoft Holdings, LLC Revolver 12/16/2025  481,472   (10,833  547,128   (12,310
The Center for Orthopedic and Research Excellence, Inc. Delayed Draw Term Loan 03/31/2024  1,176,326   (11,763  1,253,266   (18,799
The Center for Orthopedic and Research Excellence, Inc. Revolver 08/15/2025  138,106   (2,417  138,106   (3,453
Thrive Buyer, Inc. Revolver 01/22/2027  739,815   (5,549  961,759   (14,426
Towerco IV Holdings, LLC Delayed Draw Term Loan 10/23/2023  1,814,778   (27,222  3,080,902   (46,214
TRGRP, Inc. Revolver 11/01/2023  —     —     333,333   —   
TRGRP, Inc. Revolver 06/09/2024  300,000   —     —     —   
Unanet, Inc. Delayed Draw Term Loan 12/09/2024  3,790,435   (18,952  3,790,435   (37,904
Unanet, Inc. Revolver 12/08/2028  1,263,478   (18,952  1,263,478   (25,270
54
Ungerboeck Systems International, LLC Delayed Draw Term Loan 08/02/2023  44,570   (780  204,574   (2,046
Ungerboeck Systems International, LLC Revolver 04/30/2027  180,451   (3,158  229,387   (4,588
Valcourt Holdings II, LLC Delayed Draw Term Loan 01/09/2023  —     —     279,947   —   
Vectra AI, Inc. Delayed Draw Term Loan 03/18/2023  —     —     1,163,793   (34,914
Vectra AI, Inc. Revolver 03/18/2026  —     —     232,759   (6,983
Vectra AI, Inc. Revolver 03/02/2028  232,759   (4,655  —     —   
Vehlo Purchaser, LLC Revolver 05/24/2028  991,229   (17,347  1,239,037   (18,586
Velocity Purchaser Corporation Revolver 12/01/2023  —     —     193,237   (483
Velocity Purchaser Corporation Revolver 12/01/2024  193,237   —     —     —   
Veracross LLC Delayed Draw Term Loan 12/28/2023  —     —     1,668,830   (37,549
Veracross LLC Revolver 12/28/2027  1,112,554   (22,251  1,112,554   (36,158
Vhagar Purchaser, LLC Delayed Draw Term Loan 06/09/2025  746,711   (11,201  —     —   
Vhagar Purchaser, LLC Revolver 06/11/2029  373,356   (11,201  —     —   
Wealth Enhancement Group, LLC Delayed Draw Term Loan 05/02/2024  398,757   (4,984  718,075   (10,771
Wealth Enhancement Group, LLC Revolver 10/04/2027  457,366   (6,861  457,366   (8,004
West Dermatology Delayed Draw Term Loan 06/17/2024  —     —     3,731,767   (522,447
West Dermatology Delayed Draw Term Loan 03/31/2025  3,731,767   (279,881  —     —   
West Dermatology Revolver 03/17/2028  1,243,922   (105,733  1,243,922   (186,588
Zendesk, Inc. Delayed Draw Term Loan 11/22/2024  3,333,525   (8,334  3,333,525   (33,335
Zendesk, Inc. Revolver 11/22/2028  1,372,628   (17,158  1,372,628   (27,453
                  
Total   $172,834,987  $(3,312,188 $193,536,127  $(5,029,664
                  
(1)Commitments are generally subject to borrowers meeting certain criteria such as compliance with covenants and certain operational metrics. These amounts may remain outstanding until the commitment period of an applicable loan expires, which may be shorter than its maturity.
(2)Net of capitalized fees, expenses and original issue discount (“OID”).
(3)A negative fair value was reflected as investments, at fair value in the consolidated statements of assets and liabilities. The negative fair value is the result of the capitalized discount on the loan.
Contingencies
In the normal course of business, the Fund enters into contracts that provide a variety of general indemnifications. Any exposure to $534,500.

6.the Fund under these arrangements could involve future claims that may be made against the Fund. Currently, no such claims exist or are expected to arise and, accordingly, the Fund has not accrued any liability in connection with such indemnifications.

7. Net Assets

Equity Issuance
In connection with its formation, the Fund has the authority to issue 200,000,000 shares of the Fund’s common stock, par value $0.01 per share.

Shares.

On September 29, 2017, the Fund completed its Initial Closing after entering into Subscription Agreements with several investors, including the Adviser, providing for the private placement of the Fund’s common shares.Shares. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase the Fund’s common sharesShares up to the amount of their respective Capital Commitments on an
as-needed
basis upon the issuance of a capital drawn-downdraw-down notice. At SeptemberJune 30, 20172023 the Fund had total Capital Commitments of $70,928,060,$611,970,154, of which 100%14% or $88,163,879 is unfunded. At December 31, 2022, the Fund had total Capital Commitments of $572,772,226, of which 14% or $77,483,361 was unfunded. The minimum Capital Commitment of an investor is $50,000. The Fund,Adviser, however, may waive the minimum Capital Commitment at its discretion.

55

Capital Commitments may be drawn down by the Fund on a pro rata basis, as needed (including for
follow-on
investments), for paying the Fund’s expenses, including fees under the Amended and Restated Advisory Agreement, and/or maintaining a reserve account for the payment of future expenses or liabilities.

The following table summarizes the total Shares issued and amount received related to capital drawdowns delivered pursuant to the Subscription Agreements during the six months ended June 30, 2023 and June 30, 2022:
   
For the six months ended

June 30, 2023
   
For the six months ended

June 30, 2022
 
Quarter Ended
  
Shares
   
Amount
   
Shares
   
Amount
 
March 31   —      —      3,095,246   $30,684,000 
June 30   2,776,754   $25,792,451    5,759,395   $56,263,228 
                    
Total capital drawdowns   2,776,754   $25,792,451    8,854,641   $86,947,228 
                    
Distributions
The following tables reflect the distributions declared on Shares during the six months ended June 30, 2023 and June 30, 2022:
Date Declared
  
Record Date
   
Payment Date
   
Amount Per Share
   
Dollar Amount
 
3/29/2023   3/29/2023    4/25/2023   $0.10   $5,139,617 
6/28/2023   6/28/2023    7/24/2023   $0.20   $10,402,344 
           
        $15,541,961 
           
Date Declared
  
Record Date
   
Payment Date
   
Amount Per Share
   
Dollar Amount
 
3/29/2022   3/29/2022    4/28/2022   $0.25   $9,709,845 
6/28/2022   6/28/2022    7/27/2022   $0.15   $6,590,492 
           
        $16,300,337 
           
Dividend Reinvestment Plan
On September 26, 2017, the Fund adopted a dividend reinvestment plan, which was amended and restated on November 11, 2021 (the “DRIP”). Pursuant to the DRIP (both before and after it was amended), stockholders receive dividends or other distributions in cash unless a stockholder elects to reinvest his or her dividends and other distributions. As a result of adopting the DRIP, if the Board authorizes, and the Fund declares, a cash dividend or distribution, stockholders who have opted into the DRIP will have their cash dividends or distributions automatically reinvested in additional Shares, rather than receiving cash.
The following tables summarize Shares distributed pursuant to the DRIP during the six months ended June 30, 2023 and June 30, 2022 to stockholders who opted into the DRIP:
Date Declared
  
Record Date
   
Reinvestment Date
   
Shares
   
Dollar Amount
 
3/29/2023   3/29/2023    3/31/2023    294,604   $2,740,870 
6/28/2023   6/28/2023    6/30/2023    606,230   $5,552,823 
              
       900,834   $8,293,693 
              
Date Declared
  
Record Date
   
Reinvestment Date
   
Shares
   
Dollar Amount
 
3/29/2022   3/29/2022    3/31/2022    526,163   $5,101,704 
6/28/2022   6/28/2022    6/30/2022    360,978   $3,500,728 
              
       887,141   $8,602,432 
              
General Tender Program
Beginning with the quarter ended March 31, 2021, the Fund began to conduct quarterly general tender offers (each, a “General Tender,” and collectively, the “General Tender Program”), at the Board’s discretion, in accordance with the requirements of Rule
13e-4
under the Exchange Act and the 1940 Act, to allow each of its stockholders to tender Shares at a specific per Share price (the “Purchase Price”) based on the Fund’s net asset value as of the last date of the quarter in which the General Tender is conducted.
56

The Fund intends to conduct each General Tender to repurchase up to a certain percentage of the weighted average of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.
The following table summarizes share repurchases completed during the six months ended June 30, 2023:
Quarter Ended
  
Repurchase Date
  
Total Number of
Shares Offered
to Repurchase
   
Total Number of
Shares
Repurchased
   
Total
Consideration
   
No. of Shares
Repurchased/
Total Offer
   
Price Paid
Per Share
 
March 31  February 24, 2023   1,215,454    627,518   $5,837,993    52  $9.30 
June 30  May 26, 2023   1,255,610    461,364   $4,225,901    37  $9.16 
The following table summarizes share repurchases completed during the six months ended June 30, 2022:    
Quarter Ended
  
Repurchase Date
  
Total Number of
Shares Offered
to Repurchase
   
Total Number of
Shares
Repurchased
   
Total
Consideration
   
No. of Shares
Repurchased/
Total Offer
   
Price Paid
Per Share
 
March 31  February 25, 2022   795,164    420,864   $4,081,370    53  $9.70 
June 30  May 27, 2022   911,141    617,738   $5,990,765    68  $9.70 
8. Earnings Per Share
The following information sets forth the computation of basic and diluted earnings per Share for the three and six months ended June 30, 2023 and June 30, 2022:
   
For the three months ended
June 30,
   
For the six months ended
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
Net increase (decrease) in net assets from operations  $2,873,817   $6,184,258   $18,422,405   $11,695,958 
Weighted average common shares outstanding   51,975,095    41,885,326    51,104,578    39,180,515 
Earnings per common share-basic and diluted  $0.06   $0.15   $0.36   $0.30 
57

9. Financial Highlights
Below is the schedule of financial highlights of the Fund for the six months ended June 30, 2023 and June 30, 2022:
  
For the six months ended

June 30, 2023
  
For the six months ended

June 30, 2022
 
Per Share Data:
(1)(2)
 
Net asset value, beginning of period $9.10  $9.80 
Net investment income (loss)  0.42   0.40 
Net realized and unrealized gains (losses) on investments  (0.06  (0.10
        
Net increase (decrease) in net assets resulting from operations  0.36   0.30 
        
Distributions to stockholders
(3)
  (0.30  (0.40
        
Net asset value, end of period $9.16  $9.70 
Shares outstanding, end of period  52,816,794   44,047,129 
Total return at net asset value before incentive fees
(4)(5)
  5.15  3.69
Total return at net asset value after incentive fees
(4)(5)
  4.01  3.15
Ratio/Supplemental Data:
  
Net assets, end of period $483,746,801  $427,133,065 
Ratio of total expenses to weighted average net assets
(6)
  19.14  12.24
Ratio of net expenses to weighted average net assets
(6)
  19.14  11.89%
(7)
 
Ratio of net investment income (loss) before waivers to weighted average net assets
(6)
  10.69  8.76
Ratio of net investment income (loss) after waivers to weighted average net assets
(6)
  10.69  9.11%
(7)
 
Ratio of interest and credit facility expenses to weighted average net assets
(6)
  13.40  6.46
Ratio of incentive fees to weighted average net assets
(5)
  1.15  0.55
Portfolio turnover rate
(5)
  4.07  10.37
Asset coverage ratio
(8)
  160  165
(1)The per share data was derived by using the weighted average shares outstanding during the applicable period.
(2)
Ratios calculated with Net Assets excluding the
Non-Controlling
Interest.
(3)The per share data for distributions is the actual amount of distributions paid or payable per share of common stock outstanding during the entire period.
(4)Total return based on NAV is calculated as the change in NAV per share during the respective periods, assuming dividends and distributions, if any, are reinvested in accordance with the Fund’s dividend reinvestment plan.
(5)Not annualized.
(6)Annualized, except for professional fees, directors’ fees and incentive fees.
(7)For the six months ended June 30, 2023 and June 30, 2022, the Adviser voluntarily waived a portion of their management fees and collateral management fees. Additionally, the Adviser received reimbursement payments from the Fund as per the Expense Support and Conditional Reimbursement Agreement. The ratios include the effects of the waived expenses of 0% and 0.31%, for the six months ended June 30, 2023 and June 30, 2022, respectively.
(8)Asset coverage ratio is equal to (i) the sum of (A) net assets at end of period and (B) debt outstanding at end of period, divided by (ii) total debt outstanding at the end of the period.
10. Subsequent Events
Subsequent events after the consolidated statements of assets and liabilities date have been evaluated through the date the consolidated financial statements were issued. The Fund has concluded that there are no events requiring adjustment or disclosure in the consolidated financial statements.
58


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form10-Q (this “Quarterly Report”) contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about us, ourthe Fund, its current and prospective portfolio investments, ourits industry, ourits beliefs and opinions, and ourits assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond ourthe Fund’s control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

 

an economic downturn could impair ourthe Fund’s portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of ourthe Fund’s investments in such portfolio companies;

 

such an economic downturn could disproportionately impact the companies that we intendthe Fund intends to target for investment, potentially causing usthe Fund to experience a decrease in investment opportunities and diminished demand for capital from these companies;

 

a contraction of available credit and/or an inability to access the equity markets could impair ourthe Fund’s lending and investment activities;

 

interest rate volatility could adversely affect ourthe Fund’s results, particularly if we electthe Fund elects to use leverage as part of ourits investment strategy;

 

our

the Fund’s future operating results;

 

our

the Fund’s business prospects and the prospects of ourthe Fund’s portfolio companies;

 

our

the Fund’s contractual arrangements and relationships with third parties;

 

the ability of ourthe Fund’s portfolio companies to achieve their objectives;

 

competition with other entities and ourthe Fund’s affiliates for investment opportunities;

 

the speculative and illiquid nature of ourthe Fund’s investments;

 

the use of borrowed money to finance a portion of ourthe Fund’s investments;

 

the adequacy of ourthe Fund’s financing sources and working capital;

 

the loss of key personnel;

 

the timing of cash flows, if any, from the operations of ourthe Fund’s portfolio companies;

 

the ability of the Adviser to locate suitable investments for usthe Fund and to monitor and administer ourthe Fund’s investments;

 

the ability of the Adviser to attract and retain highly talented professionals;

 

our

the Fund’s ability to qualify and maintain ourits qualification as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and as a business development company (“BDC”);

 

the effect of legal, tax and regulatory changes; and

 

the other risks, uncertainties and other factors the Fund identifies under “Risk Factors” of its Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

59


the other risks, uncertainties and other factors we identify under “Item 1A. Risk Factors” of our Annual Report on Form10-K for the fiscal year ended December 31, 2016.

Although we believethe Fund believes that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this report should not be regarded as a representation by usthe Fund that ourthe Fund’s plans and objectives will be achieved. These risks and uncertainties include those described or identified in the section entitled “Item 1A. Risk Factors” of the Annual Report on Form10-K for the fiscal year ended December 31, 20162022, and elsewhere in this report. These forward-looking statements apply only as of the date of this report. Moreover, we assumethe Fund assumes no duty and dodoes not undertake to update the forward-looking statements. The forward-looking statements and projections contained in this Quarterly Report are excluded from the safe harbor protection provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) because the Fund is an investment company.

The following analysis of ourthe Fund’s financial condition and results of operations should be read in conjunction with ourthe Fund’s financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form10-Q.Report.

Overview

AB Private Credit Investors Corporation (the “Fund”)The Fund was formed on February 6, 2015 as a corporation under the laws of the State of Maryland. WeThe Fund is structured as an externally managed, non-diversified, closed-end management investment company. The Fund was formed to invest primarily in primary-issue middle-market credit opportunities that are currently in the development stagedirectly sourced and have notprivately negotiated. The Fund commenced investment operations. Since inception, there has been no investment or operational activity. In conjunction with our formation, we issued and sold (i) 100 shares of common stock, par value $0.01,operations on June 27, 2016, at an aggregate purchase price of $1,000 ($10.00 per share) and (ii) 2,400 shares of common stock, par value $0.01, on May 26,November 15, 2017 to(“Commencement”). The Fund is advised by AB Private Credit Investors LLC.

On October 6, 2016 we filedLLC (the “Adviser”), which is registered with the Securities and Exchange Commission (“SEC”) under the Investment Advisers Act of 1940, as amended (the “SEC”“Advisers Act”). The Adviser is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring the Fund’s portfolio on an ongoing basis. State Street Bank and Trust Company (the “Administrator”) an electionprovides the administrative services necessary for the Fund to operate.

The Fund has elected to be treated as a BDC under the Investment Company Act of 1940 as amended (the “1940 Act”). WeAct. The Fund has also intend to electelected to be treated and intendintends to qualify annually thereafter, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. While we intend to elect to be treated as a RIC as soon as practicable, we may have difficulty satisfying the asset diversification requirements as we deploy initial capital and build our portfolio. To the extent that we have net taxable income prior to our qualification as RIC, we will be subject to U.S. federal income tax on such income. As a BDC and a RIC, respectively, we arethe Fund is and will be required to comply with various regulatory requirements, such as the requirement to invest at least 70% of ourits assets in “qualifying assets,” source of income limitations, asset diversification requirements, and the requirement to distribute annually at least 90% of ourits taxable income andtax-exempt tax exempt interest.

Our investment activities are managed by our external investment adviser, AB Private Credit Investors LLC (the “Adviser”), an investment adviser thatThe Fund is registered under the Investment Advisers Act of 1940, as amended. We intend to enter into an administration agreement (the “Administration Agreement”) with a third party administrator (the “Administrator”), pursuant to which the Administrator will provide the administrative services necessary for us to operate.

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. We2012 (the “JOBS Act”). The Fund will remain an emerging growth company for up to five years following anits initial public offering, if any, although if the market value of ourits common stock that is held bynon-affiliates exceeds $700 million as of any June 30 before that time, wethe Fund would cease to be an emerging growth company as of the following December 31. For so long as we remainthe Fund remains an emerging growth company under the JOBS Act, weit will be subject to reduced public company reporting requirements.

60


The Private Offering

The Fund is conducting private offeringsenters into separate subscription agreements (each, a “Private Offering”“Subscription Agreement,” and collectively, the “Subscription Agreements”) with investors providing for the private placement of its common stock to investors(the “Shares”) in reliance on an exemptionexemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”(such offering, the “Private Offering”). At the closing of any Private Offering, eachEach investor will makemakes a capital commitment (a “Capital Commitment”) to purchase shares of the Fund’s common stockShares pursuant to a subscription agreement entered into with the Fund.Subscription Agreement. Investors will beare required to fund drawdownsmake capital contributions (“Capital Contributions”) to purchase shares of the Fund’s common stock up to the amount of their respective Capital Commitment on anas-needed basisShares each time the Fund delivers a capital call notice, which is issued based on the Fund’s anticipated investment activities and capital needs, delivered at least 10 business days prior to its investors. the required funding date, provided that investors may fund such requirements sooner than the deadline as agreed between the Fund and the investor. Generally, purchases of Shares are made pro rata in accordance with each investor’s Capital Commitment, in an amount not to exceed each investor’s remaining capital commitment (“Remaining Commitment”), at a per Share price equal to the net asset value per Share subject to any adjustments. Pursuant to the Private Offering, the Fund’s initial closing occurred on September 29, 2017.

The Fund anticipates commencing its loan originationmay accept additional Capital Commitments quarterly (“Subsequent Closings”) from new investors as well as existing investors that wish to increase their commitment and investment activities contemporaneously with the initial drawdown from investorsshareholding in the initial Private Offering.

On September 29, 2017,Fund. These Subsequent Closings are expected to occur on a calendar-quarter end based on investor interest as well as the state of the market and the Fund’s capacity to invest the additional capital within a reasonable period. Each Capital Commitment is for the life of the Fund completedor for a shorter period based on the initial closing (“Initial Closing”) of its Private Offering after entering into subscription agreements (collectively, the “Subscription Agreements”) with several investors, including the Adviser, providing for the private placement ofinvestor’s liquidation election, subject to the Fund’s common shares. Under the termsreceipt of the Subscription Agreements, investorsexemptive relief that would permit stockholders to liquidate their investments pursuant to transactions that are required to fund drawdowns to purchase the Fund’s common shares up to the amount of their respective Capital Commitments on anas-needed basis upon the issuance of a capital drawn-down notice. At September 30, 2017 the Fund had total Capital Commitments of $70,928,060, of which 100% is unfunded. Capital Commitments may be drawn downcurrently prohibited by the Fund on a pro rata basis, as needed (includingfollow-on investments), for paying the1940 Act and would require an SEC order in order to be established.

Revenues

The Fund’s expenses, including fees under the Advisory Agreement, and/or maintaining a reserve account for the payment of future expenses or liabilities.

Portfolio and Investment Activity

As of September 30, 2017 and December 31, 2016, we have not commenced investment activities.

Results of Operations

As of September 30, 2017, we completed the Initial Closing of our Private Offering but had not commenced any significant operational or investment activities. As of December 31, 2016, we had not completed the Initial Closing of our private offering or commenced any operational or investment activities. Therefore, no results of operations are reported.

Revenues

Our investment objective is to generate current income and prioritize capital preservation through a portfolio that primarily invests in directly-sourced, privately-negotiated, secured, middle market loans. We intendThe Fund intends to primarily invest in middle market businesses based in the United States. We expectThe Fund expects that the primary use of proceeds by the companies in which we investthe Fund invests will be for leveraged buyouts, recapitalizations, mergers and acquisitions and growth capital.

WeThe Fund will seek to build its portfolio in a defensive manner that minimizes cyclical and correlated risks across individual names and sector verticals by targeting companies with strong underlying business models and durable intrinsic value.

The Fund will primarily hold secured loans, which encompass traditional first lien, uni-trancheunitranche and second lien loans, but may also invest in mezzanine, structured preferred stock andnon-control equityco-investment opportunities. WeThe Fund will seek to deliver attractive risk adjusted returns with lower volatility and low correlation relative to the public credit markets. The Adviser believes ourthe Fund’s flexibility to invest across the capital structure and liquidity spectrum will allow usthe Fund to optimize investor risk-adjusted returns.

Expenses

Expenses for the three and nine months ended September 30, 2017 were as follows:

Expenses for the three and nine months ended September 30, 2017, were $1,002,147, which consisted of $467,647 in organizational and offering expenses, $149,000 in directors’ fees, and $385,500 in professional fees.

Pursuant to the Expense Support and Conditional Reimbursement Agreement, our Adviser provided expense support of $1,002,147, reducing our expenses to $0.00. See “Item 1. – Notes to Financial Statements – Note 3. Agreements and Related Party Transactions – Expense Support and Conditional Reimbursement Agreement.”

Organization and Offering Costs

As of September 30, 2017, the Adviser and its affiliates have incurred or expect to incur organizational costs of approximately $467,000 and offering costs of approximately $236,000 on behalf of the Fund.

Organization costs include, among other things, the cost of organizing as a Maryland corporation, including the cost of legal services, directors’ fees and other fees, including travel-related expenses, pertaining to our organization, all of which are expensed as incurred. Offering costs include, among other things, legal fees and other costs pertaining to the preparation of our private placement memorandum and other offering documents. Offering costs are being deferred and will be amortized on a straight line basis over aone-year period starting from September 29, 2017.

Pursuant to the Expense Support and Conditional Reimbursement Agreement, our Adviser provided expense support of $467,000 and $236,000 for our organizational costs and offering costs, respectively, reducing our organizational costs and offering costs to $0.00. See “Item 1. – Notes to Financial Statements – Note 3. Agreements and Related Party Transactions – Expense Support and Conditional Reimbursement Agreement.”

Operating Expenses

Under the Second Amended and Restated Advisory Agreement, ourthe Fund’s primary operating expenses will include the payment of fees to the Adviser, ourthe Fund’s allocable portion of overhead expenses under the Expense Reimbursement Agreement (as defined below) and other operating costs described below. We bearThe Fund bears all otherout-of-pocket costs and expenses of ourthe Fund’s operations and transactions, including those relating to:

 

reasonable and documented organization and offering expenses to the extent reimbursement of such expenses is included in any future agreement with the Adviser;

 

calculating ourthe Fund’s net asset value (including the cost and expenses of any independent valuation firm);

 

fees and expenses payable to third parties, including agents, consultants or other advisers, in connection with monitoring financial (including advising with respect to ourthe Fund’s financing strategy) and legal affairs for usthe Fund and in providing administrative services, monitoring ourthe Fund’s investments and performing due diligence on ourthe Fund’s prospective portfolio companies or otherwise relating to, or associated with, evaluating and making investments;

 

interest payable on debt, if any, incurred to finance ourthe Fund’s investments;

 

sales and purchases of ourthe Fund’s common stock and other securities;

 

base management fees and incentive fees payable to the Adviser;

 

transfer agent and custodial fees;

��

federal and state registration fees;

all costs of registration and listing ourthe Fund’s securities on any securities exchange;

 

61


U.S. federal, state and local taxes;

 

independent directors’ fees and expenses;

 

costs of preparing and filing reports or other documents required by the SEC, the Financial Industry Regulatory Authority or other regulators;

 

costs of any reports, proxy statements or other notices to stockholders, including printing costs;

 

our

the Fund’s allocable portion of any fidelity bond, directors’ and officers’ errors and omissions liability insurance, and any other insurance premiums;

 

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

marketing expenses; and

all other expenses incurred by us,the Fund, the Administrator or the Adviser in connection with administering ourthe Fund’s business, including payments under the Administration Agreement and payments under the Expense Reimbursement Agreement based on ourthe Fund’s allocable portion of the Adviser’s overhead in performing its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of ourthe Fund’s Chief Compliance Officer and Chief Financial Officer and their respective staffs.

Activity

The following table presents certain information regarding the Fund’s portfolio and investment activity:

   For the Three
Months Ended
June 30, 2023
  For the Three
Months Ended
June 30, 2022
  For the Six
Months Ended
June 30, 2023
  For the Six
Months Ended
June 30, 2022
 

Investments in Portfolio Companies

  $(68,793,108)(1)  $(123,608,819)(2)  $(106,811,642)(3)  $(197,870,999)(4) 

Draw Downs against Revolvers and Delayed Draw Term Loans

   (21,135,064  (23,272,355  (44,664,115  (37,236,931

Principal Repayments

   33,136,130(5)   63,752,273(6)   47,322,894(7)   91,237,994(8) 

Sales

   918,035   4,962,265   918,035   7,349,882 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net Repayments (Investments)

  $(55,874,007 $(78,166,636 $(103,234,828 $(136,520,054
  

 

 

  

 

 

  

 

 

  

 

 

 

(1)

Includes investments in 13 portfolio companies.

(2)

Includes investments in 20 portfolio companies.

(3)

Includes investments in 31 portfolio companies.

(4)

Includes investments in 42 portfolio companies.

(5)

Includes $4,769,334 in revolver and delayed draw term payments.

(6)

Includes $4,250,192 in revolver and delayed draw term payments.

(7)

Includes $8,186,322 in revolver and delayed draw term payments.

(8)

Includes $5,949,439 in revolver and delayed draw term payments.

The following table shows the composition of the investment portfolio and associated yield data as of June 30, 2023:

   As of June 30, 2023 
   Amortized Cost   Percentage of
Total
  Fair Value   Percentage of
Total
  Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

  $1,222,867,467    91.94 $1,190,640,160    91.33  10.99

Second Lien Junior Secured Debt

   10,788,331    0.81   10,435,717    0.80   13.56

Preferred Stock

   7,253,950    0.55   9,767,046    0.74   —   

Common Stock

   7,511,429    0.56   8,427,993    0.65   —   

Investment Companies

   5,196,692    0.39   6,914,124    0.53   —   

Warrants

   343,936    0.03   1,387,812    0.11   —   

Cash and cash equivalents

   76,104,236    5.72   76,104,236    5.84   —   
  

 

 

   

 

 

  

 

 

   

 

 

  

Total

  $1,330,066,041   100 $1,303,677,088    100% 
  

 

 

   

 

 

  

 

 

   

 

 

  

(1)

Based upon the par value of the Fund’s debt investments.

62


The following table shows the composition of the investment portfolio and associated yield data as of December 31, 2022:

   As of December 31, 2022 
   Amortized Cost   Percentage of
Total
  Fair Value   Percentage of
Total
  Weighted
Average
Yield(1)
 

First Lien Senior Secured Debt

  $1,115,667,642    93.36 $1,088,190,382    92.90  10.44

Second Lien Junior Secured Debt

   10,776,359    0.90   10,640,036    0.91   12.76

Preferred Stock

   8,168,876    0.69   9,218,222    0.79   —   

Common Stock

   7,179,288    0.60   7,870,756    0.67   —   

Investment Companies

   4,095,163    0.34   5,603,604    0.48   —   

Warrants

   343,936    0.03   994,095    0.08   —   

Cash and cash equivalents

   48,785,985    4.08   48,785,985    4.17   —   
  

 

 

   

 

 

  

 

 

   

 

 

  

Total

  $1,195,017,249    100 $1,171,303,080    100 
  

 

 

   

 

 

  

 

 

   

 

 

  

(1)

Based upon the par value of the Fund’s debt investments.

The following table presents certain selected financial information regarding the debt investments in the Fund’s portfolio as of June 30, 2023 and December 31, 2022:

   As of
June 30, 2023
  As of
December 31, 2022
 

Number of portfolio companies

   195   179 

Percentage of debt bearing a floating rate(1)

   100  100

Percentage of debt bearing a fixed rate(1)

   0  0

(1)

Measured on a fair value basis and excluding equity securities.

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of June 30, 2023:

   As of June 30, 2023 
   Amortized Cost   Percentage at
Amortized Cost
  Fair Value   Percentage at
Fair Value
 

Performing

  $1,210,639,244    98.13 $1,197,451,703   99.70

Non-accrual

   23,016,554    1.87  3,624,174    0.30
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $1,233,655,798   100.00 $1,201,075,877   100.00
  

 

 

   

 

 

  

 

 

   

 

 

 

The following table shows the amortized cost and fair value of the Fund’s performing and non-accrual debt investments as of December 31, 2022:

   As of December 31, 2022 
   Amortized Cost   Percentage at
Amortized Cost
  Fair Value   Percentage at
Fair Value
 

Performing

  $1,115,420,688    99.02 $1,095,916,015    99.73

Non-accrual

   11,023,313    0.98   2,914,403    0.27 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $1,126,444,001    100 $1,098,830,418    100
  

 

 

   

 

 

  

 

 

   

 

 

 

Generally, when interest and/or principal payments on a loan become past due, or if the Fund otherwise does not expect the borrower to be able to service its debt and other obligations, the Fund will place the loan on non-accrual status and will cease recognizing interest income on that loan for financial reporting purposes until all principal and interest have been brought current through payment or due to restructuring such that the interest income is deemed to be collectible. The Fund generally restores non-accrual loans to accrual status when past due principal and interest is paid and, in the management’s judgment, is likely to remain current. As of June 30, 2023 the Fund had fourteen investments, across four issuers, that were on non-accrual status. As of December 31, 2022, the Fund had seven investments, with three issuers that were on non-accrual status.

63


The following tables show the composition of the investment portfolio (excluding cash and cash equivalents) by industry, at amortized cost and fair value as of June 30, 2023 and December 31, 2022 (with corresponding percentage of total portfolio investments):

   As of June 30, 2023 
  Amortized Cost   Percentage of
Total
  Fair Value   Percentage of
Total
 

Business Services

  $93,512,976    7.46 $93,191,224    7.60

Consumer Discretionary

   321,309    0.03   253,510    0.02 

Consumer Non-Cyclical

   55,430,009    4.42   54,205,225    4.42 

Digital Infrastructure & Services

   203,995,598    16.27   201,837,520    16.44 

Energy

   3,469,755    0.28   3,769,548    0.31 

Financials

   50,859,495    4.06   49,896,555    4.06 

Healthcare & HCIT

   247,092,037    19.70   225,990,771    18.41 

Investment Companies

   5,196,692    0.41   6,914,124    0.56 

Software & Tech Services

   590,036,789    47.05   590,367,559    48.09 

Transport & Logistics

   4,047,145    0.32   1,146,816    0.09 
  

 

 

   

 

 

  

 

 

   

 

 

 
  $1,253,961,805    100 $1,227,572,852    100
  

 

 

   

 

 

  

 

 

   

 

 

 

   As of December 31, 2022 
  Amortized Cost   Percentage of
Total
  Fair Value   Percentage of
Total
 

Business Services

  $84,074,984    7.33 $83,153,924    7.41

Consumer Discretionary

   9,111,762    0.79   9,163,275    0.82 

Consumer Non-Cyclical

   52,130,891    4.55   49,936,678    4.45 

Digital Infrastructure & Services

   189,702,392    16.55   186,488,258    16.61 

Energy

   3,640,277    0.32   3,857,859    0.34 

Financial Services

   44,747,532    3.90   43,871,366    3.91 

Healthcare & HCIT

   231,062,290    20.16   217,504,759    19.38 

Investment Companies

   4,095,163    0.36   5,603,604    0.50 

Software & Tech Services

   523,456,373    45.67   521,545,397    46.46 

Transport & Logistics

   4,209,600    0.37   1,391,975    0.12 
  

 

 

   

 

 

  

 

 

   

 

 

 
  $1,146,231,264    100 $1,122,517,095    100
  

 

 

   

 

 

  

 

 

   

 

 

 

The Adviser monitors the Fund’s portfolio companies on an ongoing basis. It monitors the financial trends of each portfolio company to determine if they are meeting their respective business plans and to assess the appropriate course of action for each company. The Adviser has several methods of evaluating and monitoring the performance and fair value of the Fund’s investments, which may include the following:

assessment of success in adhering to the portfolio company’s business plan and compliance with covenants;

periodic or regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor to discuss financial position, requirements and accomplishments;

comparisons to the Fund’s other portfolio companies in the industry, if any;

attendance at and participation in board meetings or presentations by portfolio companies; and

review of monthly and quarterly consolidated financial statements and financial projections of portfolio companies.

64


Results of Operations

The following is a summary of the Fund’s operating results for the three and six months ended June 30, 2023 and June 30, 2022:

   For the
Three Months
Ended
June 30, 2023
   For the
Three Months
Ended
June 30, 2022
   For the
Six Months
Ended
June 30, 2023
   For the
Six Months
Ended
June 30, 2022
 

Total investment income

  $36,287,203   $19,936,570   $69,131,994   $39,624,007 

Total expenses

   25,651,098    12,434,969    47,456,742    24,049,007 
  

 

 

   

 

 

   

 

 

   

 

 

 

Reimbursement payments to Adviser

   —      —      —      259,263 

Waived collateral management fees

   —      (131,978   —      (588,476

Waived management fees

   —      —      —      (283,566
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income before taxes

   10,636,105    7,633,579    21,675,252    16,187,779 

Income tax expense, including excise tax

   260,725    258,256    278,026    567,083 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income after tax

   10,375,380    7,375,323    21,397,226    15,620,696 

Net realized and change in unrealized appreciation (depreciation) on investments

   (7,501,047   (1,186,520   (2,973,182   (3,920,183
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in net assets resulting from operations

   2,874,333    6,188,803    18,424,044    11,700,513 

Less: Net increase (decrease) in net assets resulting from operations related to Non-Controlling Interest in ABPCIC Equity Holdings, LLC

   516    4,545    1,639    4,555 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations related to AB Private Credit Investors Corporation

  $2,873,817   $6,184,258   $18,422,405   $11,695,958 
  

 

 

   

 

 

   

 

 

   

 

 

 

Investment Income

During the three months ended June 30, 2023, the Fund’s investment income was comprised of $35,269,067 of interest income, which includes $1,713,508 from the net amortization of premium and accretion of discounts, $662,830 of payment-in-kind interest, and $355,306 of dividend income. During the three months ended June 30, 2022, the Fund’s investment income was comprised of $19,314,117 of interest income, which includes $1,919,206 of the net amortization of premium and accretion of discounts, $605,426 of payment-in-kind interest, and $17,027 of dividend income. The increase in net investment income during the three months ended June 30, 2023, compared to the three months ended June 30, 2022, can primarily be attributed to an increase in gross assets and interest rates.

During the six months ended June 30, 2023, the Fund’s investment income was comprised of $67,028,005 of interest income, which includes $3,097,880 from the net amortization of premium and accretion of discounts, and $1,696,231 of payment-in-kind interest, and $407,758 of dividend income. During the six months ended June 30, 2022, the Fund’s investment income was comprised of $38,398,568 of interest income, which includes $3,309,963 of the net amortization of premium and accretion of discounts, $1,199,825 of payment-in-kind interest, and $25,614 of dividend income. The increase in net investment income during the six months ended June 30, 2023, compared to the six months ended June 30, 2022, can primarily be attributed to an increase in gross assets and interest rates.

65


Operating Expenses

The following is a summary of the Fund’s operating expenses for the three and six months ended June 30, 2023 and June 30, 2022:

   For the
Three Months
Ended
June 30, 2023
   For the
Three Months
Ended
June 30, 2022
   For the
Six Months
Ended
June 30, 2023
   For the
Six Months
Ended
June 30, 2022
 

Interest and borrowing expenses

  $17,260,122   $7,046,218   $31,041,782   $12,187,003 

Management fees

   4,204,038    3,391,227    8,142,942    6,794,019 

Income-based incentive fee

   2,600,473    951,206    5,355,077    2,883,145 

Professional fees

   681,896    339,678    1,197,209    816,658 

Collateral management fees

   —        131,978    —      588,476 

Administration and custodian fees

   294,109    245,103    558,564    468,340 

Insurance expenses

   135,986    155,509    271,972    308,748 

Directors’ fees

   69,875    50,000    139,750    100,000 

Transfer agent fees

   36,215    29,841    71,487    55,517 

Capital gains incentive fee

   —      (237,304   —      (784,037

Other expenses

   368,384    331,513    677,959    631,138 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

   25,651,098    12,434,969    47,456,742    24,049,007 

Reimbursement payments to Adviser

   —      —      —      259,263 

Waived collateral management fees

   —      (131,978   —      (588,476

Waived management fees

   —      —      —      (283,566

Income tax expense, including excise tax

   260,725    258,256    278,026    567,083 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

  $25,911,823   $12,561,247   $47,734,768   $24,003,311 
  

 

 

   

 

 

   

 

 

   

 

 

 

Interest and Borrowing Expenses

Interest and borrowing expenses include interest, amortization of debt issuance and deferred financing costs, upfront commitment fees and unused fees on the unused portion of the Revolving Credit Facilities, Secured Borrowings and the Notes issued in the CLO Transaction. As of June 30, 2023, there were outstanding balances of $0, $200,000,000 and $53,400,000 on the 2021 HSBC Credit Facility, Synovus Credit Facility and the Natixis Credit Facility, respectively, and an outstanding balance of $0 in Secured Borrowings.

As of December 31, 2022, there were outstanding balances of $0, $180,000,000, and $268,000,000 on the 2021 HSBC Credit Facility, Synovus Credit Facility, and the 2021 Natixis Credit Facility, respectively, and an outstanding balance of $5,917,275 in Secured Borrowings.

The outstanding amount on the Notes is $541,941,323 net of unamortized discount and debt issuance costs as of June 30, 2023. The outstanding amount on the Notes was $245,105,567 net of unamortized discount and debt issuance costs as of December 31, 2022.

Interest and borrowing expenses for the three months ended June 30, 2023 and June 30, 2022 were $17,260,122 and $7,046,218, respectively. The weighted average interest rate (excluding deferred upfront financing costs and unused fees) on the Fund’s debt outstanding was 7.74% and 3.37% for the three months ended June 30, 2023 and June 30, 2022, respectively. The increase in interest and borrowing expenses during the three months ended June 30, 2023 compared to the three months ended June 30, 2022 can primarily be attributed to an increase in debt outstanding and interest rates.

Interest and borrowing expenses for the six months ended June 30, 2023 and June 30, 2022 were $31,041,782 and $12,187,003, respectively. The weighted average interest rate (excluding deferred upfront financing costs and unused fees) on the Fund’s debt outstanding was 7.50% and 3.03% for the six months ended June 30, 2023 and June 30, 2022, respectively. The increase in interest and borrowing expenses during the six months ended June 30, 2023 compared to the six months ended June 30, 2022 can primarily be attributed to an increase in debt outstanding and interest rates.

66


Management Fee

The gross management fee expenses for the three months ended June 30, 2023 and June 30, 2022 were $4,204,038 and $3,391,227, respectively. The increase in the management fee for the three months ended June 30, 2023 was a result of the increase in average gross assets during this period, which are the basis used to calculate management fees.

The gross management fee expenses for the six months ended June 30, 2023 and June 30, 2022 were $8,142,942 and $6,794,019, respectively. The increase in the management fee for the six months ended June 30, 2023 was a result of the increase in average gross assets during this period, which are the basis used to calculate management fees. For the six months ended June 30, 2023 and June 30, 2022, the Adviser waived management fees of $0 and $283,566, respectively.

Fund Expenses

For the three months ended June 30, 2023, the Fund incurred $25,651,098 of expenses in relation to interest and borrowing expenses, management fees, incentive fees, professional fees, administration and custodian fees, insurance expenses, directors’ fees, and other expenses. The Fund incurred $260,725 of tax expense.

For the three months ended June 30, 2022, the Fund incurred $12,434,969 of expenses in relation to interest and borrowing expenses, management fees, incentive fees, professional fees, administration and custodian fees, insurance expenses, directors’ fees, collateral management fees, transfer agent fees, and other expenses. Further, $131,978 of collateral management fees were waived by the Adviser. The Fund incurred $258,256 of tax expense.

For the six months ended June 30, 2023, the Fund incurred $47,456,742 of expenses in relation to interest and borrowing expenses, management fees, incentive fees, professional fees, administration and custodian fees, insurance expenses, directors’ fees, transfer agent fees, and other expenses. The Fund incurred $278,026 of tax expense.

For the six months ended June 30, 2022, the Fund incurred $24,049,007 of expenses in relation to interest and borrowing expenses, management fees, incentive fees, professional fees, administration and custodian fees, insurance expenses, directors’ fees, collateral management fees, transfer agent fees, and other expenses. Additionally, $259,263 was reimbursed by the Fund to the Adviser and its affiliates. Further, $283,566 of management fees and $588,476 of collateral management fees were waived by the Adviser. The Fund incurred $567,083 of tax expense.

Net Realized Gain (Loss) on Investments

During the three months ended June 30, 2023, the Fund had principal repayments and sales which resulted in $303,851 of net realized loss. During the six months ended June 30, 2023, the Fund had principal repayments and sales which resulted in $298,398 of net realized loss.

During the three months ended June 30, 2022, the Fund had principal repayments and sales which resulted in $644,621 of net realized gain. During the six months ended June 30, 2022, the Fund had principal repayments and sales which resulted in $816,953 of net realized gain.

Net Change in Unrealized Appreciation (Depreciation) on Investments

During the three months ended June 30, 2023, the Fund had $7,197,196 in net change in unrealized depreciation on $1,253,961,805 of investments in 195 portfolio companies. Unrealized depreciation for the three months ended June 30, 2023, resulted from an decrease in fair value, primarily due to negative valuation adjustments on level 3 securities.

During the three months ended June 30, 2022, the Fund had $1,831,141 in net change in unrealized depreciation on $1,027,727,319 of investments in 178 portfolio companies. Net change in unrealized depreciation for the three months ended June 30, 2022, resulted from a broad portfolio decline due to a decline in loan market secondary prices and widening primary issue credit spreads. This depreciation was partially offset by gains on debt and equity positions marked up due to company performance or expectation of near-term repayment at par.

During the six months ended June 30, 2023, the Fund had $2,674,784 in net change in unrealized depreciation on $1,253,961,805 of investments in 195 portfolio companies. Net change in unrealized depreciation for the six months ended June 30, 2023, resulted from a decrease in fair value, primarily due to negative valuation adjustments on debt securities, which were slightly offset by positive valuation adjustments on equity securities.

67


During the six months ended June 30, 2022, the Fund had $4,737,136 in net change in unrealized depreciation on $1,027,727,319 of investments in 178 portfolio companies. Net change in unrealized depreciation for the six months ended June 30, 2022, resulted from a broad portfolio decline due to a decline in loan market secondary prices and widening primary issue credit spreads as well as a reclass of prior unrealized gain to investment income from a large prepayment fee on one investment. This depreciation was partially offset by gains on debt and equity positions marked up due to company performance or expectation of near-term repayment at par.

Net Increase (Decrease) in Net Assets Resulting from Operations

For the three months ended June 30, 2023 and 2022, the net increase in net assets resulting from operations was $2,874,333 and $6,188,803, respectively. Based on the weighted average shares of common stock outstanding for the three months ended June 30, 2023 and 2022, the Fund’s per share net increase in net assets resulting from operations was $0.06 and $0.15, respectively.

For the six months ended June 30, 2023 and 2022, the net increase in net assets resulting from operations was $18,424,044 and $11,700,513, respectively. Based on the weighted average shares of common stock outstanding for the six months ended June 30, 2023 and 2022, the Fund’s per share net increase in net assets resulting from operations was $0.36 and $0.30, respectively.

Cash Flows

For the six months ended June 30, 2023, cash increased by $27,318,251. During the same period, the Fund used $71,685,716 in operating activities, primarily as a result of net purchases of investments. During the six months ended June 30, 2023, the Fund generated $99,003,967 from financing activities, primarily from issuance of common stock and issuance of new CLO Notes.

For the six months ended June 30, 2022, cash increased by $6,167,374. During the same period, the Fund used $133,305,815 in operating activities, primarily as a result of net purchases of investments. During the six months ended June 30, 2022, the Fund generated $139,473,189 from financing activities, primarily from issuance of common stock, net borrowings on the Revolving Credit Facilities and refinance of the CLO Notes.

Hedging

The Fund may enter into currency hedging contracts, interest rate hedging agreements such as futures, options, swaps and forward contracts, and credit hedging contracts, such as credit default swaps. However, no assurance can be given that such hedging transactions will be entered into or, if they are, that they will be effective. For the six months ended June 30, 2023 and June 30, 2022, the Fund did not enter into any hedging contracts.

Financial Condition, Liquidity and Capital Resources

We expectAs of June 30, 2023, and December 31, 2022, the Fund had $76,104,236 and $48,785,985 in cash and cash equivalents, respectively. The Fund expects to generate cash primarily from (i) the net proceeds of the Private Offering, (ii) cash flows from ourthe Fund’s operations, (iii) any financing arrangements wenow existing or that the Fund may enter into in the future and (iv) any future offerings of ourthe Fund’s equity or debt securities. WeThe Fund may fund a portion of ourits investments through borrowings from banks, or other large global institutions such as insurance companies, and issuances of senior securities.

OurThe Fund’s primary use of funds from a credit facility will be investments in portfolio companies, cash distributions to holders of ourits common stock and the payment of operating expenses.

In the future, wethe Fund may also securitize or finance a portion of ourits investments with a special purpose vehicle. If we undertakethe Fund undertakes a securitization transaction, wethe Fund will consolidate ourits allocable portion of the debt of any securitization subsidiary on ourits financial statements, and include such debt in ourthe Fund’s calculation of the asset coverage test, if and to the extent required pursuant to the guidance of the staff of the SEC.

Cash and cash equivalents as of SeptemberJune 30, 2017,2023, taken together with ourthe Fund’s uncalled Capital Commitments of $70,928,060,$88,163,879 and $31,000,000 undrawn amount on the 2021 HSBC Credit Facility and $146,600,000 undrawn amount on the Natixis Credit Facility, is expected to be sufficient for ourthe Fund’s investing activities and to conduct ourthe Fund’s operations for at least the next twelve months.

68


As of June 30, 2023, the Fund has unfunded commitments to fund future investments in the near term. Asamount of September 30, 2017, we had $25,000$172,834,987, and contractual obligations in cashthe form of Revolving Credit Facilities of $253,400,000 and cash equivalents. During the nine months ended September 30, 2017, we used no cash for operating activities, as theNotes of $541,941,323.

Equity Activity

The Fund had not yet begun investment activities.

Equity Activity

In connection with our formation, we havehas the authority to issue 200,000,000 sharesShares.

The Fund has entered into Subscription Agreements with investors providing for the private placement of common stock at a $0.01 per share par value.

On June 27, 2016, we issued 100 sharesShares. Under the terms of our common stockthe Subscription Agreements, investors are required to fund drawdowns to purchase Shares up to the Adviser, foramount of their respective Capital Commitments on an aggregate purchase priceas-needed basis upon the issuance of $1,000. On May 26, 2017, we issued 2,400 sharesa capital draw down notice. As of our common stockJune 30, 2023, the Fund received Capital Commitments of $611,970,154. Inception to June 30, 2023, the Fund received Capital Contributions to the Adviser,Fund of $523,806,275. Proceeds from the issuances of Shares in respect of drawdown notices described below were used for an aggregate purchase price of $24,000. We have not had anyinvesting activities and for other equity transactions as of September 30, 2017 and December 31, 2016.general corporate purposes.

Contractual Obligations

As of September 30, 2017 and December 31, 2016, we have not commenced operations.

We have entered into the Advisory AgreementConsistent with the AdviserFund’s offering documents, beginning with the quarter ending June 30, 2021, the Fund was required to begin conducting quarterly General Tenders. Pursuant to the General Tender Program, at the Board’s discretion and in accordance with the requirements of Rule 13e-4 under the Exchange Act and the 1940 Act. UnderAct, each stockholder is given the Advisory Agreement,opportunity to tender Shares at a specific Purchase Price based on the AdviserFund’s net asset value as of the last date of the quarter in which the General Tender is responsible for sourcing, reviewing and structuring investment opportunities for us, underwriting and conducting diligence on our investments and monitoring our investment portfolio on an ongoing basis. For these services, we will pay (i) a base management fee equalconducted. The Fund intends to conduct each General Tender to repurchase up to a certain percentage of the weighted average

outstanding assets of the number of Shares outstanding during the three-month period prior to the quarter in which the General Tender is conducted, as determined by the Board. The General Tender Program includes numerous restrictions that limit stockholders’ ability to sell their Shares.

On February 24, 2023, the Fund (which equalscommenced the gross value of equity and debt instruments, including investments made utilizing leverage), excluding cash and cash equivalents, during such fiscal quarter and (ii) an incentive fee based on our performance.Q1 2023 Tender Offer for up to 1,215,454 Shares. The cost of bothPurchase Price for the base management feeQ1 2023 Tender Offer was $9.30 per Share and the incentive fee will ultimately be borne by our stockholders. We have entered intoQ1 2023 Tender Offer expired on March 31, 2023. On May 26, 2023, the Administration Agreement withFund commenced the AdministratorQ2 2023 Tender Offer for up to 1,255,610 Shares. The Purchase Price for the Q2 2023 Tender Offer was $9.16 per Share and the Q2 2023 Tender Offer expired on June 30, 2023.

On February 25, 2022, the Fund commenced the Q1 2022 Tender Offer for up to 795,164 Shares. The Purchase Price for the Q1 2022 Tender Offer was $9.70 per Share and the Q1 2022 Tender Offer expired on March 31, 2022. On May 27, 2022, the Fund commenced the Q2 2022 Tender Offer for up to 911,141 Shares. The Purchase Price for the Q2 2022 Tender Offer was $9.70 per Share and the Q2 2022 Tender Offer expired on June 30, 2022.

Stockholders who tendered Shares in the Q1 2023 Tender Offer, Q2 2023 Tender Offer, Q1 2022 Tender Offer, and Q2 2022 Tender Offer received a separate expense reimbursement agreement withnon-interest bearing, non-transferable promissory note entitling such stockholders to an amount in cash equal to the Adviser (the “Expense Reimbursement Agreement”) under which any allocable portionnumber of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs will be reimbursedShares accepted for purchase multiplied by the Fund. Under the Administration Agreement, the Administrator will be responsible for providing us with clerical, bookkeeping, recordkeeping and other administrative services. We will reimburse the Adviser an amount equal to our allocable portion (subject to the review of our Board) of its overhead resulting from its obligations under the Expense Reimbursement Agreement, including the allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staffs. Stockholder approvalapplicable Purchase Price.

69


The following is not required to amend the Administration Agreement or the Expense Reimbursement Agreement.

If any of the contractual obligations discussed above are terminated, our costs under any new agreements that we enter into may increase. In addition, we would likely incur significant time and expense in locating alternative parties to provide the services we receive under the Advisory Agreement, the Administration Agreement and the Expense Reimbursement Agreement. Any new investment advisory agreement would also be subject to approval by our stockholders.

Expense Support and Conditional Reimbursement Agreement

On September 29, 2017, the Fund and the Adviser entered into an agreement (the “Expense Support and Conditional Reimbursement Agreement”) to limit certaina summary of the Fund’s Operating Expenses, as defined inequity activity for the Expense Supportthree and Conditional Reimbursement Agreement,six months ended June 30, 2023 and June 30, 2022.

   For the Three
Months
Ended
June 30, 2023
   For the Three
Months
Ended
June 30, 2022
   For the Six
Months
Ended
June 30, 2023
   For the Six
Months
Ended
June 30, 2022
 

Capital Commitments

  $23,027,241   $34,442,052   $49,576,874   $85,045,402 

Capital Commitments rescinded due to participation in General Tender Program

  $5,562,750   $8,565,065   $10,378,946   $15,680,265 

Dividend reinvestments

  $5,552,823   $3,500,728   $8,293,693   $8,602,432 

Shares issued to investors under DRIP

   606,230    360,978    900,384    887,141 

Value of capital drawdown notices

  $25,792,451   $56,263,228   $25,792,451   $86,947,228 

Shares issued to investors under capital drawdown notices

   2,776,754    5,759,395    2,776,754    8,854,641 

Value of Shares purchased in General Tender Program

  $4,225,901   $5,990,765   $10,063,894   $10,072,135 

Shares purchased in General Tender Offer

   461,364    617,738    1,088,882    1,038,602 

Distributions

Distributions to no more than 1.5% ofstockholders are recorded on the Fund’s average quarterly gross assets.record date. To achieve this percentage limitation, the Adviser has agreed to reimburse the Fund for certain Operating Expenses on a quarterly basis (any such payment by the Adviser, an (“Expense Payment”) andextent that the Fund has agreed to later repay such amounts (any such payment byincome available, the Fund a “Reimbursement Payment”), pursuantintends to the terms of the Expense Support and Conditional Reimbursement Agreement.distribute quarterly distributions to its stockholders. The actual percentage of Operating Expenses paid by the Fund in any quarter after deducting any Expense Payment, as a percentage of the Fund’s average quarterly gross assets, is referred to as the “Percentage Limit”).

Any Expense Payment by the Adviser pursuant to the Expense Support and Conditional Reimbursement Agreement will be subject to repayment by the Fund on a quarterly basis within the three years following the fiscal quarter of the Fund in which the Operating Expenses were paid or absorbed, if the total Operating Expenses for the current quarter, including Reimbursement Payments, expressed as a percentage of the Fund’s average gross assets during such quarter is less than the then-current Percentage Limit, if any, and the Percentage Limit that was in effect at the time when the Advisor reimbursed the Operating Expenses that are the subject of the repayment, subject to Sections 2(b) and 2(c) as applicable. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Operating Expenses” means the Fund’s Total Operating Expenses (as defined below), excluding base management fees, incentive fees, distribution and shareholder servicing fees, financing fees and costs, interest expense, brokerage commissions and extraordinary expenses, and “Total Operating Expenses” means all of the Fund’s operating costs and expenses incurred, as determined in accordance with generally accepted accounting principles for investment companies. The calculation of average net assets will be consistent with such periodic calculations of average net assets in the Fund’s financial statements.

However, no Reimbursement Payment for any quarter will be made if: (1) the Effective Rate of Distributions Per Share (as defined below) declared by the Fund at the time of such Reimbursement Payment is less than or equal to the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio at the time of such Reimbursement Payment is greater than or equal to the Operating Expense Ratio (as defined below) at the time the Expense Payment was made to which such Reimbursement Payment relates. For purposes of the Expense Support and Conditional Reimbursement Agreement, “Effective Rate of Distributions Per Share” means the annualized rate (based on a365-day year) of regular cash distributions, per share exclusive of returns of capital, distribution rate reductions due to distribution and shareholder fees, and declared special dividends or special distributions, if any. The “Operating Expense Ratio” is calculated by dividing Operating Expenses in any quarter by the Fund’s average net assets in such quarter.

The specific amount of expenses paid by the Adviser, if any, will be determined by the Board. Any distributions to the Fund’s stockholders will be declared out of assets legally available for distribution.

The following table summarizes distributions declared during the six months ended June 30, 2023:

Date Declared

  Record Date   Payment Date   Amount Per Share   Total Distributions 

March 29, 2023

   March 29, 2023    April 25, 2023   $0.10   $5,139,617 

June 28, 2023

   June 28, 2023    July 24, 2023   $0.20   $10,402,344 
      

 

 

   

 

 

 

Total distributions declared

      $0.30   $15,541,961 
      

 

 

   

 

 

 

The following table summarizes distributions declared during the six months ended June 30, 2022:

Date Declared

  Record Date   Payment Date   Amount Per Share   Total Distributions 

March 29, 2022

   March 29, 2022    April 28, 2022   $0.25   $9,709,845 

June 28, 2022

   June 28, 2022    July 27, 2022   $0.15   $6,590,492 
      

 

 

   

 

 

 

Total distributions declared

      $0.40   $16,300,337 
      

 

 

   

 

 

 

The federal income tax characterization of distributions declared and paid for the fiscal year will be determined at fiscal year-end based upon the end of each quarter. The Fund orFund’s investment company taxable income for the Adviser may terminatefull fiscal year and distributions paid during the Expense Support and Conditional Reimbursement Agreement at any time, with or without notice. The Expense Support and Conditional Reimbursement Agreement will automatically terminate infull year. For the event of (a) the terminationsix months ended June 30, 2023, all of the Investment Advisory Agreement,Fund’s distributions to stockholders were attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or (b)gains.

To the Boardextent the Fund’s taxable earnings fall below the total amount of the Fund makesits distributions paid for that fiscal year, a determination to dissolve or liquidate the Fund. Upon terminationportion of the Expense Support and Conditional Reimbursement Agreement, the Fund willthose distributions may be required to fund any Expense Payments, subjectdeemed a return of capital to the aforementioned requirements perFund’s stockholders for U.S. federal income tax purposes. Thus, the Expense Support and Conditional Reimbursement Agreement that have not been reimbursedsource of a distribution to stockholders may be the original capital invested by the Fund tostockholder rather than the Adviser.Fund’s income or gains.

For the quartersix months ended SeptemberJune 30, 2017, the Adviser’s Expense Payment amounted to $1,002,147. See “Item 1. – Notes to Financial Statements – Note 3. Agreements and Related Party Transactions – Expense Support and Conditional Reimbursement Agreement.”

Off-Balance Sheet Arrangements

We had nooff-balance sheet arrangements as of December 31, 2016.

As of September 30, 2017, we had $70,928,060 in total Capital Commitments from investors,2023, all of the Fund’s distributions to stockholders were attributable to ordinary income. The character of distributions for federal income tax purposes are determined in accordance with income tax regulations which were unfunded.may differ from GAAP. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is only ordinary income or gains.

70


Co-investment Exemptive Order

On October 11, 2016,August 6, 2018, the SEC granted usthe Fund relief sought in ana new exemptive application that expands our abilitythe co-investment exemptive relief previously granted to the Fund in October 2016 to allow the Fund to co-invest in portfolio companies with certain of our affiliates managed by the Adviser (“Affiliated Funds”)Funds in a manner consistent with ourits investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, subject to compliance with certain conditions (the “Order”).the Order. Pursuant to the Order, we arethe Fund is permitted toco-invest with Affiliated Funds, which the new exemptive relief defines to include affiliated managed accounts, if, among other things, a “required majority” (as defined in Section 57(o) of the 1940 Act) of ourthe Fund’s independent directors make certain conclusions in connection with aco-investment transaction, including that (1) the terms of the transactions, including the consideration to be paid, are reasonable and fair to usthe Fund and ourthe Fund’s stockholders and do not involve overreaching in respect of usthe Fund or ourthe Fund’s stockholders on the part of any person concerned, and (2) the transaction is consistent with the interests of ourthe Fund’s stockholders and is consistent with ourthe Fund’s investment objective and strategies. We intendThe Fund intends toco-invest with Affiliated Funds, subject to the conditions included in the Order.

Revolving Credit Facilities

2021 HSBC Credit Facility

On July 8, 2021, the Fund entered into the HSBC Joinder, pursuant to which the Fund became a party to the 2021 HSBC Credit Facility evidenced by the 2021 HSBC Credit Agreement. As of June 30, 2023, the Fund had $0 outstanding on the 2021 HSBC Credit Facility and the Fund was in compliance with the terms of the 2021 HSBC Credit Facility. As of December 31, 2022, the Fund had $0 outstanding on the 2021 HSBC Credit Facility and the Fund was in compliance with the terms of the 2021 HSBC Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Synovus Credit Facility

On October 15, 2020, ABPCIC Funding II entered into the Synovus Credit Facility. In connection with the Synovus Credit Facility, ABPCIC Funding II entered into, among other agreements, (i) the Synovus Loan Agreement, (ii) the securities account control agreement (the “Synovus Control Agreement”), by and among ABPCIC Funding II, the Synovus Collateral Agent and the Synovus Securities Intermediary and (iii) the amended and restated sale and contribution agreement (the “Synovus Transfer Agreement”) by and between the Fund, as seller, and ABPCIC Funding II, as purchaser.

Borrowings of ABPCIC Funding II are considered borrowings by the Fund for purposes of complying with the asset coverage requirements under the 1940 Act applicable to business development companies. As of June 30, 2023, the Fund had $200,000,000 outstanding on the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility. As of December 31, 2022, the Fud had $180,000,000 outstanding on the Synovus Credit Facility and the Fund was in compliance with the terms of the Synovus Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Natixis Credit Facility

On April 21, 2023, ABPCIC Funding IV entered into the Natixis Credit Facility. As of June 30, 2023, the Fund had $53,400,000 outstanding on the Natixis Credit Facility and the Fund was in compliance with the terms of the Natixis Credit Facility.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

2021 Natixis Credit Facility

On March 24, 2021, ABPCIC Funding III entered into the 2021 Natixis Credit Facility. As of June 30, 2023, the Fund had $0 outstanding on the Natixis Credit Facility. As of December 31, 2022, the Fund had $268,000,000 outstanding on the 2021 Natixis Credit Facility. The 2021 Natixis Credit Facility was terminated in connection with the ABPCIC Funding III Merger.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Secured Borrowings

From time to time, the Fund may engage in sale/buy-back agreements, which are a type of secured borrowing. The amount, interest rate and terms of these agreements will be individually negotiated on a transaction-by-transaction basis. Each borrowing is secured by an interest in an underlying asset which is participated or assigned to the sale/buy-back counterparty for the duration of the agreement.

Outstanding Secured Borrowings pursuant to the Macquarie Sale/Buy-Back was $0 and $5,917,275 as of June 30, 2023 and December 31, 2022, respectively.

71


For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Debt Securitization

On August 9, 2019, the VI Co-Issuers completed the CLO VI Transaction. On April 28, 2022, the CLO VI indenture was refinanced under terms of the first supplemental indenture among the VI Issuer and U.S. Bank National Association, as trustee. As a result of the refinancing, the outstanding notes (other than the Subordinated Notes) under the indenture dated August 9, 2019 in the amount of $246,900,000 were paid off, and the unamortized debt discount and debt issuance costs were accelerated into interest and borrowing expenses on the consolidated statements of operations (the “CLO VI Refinancing”). The CLO VI Refinancing was executed through a private placement of: (i) $98,250,000 of Class A-1-R Senior Secured Floating Rate Notes, which bear interest at Term SOFR plus 1.83% per annum; (ii) $75,000,000 of Class A-1L Senior Secured Floating Rate Loans, which bear interest at Term SOFR plus 1.83% per annum; (iii) $30,000,000 of Class A-1F Senior Secured Fixed Rate Notes, which bear interest at 4.305% per annum; (iv) $43,550,000 of Class A-2-R Senior Secured Floating Rate Notes, which bear interest at Term SOFR plus 2.25% per annum; (v) $19,250,000 of Class B-R Secured Deferrable Floating Rate Notes, which bear interest at Term SOFR plus 3.10% per annum; and (vi) $20,125,000 of Class C-R Secured Deferrable Floating Rate Notes, which bear interest at Term SOFR plus 4.15% per annum, as well as Subordinated Notes in the amount of $61,320,000. The VI Notes are scheduled to mature on April 27, 2034.

On May 3, 2023, the XIII Issuer Entities completed the CLO XIII Transaction. The CLO Transaction was executed through a private placement of: (i) $228,000,000 of Class A Senior Secured Floating Rate Notes, which bear interest at Term SOFR plus 2.60% per annum; (ii) $36,000,000 of Class B Senior Secured Floating Rate Notes, which bear interest at Term SOFR plus 3.65% per annum; (iii) $36,000,000 of Class C Secured Deferrable Floating Rate Notes, which bear interest at Term SOFR plus 4.55% per annum; (iv) $28,000,000 of Class D Secured Deferrable Floating Rate Notes, which bear interest at Term SOFR plus 6.90% per annum; and (v) $67,000,000 of subordinated notes. The XIII Notes are scheduled to mature on April 27, 2035.

The VI Notes are the secured obligations of the VI Co-Issuers, and the XIII Notes are the secured obligations of the XIII Issuer Entities. The indentures governing the VI Notes and the XIII Notes each include customary covenants and events of default. The VI Notes and the XIII Notes have not been, and will not be, registered under the Securities Act or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.

The Adviser serves as collateral manager to the VI Issuer and the XIII Issuer pursuant to the CLO VI Collateral Management Agreement and the CLO XIII Collateral Management Agreement, respectively. For so long as the Adviser serves as collateral manager to the VI Issuer, a collateral management fee shall not be charged under the CLO VI Collateral Management Agreement, and for so long as the Adviser serves as collateral manager to the XIII Issuer, a collateral management fee shall not be charged under the CLO XIII Collateral Management Agreement.

For further details, see “Note 4. Borrowings,” to the Fund’s consolidated financial statements.

Asset Coverage

In accordance with the 1940 Act, the Fund has historically only been allowed to borrow amounts such that its “asset coverage,” as defined in the 1940 Act, is at least 200% after such borrowing, permitting the Fund to borrow up to one dollar for investment purposes for every one dollar of investor equity. “Asset coverage” generally refers to a company’s total assets, less all liabilities and indebtedness not represented by “senior securities,” as defined in the 1940 Act, divided by total senior securities representing indebtedness and, if applicable, preferred stock. “Senior securities” for this purpose includes borrowings from banks or other lenders, debt securities and preferred stock.

On March 23, 2018, the SBCAA was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, at the Fund’s 2018 annual meeting of stockholders, the Fund’s stockholders approved the reduction of the required minimum asset coverage ratio applicable to the Fund from 200% to 150%, which took effect on September 27, 2018. This reduction in the required minimum asset coverage ratio increases the amount of debt that the Fund is permitted to incur, permitting the Fund to borrow up to two dollars for investment purposes for every one dollar of investor equity.

72


As of June 30, 2023, and December 31, 2022, the Fund had total senior securities of $800,150,000 and $700,313,290, respectively, consisting of borrowings under the Revolving Credit Facilities, secured borrowings and the Notes, and had asset coverage ratios of 160% and 165%, respectively.

Critical Accounting Policies

Valuation of Investments

We measureThe Fund measures the value of ourits investments at fair value accordance with Accounting Standards Codification Topic 820, Fair Value Measurements and Disclosure, or “ASC Topic 820,” issued by the Financial Accounting Standards Board, (“FASB”).or “FASB.” Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

Pursuant to the amended SEC Rule 2a-5 of the 1940 Act, the Board designated the Adviser as the Fund’s “valuation designee.” In this capacity, the Adviser is responsible, among other things, for making all fair value determinations relating to the Fund’s portfolio investments, subject to the Board’s oversight. Investments are valued at fair value as determined in good faith by our Adviser, as valuation designee, based on input of management, the audit committee and independent valuation firms that have been engaged to assist in the valuation of each portfolio investment without a readily available market quotation under a valuation policy. The Adviser principally carries out its fair value responsibilities through its Valuation Sub-Committee. This valuation process is conducted at the end of each fiscal quarter.

The audit committee of ourthe Board (the “Audit Committee’Committee”) is also responsible for assisting our Boardthe Adviser, as valuation designee in valuing investments that are not publicly traded or for which current market values are not readily available. Investments for which market quotations are readily available are valued using market quotations, which are generally obtained from independent pricing services, broker-dealers or market makers. With respect to portfolio investments for which market quotations are not readily available, our Board, with the assistance of the Adviser, as valuation designee and its senior investment team and independent valuation firms, is responsible for determining in good faith the fair value in accordance with the valuation policy approved by ourthe Board. If more than one valuation method is used to measure fair value, the results are evaluated and weighted, as appropriate, considering the reasonableness of the range indicated by those results. We considerThe Fund considers a range of fair values based upon the valuation techniques utilized and selectselects the value within that range that was most representative of fair value based on current market conditions as well as other factors the Adviser’s senior investment team considers relevant.

Our Board will make this fair value determination on a quarterly basis and any other time when a decision regarding the fair value of the portfolio investments is required. A determination of fair value involves subjective

judgments and estimates and depends on the facts and circumstances. Due to the inherent uncertainty of determining the fair value of portfolio investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

 

Level 1—Valuations are based on quoted1 – Quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.investments.

 

Level 2—Valuations are based on2 – Other significant observable inputs (including quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and model-based valuation techniques for which all significant inputs are observable.similar investments, interest rates, prepayment speeds, credit risk, etc.).

 

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Level 3 assets and liabilities include financial instruments whose value is determined using pricing models incorporating significant– Significant unobservable inputs such as discounted cash flow models and other similar valuations techniques. The valuation of Level 3 assets and liabilities generally requires significant management judgment due to(including the inability to observe inputs to valuation.

In certain cases, the inputs used to measure fair value may fall into different levels ofFund’s own assumptions in determining the fair value hierarchy. In such cases, an investment’sof investments at the reporting date).

The level withinin the fair value hierarchy within which the fair value measurement is basedcategorized in its entirety is determined on the basis of the lowest level of observable input that is significant to the fair value measurement in its entirety. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. The assessment ofIf a fair value measurement uses price data vendors or observable market price quotations, that measurement is a Level 2 measurement. Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, and considersconsidering factors specific to the investment.asset or liability.

Under ASC Topic 820,The determination of what constitutes “observable” requires significant judgment by the fair value measurement also assumesFund. The Fund considers observable data to be that the transaction to sell an asset occursmarket data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the principal market for the asset or, in the absence of a principal market, the most advantageous market for the asset, which may be a hypothetical market, and excludes transaction costs. The principal market for any asset is the market with the greatest volume and level of activity for such asset in which the reporting entity would or could sell or transfer the asset. In determining the principal market for an asset or liability under ASC Topic 820, it is assumed that the reporting entity has access to such market as of the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable and willing and able to transact.relevant market.

With respect to investments for which market quotations are not readily available, our Board will undertake a multi-step valuation process each quarter, as described below:

Our quarterly valuation process will begin with each portfolio company or investment being initially valued by the Adviser’s professionals that are responsible for the portfolio investment;

Preliminary valuation conclusions will then be documented and discussed with the Adviser’s senior investment team;

Our Audit Committee will then review these preliminary valuations;

At least once annually, the valuation for each portfolio investment will be reviewed by an independent valuation firm; and

Our Board will then discuss valuations and determine the fair value of each investment in our portfolio in good faith, based on the input of the Adviser, the respective independent valuation firms and the Audit Committee.

Because of the inherent uncertainty of valuation for all fair value investments and interests, the Board’s determination of fair value may differ from the values that would have been used had a ready market existed, or that could have been (or will be) realized in an actual sale, and such differences could be material.

73


The value of any investment on any valuation date is intended to represent the fair value of such investment on such date based upon the amount at which the investment could be exchanged between willing parties, other than in a forced liquidation sale, and reflects the Board’s determination of fair value using the methodology described herein. Any valuation of an investment may not reflect the actual amount received by the Fund upon the liquidation of such investment.

OurThe Fund’s investments will be primarily loans made to middle-market companies. These investments are mostly considered Level 3 assets under ASC Topic 820 because there is not usually a known or accessible market or market indices for these types of debt instruments and, thus, the Adviser’s senior investment team must estimate the fair value of these investment securities based on models utilizing unobservable inputs.

Security Transactions, Realized/Unrealized Gains or Losses, and Income Recognition

Security transactions are recorded on a trade-date basis. We measure realized gains or losses from the repayment or sale of investments using the specific identification method. The amortized cost basis of investments represents the original cost adjusted for the accretion/amortization of discounts and premiums and upfront loan origination fees. We report changes in fair value of investments that are measured at fair value as a component of net change in unrealized appreciation (depreciation) on investments in the statement of operations.

Interest income, adjusted for amortization of market premium and accretion of market discount, is recorded on an accrual basis to the extent that we expect to collect such amounts. Original issue discount, principally representing the estimated fair value of detachable equity or warrants obtained in conjunction with our debt investments, and market discount or premium are capitalized and accreted or amortized into interest income over the life of the respective security using the effective interest method. Loan origination fees received in connection with the closing of investments are reported as unearned income which is included as amortized cost of the investment; the unearned income from such fees is accreted over the contractual life of the loan based on the effective interest method. Upon prepayment of a loan or debt security, any prepayment penalties, unamortized loan origination fees, and unamortized market discounts are recorded as interest income.

Management and Incentive Fees

WeThe Fund will accrue for the base management fee and incentive fee. The accrual for the incentive fee includes the recognition of the incentive fee on unrealized capital gains, even though such incentive fee is neither earned nor payable to the Adviser until the gains are both realized and in excess of unrealized depreciation on investments. The amount of capital gains incentive fee expense related to the hypothetical liquidation of the portfolio (and assuming no other changes in realized or unrealized gains and losses) would only become payable to the Adviser in the event of a complete liquidation of the Fund’s portfolio as of period end and the termination of the Amended and Restated Advisory Agreement on such date. Also, it should be noted that the capital gains incentive fee expense fluctuates with the Fund’s overall investment results.

Federal Income Taxes

We intend to electThe Fund has elected to be treated, and intend to qualify annually, thereafter, as a RIC under Subchapter M of the Code as soon as practicable.Code. Generally, a RIC is not subject to federal income taxes on distributed income and gains if it distributes at least 90% of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. We intendThe Fund intends to distribute sufficient dividends to maintain ourits RIC status each year and we dothe Fund does not anticipate paying any material federal income taxes in the future.

Item 3.

Quantitative and Qualitative Disclosures aboutAbout Market Risk

As of September 30, 2017 and December 31, 2016, we had not commenced investment activities.

When investing commences, we will beThe Fund is subject to financial market risks, including changes in interest rates. To the extent that we borrowthe Fund borrows money to make investments, ourthe Fund’s net investment income will beis dependent upon the difference between the rate at which we borrowthe Fund borrows funds and the rate at which we investthe Fund invests these funds. In periods of rising interest rates, ourthe Fund’s cost of funds would increase, which may reduce ourthe Fund’s net investment income. Because we expectthe Fund expects that most of ourits investments will bear interest at floating rates, we anticipatethe Fund anticipates that an increase in interest rates would have a corresponding increase in ourthe Fund’s interest income that would likely offset any increase in ourthe Fund’s cost of funds and, thus, net investment income would not be reduced. However, there can be no assurance that a significant change in market interest rates will not have an adverse effect on ourthe Fund’s net investment income. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic and rising inflation, which has resulted in an increase in the level of volatility across such markets and a general decline in the value of the securities held by the Fund.

The Fund will generally invest in illiquid loans and securities including debt and equity securities of middle-market companies. Because the Fund expects that there will not be a readily available market for many of the investments in the Fund’s portfolio, the Fund expects to value many of its portfolio investments at fair value as determined in good faith by the Board using a documented valuation policy and a consistently applied valuation process. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund’s investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.

In connection with the COVID-19 pandemic and rising inflation, the U.S. Federal Reserve and other central banks have increased interest rates. A prolonged increase in interest rates could result in an increase in the Fund’s non-performing assets and a decrease in the value of its portfolio because the portfolio companies paying interest at such increasing floating rates may be unable to meet higher payment obligations. In periods of rising interest rates, the Fund’s cost of funds would increase, which, if not matched with the rising interest rates of its performing floating-rate assets, could result in a decrease in its net investment income. Incurring additional leverage will magnify the impact of an increase to the Fund’s cost of funds. A decrease in interest rates may reduce net income, because new investments may be made at lower rates despite the increased demand for the Fund’s capital that the decrease in interest rates may produce.

Assuming that the consolidated statement of assets and liabilities as of June 30, 2023, were to remain constant and that the Fund took no actions to alter its existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

74


Change in Interest Rates

  Increase (Decrease) in
Interest Income
   Increase (Decrease) in
Interest Expense
   Net Increase (Decrease) in
Net Investment Income
 

Down 25 basis points

  $(3,131,257  $(1,925,375  $(1,205,882

Up 100 basis points

   12,525,028    5,511,724    7,013,304 

Up 200 basis points

   25,050,056    15,403,000    9,647,056 

Up 300 basis points

   37,575,084    23,104,500    14,470,584 

The above outcomes are estimates based on models that use assumptions, and such assumptions may not hold true should any of the listed scenarios occur. The table should be read in conjunction with the “Forward-Looking Statements” section to this quarterly report.

In addition, although we dothe Fund does not currently intend to make investments that are denominated in a foreign currency, to the extent we do, weit does, the Fund will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved.

WeThe Fund may hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate usthe Fund against adverse changes in interest rates, they may also limit ourthe Fund’s ability to participate in benefits of lower interest rates with respect to ourthe Fund’s portfolio of investments with fixed interest rates.

 

Item 4.

Controls and Procedures

As of the end of the period covered by this report, wethe Fund carried out an evaluation, under the supervision and with the participation of ourthe Fund’s management, including our Presidentthe Fund’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of ourthe Fund’s disclosure controls and procedures (as defined in Rule13a-1513a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our Presidentthe Fund’s Chief Executive Officer and Chief Financial Officer have concluded that ourthe Fund’s current disclosure controls and procedures are effective in timely alerting them to material information relating to usthe Fund that is required to be disclosed by usthe Fund in the reports we fileit files or submitsubmits under the Exchange Act.

There have been no changes in ourthe Fund’s internal control over financial reporting that occurred during ourthe Fund’s most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, ourthe Fund’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

We areThe Fund is not currently subject to any material legal proceedings, nor, to ourthe Fund’s knowledge, is any material legal proceeding threatened against us.the Fund. From time to time, wethe Fund may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of ourthe Fund’s rights under contracts with ourits portfolio companies. OurThe Fund’s business is also subject to extensive regulation, which may result in regulatory proceedings against us.the Fund. While the outcome of these legal proceedings cannot be predicted with certainty, we dothe Fund does not expect that these proceedings will have a material effect upon ourits financial condition or results of operations.

 

Item 1A.

Risk Factors

As of SeptemberIn addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in the Fund’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which could materially affect the Fund’s business, financial condition and/or operating results. The risks described in the Fund’s Annual Report on Form 10-K are not the only risks the Fund faces. Additional risks and uncertainties that are not currently known to the Fund or that the Fund currently deems to be immaterial also may materially adversely affect the Fund’s business, financial condition and/or operating results. During the six months ended June 30, 2017,2023, there have been no material changes from the risk factors set forth in ourthe Fund’s Annual Report on Form10-K for the year ended December 31, 2016.2022, except for the following.

The Small Business Credit Availability Act allows the Fund to incur additional leverage, which may increase the risk of investing with the Fund.

On March 23, 2018, the SBCAA was signed into law. The SBCAA, among other things, modifies the applicable provisions of the 1940 Act to reduce the required asset coverage ratio applicable to BDCs from 200% to 150% subject to certain approval, time and disclosure requirements (including either stockholder approval or approval of a majority of the directors who are not interested persons of the BDC and who have no financial interest in the proposal). On July 5, 2018, the Board voted to approve the adoption of the reduced asset coverage ratio and separately recommended that Investors approve the reduced asset coverage requirements at the 2018 annual meeting of stockholders. On September 26, 2018, the Fund’s stockholders voted to approve the adoption of the reduced asset coverage ratio, effective September 27, 2018.

75


Increased leverage could increase the risks associated with investing in the Fund. For example, if the value of the Fund’s assets decreases, although the asset base and expected revenues would be larger because increased leverage would permit the Fund to acquire additional assets, leverage will cause the Fund’s net asset value to decline more sharply than it otherwise would have without leverage or with lower leverage. Similarly, any decrease in the Fund’s revenue would cause its net income to decline more sharply, on a relative basis, than it would have if the Fund had not borrowed or had borrowed less (although, as noted above, the Fund’s asset base and expected revenues would likely be larger). However, since the Fund already uses leverage in optimizing its investment portfolio, there are no material new risks associated with increased leverage other than the amount of the leverage.

If the Fund’s asset coverage ratio falls below the required limit, the Fund will not be able to incur additional debt until it is able to comply with the asset coverage ratio. This could have a material adverse effect on the Fund’s operations, and the Fund may not be able to make distributions to stockholders. The actual amount of leverage that the Fund employs will depend on the Board’s and the Adviser’s assessment of market and other factors at the time of any proposed borrowing. The Fund currently anticipates being able to obtain sufficient credit on acceptable terms, although the Fund can make no assurance that this will be the case or that it will remain such in the future.

The following table illustrates the effect of leverage on returns from an investment in the Shares assuming that the Fund employs leverage such that the Fund’s asset coverage equals (1) the Fund’s actual asset coverage as of June 30, 2023 and (2) 150%, each at various annual returns, net of expenses and as of June 30, 2023.

The calculations in the tables below are hypothetical, and are provided for illustrative purposes only. Actual returns may be higher or lower than those appearing below.

Assumed Return on the Fund’s Portfolio (net of expenses)

   (10.00)%   (5.00)%   0.00  5.00  10.00
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Corresponding net return to holders of common stock assuming actual asset coverage as of June 30, 2023(1)

   (41.6)%   (27.9)%   (14.3)%   (0.7)%   13.0

Corresponding net return to holders of common stock assuming 150% asset coverage(2)

   (46.6)%   (31.6)%   (16.6)%   (1.6)%   13.4
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

 

(1)

Assumes $1,320 million in total portfolio assets, $836 million in debt outstanding, $484 million in net assets, and an average cost of funds of 8.28%. Actual interest payments may be different.

(2)

Assumes $1,320 million in total portfolio assets, $880 million in debt outstanding, $440 million in net assets, and an average cost of funds of 8.28%. Actual interest payments may be different.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Except as previously reported by the Fund on its current reports on Form 8-K, the Fund did not sell any securities during the period covered by this Quarterly Report that were not registered under the Securities Act.

Item 3.

Defaults Upon Senior Securities

None.

 

Item 3.Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosure

Not applicable.

 

Item 5.

Other Information

Not applicable.During the three months ended June 30, 2023, no director or officer of the Fund adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as such terms are defined in paragraphs (a) and (c), respectively, of Item 408 of Regulation S-K promulgated under the Securities Act of 1933, as amended.

 

76


Item 6.

Exhibits

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

 

  3.1Articles of Incorporation(1)
  3.2Articles of Amendment(1)
  3.3Articles of Amendment and Restatement(3)
  3.4Bylaws(2)
10.1  Investment AdvisoryCredit Agreement, betweendated as of April 21, 2023, among ABPCIC Funding IV LLC, as borrower, the Fundlenders referred to therein, Natixis, New York Branch, as administrative agent and U.S. Bank Trust Company, National Association, as collateral agent and collateral administrator (incorporated by reference to Exhibit 10.1 to the Adviser, dated July 27, 2017(3)Fund’s Current Report on Form 8-K (File No. 814-01196) filed on April 24, 2023).
10.2  LicenseAccount Control Agreement, between the Funddated as of April 21, 2023, among ABPCIC Funding IV LLC, as debtor, U.S. Bank Trust Company, National Association, as collateral agent and the Adviser, dated August 14, 2017(3)secured party and U.S. Bank National Association, as securities intermediary (incorporated by reference to Exhibit 10.2 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on April 24, 2023).
10.3  Collateral Management Agreement, dated as of April 21, 2023, by and between ABPCIC Funding IV LLC, as borrower, and AB Private Credit Investors LLC, as collateral manager (incorporated by reference to Exhibit 10.3 to the Fund’s Current Report on Form of Subscription Agreement*8-K (File No. 814-01196) filed on April 24, 2023).
10.4  Expense ReimbursementCollateral Administration Agreement, dated August 14, 2017(3)as of April 21, 2023, among ABPCIC Funding IV LLC, AB Private Credit Investors LLC, as collateral manager, and U.S. Bank Trust Company, National Association, as collateral administrator (incorporated by reference to Exhibit 10.4 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on April 24, 2023).
10.5  AdministrationMaster Loan Sale and Contribution Agreement, dated September 29, 2017(4)as of April 21, 2023, by and between AB Private Credit Investors Corporation, as seller, and ABPCIC Funding IV LLC, as buyer (incorporated by reference to Exhibit 10.5 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on April 24, 2023).
10.6  Custodian Agreement,Indenture by and among ABPCI Direct Lending Fund CLO XIII Ltd, as issuer, ABPCI Direct Lending Fund CLO XIII First Static Subsidiary Ltd, as first static subsidiary, ABPCI Direct Lending Fund CLO XIII Second Static Subsidiary Ltd, as second static subsidiary, ABPCI Direct Lending Fund CLO XIII LLC, as co-issuer and U.S. Bank Trust Company, National Association, as trustee, dated September 29, 2017(4)as of May 3, 2023 (incorporated by reference to Exhibit 10.1 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on May 5, 2023).
10.7  Expense SupportAmended and Conditional ReimbursementRestated Loan Sale and Contribution Agreement by and among AB Private Credit Investors Corporation, as the Seller, ABPCI Direct Lending Fund CLO XIII Depositor LLC, as the Depositor, and ABPCI Direct Lending Fund CLO XIII Ltd, as the Buyer, dated September 29, 2017(4)as of May 3, 2023 (incorporated by reference to Exhibit 10.2 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on May 5, 2023).
10.8  Dividend Reinvestment Plan,Ninth Amendment to Revolving Credit Agreement, dated September 29, 2017(4)as of June 9, 2023, by and among AB-Abbott Private Equity Investors 2019 (Delaware) Fund L.P., AB-Abbott Private Equity Investors 2020 (Delaware) Fund L.P., AB-Abbott Private Equity Solutions 2021 (Delaware) Fund L.P., AB Private Credit Investors Middle Market Direct Lending Fund, L.P., AB Private Credit Investors Corporation, AB-Abbott Private Equity Solutions 2022 (Delaware) Fund L.P. and AB-Abbott Private Equity Solutions 2023 (Delaware) Fund L.P., as borrowers, AB-Abbott Private Equity Investors G.P. L.P., AB-Abbott Private Equity Investors 2020 G.P. L.P., AB-Abbott Private Equity Solutions 2021 G.P. L.P., AB Private Credit Investors Middle Market Direct Lending G.P. L.P., AB-Abbott Private Equity Solutions 2022 G.P. L.P. and AB-Abbott Private Equity Solutions 2023 G.P. L.P., as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC Bank USA, National Association as the administrative agent for the secured parties and a lender (incorporated by reference to Exhibit 10.1 to the Fund’s Current Report on Form 8-K (File No. 814-01196) filed on June 13, 2023).
31.1  Certification of Chief Executive Officer pursuant to Rule13a-14 of the Securities Exchange Act of 1934, as amended*amended.*
31.2  Certification of Chief Financial Officer pursuant to Rule13a-14 of the Securities Exchange Act of 1934, as amended*amended.*
32.1  Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*2002, as amended.*
32.2101.INS  Certification of Chief Financial Officer pursuant to Section 906 of XBRL Instance Document—the Sarbanes-Oxley Act of 2002*instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the XBRL document*
101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CALInline XBRL Taxonomy Calculation Linkbase Document*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
101.LABInline XBRL Taxonomy Label Linkbase Document*
101.PREInline XBRL Taxonomy Presentation Linkbase Document*
104Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)*

 

(1)*Previously filed as an exhibit to the Registration Statement on Form 10 (FileNo. 000-55640) filed with the SEC on April 8, 2016.

Filed herewith

(2)Previously filed as an exhibit to the Registration Statement on Form 10 (FileNo. 000-55640) filed with the SEC on July 1, 2016.
(3)Previously filed as an exhibit to the Fund’s quarterly report on Form10-Q (FileNo. 814-01196) filed with the SEC on August 14, 2017.
(4)Previously filed as an exhibit to the Fund’s current report on Form8-K (File No.814-01196 filed with the SEC on September 29, 2017.
*Filed herewith

77


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  

AB PRIVATE CREDIT INVESTORS CORPORATION

Date: November 13, 2017 August 14, 2023

 

By:

 

/s/ J. Brent Humphries

  J. Brent Humphries
  President and Chief Executive Officer
  (Principal Executive Officer)

Date: November 13, 2017August 14

, 2023

 

By:

 

/s/ Wesley Raper

  Wesley Raper
  Chief Financial Officer and Treasurer
  (Principal Financial and Accounting Officer)

78